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The field of optogenetics involves using light responsive proteins to regulate 
signaling events in order to probe cellular processes. Optogenetic tools are engineered based 
on naturally occurring photosensory proteins, and they have been shown to regulate 
biological processes such as ion channel activation, transcription, enzyme activity, signaling 
events, and many more. Scientists use these tools to harness the benefits of light, which 
offers superior spatial and temporal precision over traditional chemical means of control. In 
this thesis, I focus on using optogenetic tools to modulate protein function in subcellular 
compartments by regulating protein localization.  
It has been shown many times that a protein’s functional efficiency is directly 
connected to its microenvironment. By controlling protein localization using optogenetic 
tools, it is hypothesized that a protein’s function can be altered using light illumination. Two 
optogenetic approaches were taken in order to modulate function: first, using light we 
sequestered proteins out of the cytosol in order to block their function, and second, we 
facilitated redistribution of the proteins in the nucleus to specific locations to stimulate or 
block function with light.  
 iv	
To sequester proteins from their activity in the cytosol, we synthesized a protein tag 
with a engineered a short peroxisomal targeting sequence in the Jα-helix of the LOV domain, 
a blue light responsive photoreceptor. In the dark, the Jα-helix is docked to the core of the 
LOV domain but when it is illuminated the Jα-helix unwinds and reveals the peroxisomal 
targeting sequence triggering peroxisomal trafficking of tagged proteins. This optogenetic tag 
was fused to cytosolic GFP in order to mediate trafficking of GFP into peroxisomes with 
light. This novel tag can be used to reduce protein activity in the cytosol and also to explore 
components of peroxisomal trafficking, which can lead to life-threatening peroxisomal 
biogenesis disorders when trafficking goes awry. 
 After exploring regulation of cytosolic proteins, we switched our focus to nuclear 
protein regulation. The compartmental switch led us to discover that fusion of photoreceptor 
cryptochrome 2 (CRY2) to a dimeric transcription factor induces clearing of the fusion 
protein in the nucleus upon illumination. This clearing phenotype is associated with a 
significant reduction of transcriptional activity, allowing us to develop an optogenetic tool to 
abrogate transcription using light. Reducing the multimeric state of CRY2-fused transcription 
factors retains the protein in the nucleus. We deleted the dimerization motif of a Gal4 DNA 
binding domain fused to CRY2 and co-expressed it with an activation domain fused to CIB1. 
Illumination stimulates the interaction between CRY2 and CIB1 reconstituting a split Gal4 
transcription factor at the GalUAS promoter to activate transcription. Thus, with the 
developed CRY2 optogenetic tools described, illumination can reduce or activate 
transcription. 
The form and content of this abstract are approved. I recommend its publication. 
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Protein Function as it Relates to Localization 
 Eukaryotic cells are highly compartmentalized, with structural barriers that create 
functionally distinct regions of the cell. Each region has its own biochemical activities that 
require specific local environments for proteins to function optimally. Consequently, protein 
localization is critical for protein function, and when there is abnormal localization the 
protein may not function optimally. 
 Membrane bound organelles are one of the cellular barriers that create 
microenvironments within the cell. These endomembrane systems differ in their local 
environment in characteristics such as pH, substrate availability, protein concentration and 
diversity, and morphology. These factors lead to changes in protein function, for instance 
lysosomal acid hydrolases are inactive at neutral pH but are most effective at a pH of about 5, 
which is optimal due to the acidity of that specific organelle. Compartmentalization not only 
increases efficiency by providing the right conditions for proteins, but it also localizes 
proteins and substrates in the same microenvironment to enhance reactions. Organelle 
structures are not the only spatial regulation in the cell. Protein recruitment to specific 
subcellular locations can act similarly to membrane barriers, for example plasma membrane 
recruitment of AKT where it gets activated by membrane bound phosphoinositide-dependent 
kinases. These examples demonstrate how specificity and protein function are enhanced by 
spatial compartmentalization.   
1 A portion of this introduction is under review for a book chapter in Optogenetics: Spiltoir 
and Tucker © Wiley-VCH  
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Endomembrane systems provide a protein trafficking challenge to ensure proper localization 
after translation. The signal for localization of a protein is generally encoded in the protein’s 
sequence, but proteins can also be post-translationally modified to alter their localization. 
Peroxisomal proteins have specific sequences at their N- and C- termini to recruit import 
receptor proteins to shuttle them to the peroxisomal membrane for import where they stay. 
Transcription factors have been well characterized for their change in translocation between 
the cytosol and nucleus. External stimuli signal cytosolic transcription factors to translocate 
to the nucleus through processes such as dephosphorylation or phosphorylation events that 
unmask a nuclear localization signal or hide a nuclear export signal respectively. There are 
also examples of localization facilitated through anchoring to/release of cytoplasmic proteins 
and modulation of the nuclear import machinery to control transcription factors. The cell has 
established specific signals that allow proteins to traffic to the proper location and bypass the 
barriers of the cell. 
 The experiments in this thesis are set up to explore the regulation of a protein’s 
localization and distribution in order to modulate its function. Using optogenetics we aim to 
control trafficking of proteins from the cytosol into specific organelles, in our case 
peroxisomes, to sequester protein activity from the cytosol. We also aim to regulate 
transcription by developing optogenetic tools to regulate transcription factor localization in 
the nucleus. As we develop these novel systems I have also sought to characterize and 
understand the mechanism behind these new tools. 
Optogenetics Overview 
 Optogenetics is an innovative field of science that uses light to precisely regulate 
cellular processes. The field involves the use of naturally occurring photosensory proteins to 
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develop optogenetic tools allowing scientists to probe signaling pathways with 
spatiotemporal precision unmatched by chemical means of regulation. Due to the spatial 
precision in which light can be administered, subcellular regions can be independently 
stimulated teasing apart local effects of activation. With the reversible nature of photosensory 
proteins in conjunction with the ability to regulate light intensity and duration, the tools can 
provide a dose dependent and reversible means of control. Many of the early years of 
optogenetics focused on membrane bound ion-channel regulation. The first system used 
optogenetics to modulate a cation channel, channelrhodopsin2 (ChR2), from green algae 
Chlamydomonas reinhardtii in cell culture models (Nagel et al., 2003). The Tucker 
laboratory and many others have been developing new optogenetic tools in the recent decade 
using soluble protein domains that have opened possibilities for exploring global regions of 
the cell beyond membrane signaling.  
 Soluble optogenetic tools use photoreceptors in four broad but distinct modes: caging, 
association, dissociation, and oligomerization (Figure I-1). Caging has been used to mask 
peptides, enzyme, and other molecules within either a single domain (Figure I-1A) or 
between two photoreceptor domains (Figure I-1B). Dimerization is used to stimulate 
interactions (Figure I-1C) while dissociation is used to induce separation (Figure I-1D). 
Oligomerization, while similar to dimerization, is a more dramatic clustering involving many 
molecules (Figure I-1E). These unique exchanges are the basis of soluble optogenetic tools 
that will be discussed throughout this thesis. After this introduction, the history of 
optogenetics, considerations to make while designing optogenetic tools, photoreceptors 
available, and more specific methods of utilization will be discussed. 
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Figure I-1: Optogenetic modes of using natural properties of photosensory proteins. 
Caging can be obtained with a (A) single component or (B) dual component photoreceptor 
approach. (C) Dimerization requires two proteins to interact, but those can be two 
photoreceptors or a photoreceptor and it interacting partner. (D) Dissociation is the loss of 
interaction between two proteins and that can occur between homo- or hetero-interacting 















Single Domain Caging Dual Domain Caging
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History of Soluble Optogenetic Systems 
 In 2002 the first demonstration of using soluble photosensitive proteins was published 
by Peter Quail and colleagues showing the ability to regulate transcription with 
light(Shimizu-Sato et al., 2002). A transcription factor was split between the DNA binding 
domain and the activation domain and fused to a red light responsive phytochrome B (phyB) 
and PIF3 respectively. Upon red light illumination phyB and PIF3 interact reconstituting the 
split transcription factor and stimulating transcription. This system was shown to be 
reversible, as the phyB/PIF3 interaction can be released with far red light. This was an 
extremely innovative approach that demonstrated a dynamic range of 50-fold transcriptional 
activation after 30 minutes in a reversible manner, but there was a pitfall. PhyB has a 
necessary cofactor of a bilin chromophore, phycocyanobilin (PCB), which is not naturally 
found in non-plant cells. When added to the media, the yeast absorbed the PCB, but access 
and delivery of PCB would be a deterrent to using this system. 
 A lull over the next six years was broken when two groups independently used the 
phyB/PIF3 light dependent interaction to develop novel light inducible systems. While 
chemical dimerizers had been used to reconstitute split enzymes, Tyszkiewicz and Muir 
developed the first optogenetically regulated split enzyme using the phyB/PIF3 interaction to 
reconstitute a split vacuolar ATPase (VMA) intein enzyme in yeast (Tyszkiewicz and Muir, 
2008). Another group used the phyB/PIF3 interaction to explore actin assembly by recruiting 
a GDP-bound form of Rho family GTPase Cdc42 to Wiskott-Aldrich Syndrome Protein 
(WASP) stimulating actin assembly with light (Leung et al., 2008). These systems 
demonstrated reconstitution of split proteins and inducible protein recruitment to specific 
cellular locations and were the foundation upon which many optogenetic systems were built. 
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In 2009 a novel pair of light inducible dimerizers, phyB and PIF6, were used to 
bridge the gap into mammalian cells (Levskaya et al., 2009). This study was the first to 
demonstrate morphologic changes of the cell membrane in response to light.  Using the 
phyB/PIF6 interaction, catalytic domains of Guanine Nucleotide Exchange Factors (GEFs) 
were recruited to the plasma membrane stimulating lamellipodia and filopodia extensions. 
Levskaya et al. were able to show with spatial precision that they could cause these 
membrane disruptions at specific locations on the membrane by precise application of light, 
and the reaction was reversible with far-red light. As with the other phytochrome systems the 
cofactor bilin needed to be added which was a disadvantage to this tool.  
 Within the next several years, blue light-regulated systems were developed for 
optogenetic approaches, which because their cofactor is ubiquitously found in eukaryotes, 
overcame phytochrome’s limitation of necessary addition of exogenous cofactors. In addition 
to novel dimerization tools, optogenetic caging tools were established with the LOV domain. 
The caging property of the LOV domain uses structural changes to control access to small 
peptide sequences in light versus dark conditions. These novel blue light regulated tools 
included dimerization with FKF1/Gigantea (Yazawa et al., 2009), caging with AsLOV2 (Wu 
et al., 2009), and dimerization with cryptochrome 2(CRY2)/CIB1 (Kennedy et al., 2010). 
Because the photosensory proteins in these systems do not require a cofactor addition, tools 
developed with these tools translate more easily to eukaryotic models. 
 The past five years have seen exponential growth of new optogenetic modules based 
on growing, diverse set of LOV domains. These include LOV-based: TULIPs which used 
caging and dimerization (Strickland et al., 2012); SsrA/SspB dimerizers (Lungu et al., 2012), 
which were later optimized to develop iLIDs and other variants that explore kinetics (Guntas 
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et al., 2015; Zimmerman et al., 2016); VVD/VVD dimerizers (Chen et al., 2013), which 
homodimerize upon illumination; pMag/nMag, based on engineered heterodimers of VVD 
(Kawano et al., 2015); homodimerizing aureochrome-1 (Grusch et al., 2014); and EL222 
homodimerizers (Motta-Mena et al., 2014). Due to the natural diversity of LOV domains 
(Glantz et al., 2016) there are many options to explore when applying LOV photoreceptors to 
optogenetic tools. 
Photoreceptors with unique activation wavelengths have also been added to the 
optogenetic toolkit. The UVR8/COP1 light dependent interaction uses UV light to stimulate 
association (Crefcoeur et al., 2013). A new phytochrome dimerizing tool was developed  
from bacterial BphP1/PpsR2 that associates with far red light and dissociates with red light 
(Kaberniuk et al., 2016). In addition to the altered activation wavelengths differing from 
other phytochromes, this dimerization pair relies on biliverdin cofactor, which is more 
readily found in eukaryotic cells.  
Photoreceptors’ light inducible dissociation properties have also proven useful for 
studying signaling events during the past five years. UVR8 dimerizes in the dark and 
monomerizes upon UV illumination, and this photoreceptor was the first to use dissociation 
as a tool to trap proteins in a dimerized form and release them as monomers (Chen et al., 
2013). Shortly following, phyB/PIF6’s far-red triggered dissociation was utilized to regulate 
signaling in yeast (Yang et al., 2013). Dronpa is a photoswitchable fluorescent protein that 
tetramerizes in dark and monomerizes with light, and this dissociation has been used to 
uncage molecules sequestered between two Dronpa modules (Zhou et al., 2012). A LOV-
based dissociation tool, LOV-TRAP, was developed based on the strong dark interaction of  
 
	 8 
synthetic peptide, Zdark, with AsLOV2, and upon illumination this affinity is reduced 
allowing the diffusion of the Zdark peptide (Wang et al., 2016).  
CRY2 has low-level self-association in the dark, but upon illumination the protein 
oligomerizes. This light dependent homo-interaction has been utilized to regulate cellular 
events through clustering of fused proteins (Bugaj et al., 2013, 2015; Kim et al., 2014; Lee et 
al., 2014; Ozkan-Dagliyan et al., 2013; Wend et al., 2014). Optimizing on the homo-
interaction, in a randomized mutagenesis screen the Tucker laboratory found a light 
dependent enhanced oligomerization mutant, CRY2olig, that was able to disrupt cellular 
signaling (Taslimi et al., 2014). These oligomerization tools developed have proven 
efficatious for clustering proteins to stimulate and sequester their activity, demonstrating 
their diverse function. 
Considerations for Photoreceptors when Designing Optogenetic Tools 
 Each photosensory protein has unique characteristics that make it more or less ideal 
for specific utilizations. When developing an optogenetic tool one must consider the overall 
size, availability of potential cofactors, kinetic properties, and the wavelength of stimulation 
in order to create an optimal system. A substantial amount of engineering goes into each 
novel optogenetic tool, but making careful considerations when choosing a photoreceptor 
makes optimization more efficient.  
 Size can be a critical issue when considering engineering a soluble optogenetic tool 
because bulky tools can cause steric hindrance on small proteins and also the ability to 
dissociate throughout the cells can be obstructed by large protein tags. In addition, if a tool is 
going to be expressed in a model organism one way to deliver the tool is via viral packaging, 
which has a size limitation for synthesis of viral particles. This makes the small, yet versatile 
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LOV family of photoreceptors a popular choice for small protein tags, whereas the 
phytochrome and cryptochrome modules add more bulk to a tool.  
 Availability of cofactors is another consideration. Some photoreceptors use 
endogenous cofactors while others require exogenous cofactors to be added. The first 
systems developed used phytochromes which require tetrapyrrole chromophores, which are 
not found naturally in non-plant cells. New bacterial phytochromes that use biliverdin IXα 
have recently been developed as optogenetic photoreceptors. Biliverdin IXα is found in 
eukaryotic cells conferring the potential for red light sensitive photoreceptors to be used 
without exogenous cofactor addition (Kaberniuk et al., 2016). The blue light photoreceptors 
such as CRYs, BLUF domains, and the LOV domain family utilize cofactors endogenous to 
all organisms, positioning them to be used easily in any cell type. Other photoreceptors such 
as Dronpa and UVR8 are able to function without a cofactor making them ideal for universal 
use.   
 Kinetics are key considerations and cover rates of activation and reversibility. Each 
photoreceptor will eventually revert back to its dark state, but for some this is a fast process 
taking only seconds while others such as UVR8 can take over 8 hours. The phytochromes 
and Dronpa are distinct in their ability to be turned on and off with separate wavelengths 
giving them temporally the most precise control. Systems such as the LOV family have been 
well characterized to find mutations that can alter the on/off rates. This is one area in which 
the photosensory proteins can be mutated to change their properties to create an optimal tool, 
and the Tucker laboratory has been exploring mutations that alter the kinetics of CRY2 
(Taslimi et al., 2016). The rates of kinetics of each photoreceptor will determine the temporal 
precision a system can achieve.  
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 The photoreceptor’s wavelength of activation is especially important when frequent 
illumination must be used and when determining other fluorescent tags that may need to be 
detected. Certain wavelengths such as ultraviolet can have toxicity associated with exposure, 
so for longer illumination periods a longer wavelength is optimal. Another benefit of longer 
wavelengths, such as those that regulate red light photoreceptors, is the ability for the light to 
penetrate deeper into tissues of model organisms. Overall, the longer the wavelength the less 
harmless and the more penetrable, which is optimal. 
Soluble Optogenetic Photoreceptors 
 There are a growing number of photoreceptors that have been used for optogenetics, 
and each has its own individual characteristics. This section details the photoreceptors that 
have been used to date and gives insights into the benefits and pitfalls of each. Table I-1 
summarizes the characteristics of the photoreceptors used in optogenetic systems. The studies 
in this thesis use a combination of LOV and CRY2 based optogenetic tools, and thus they are 
described first. 
LOV-Domains 
Light-oxygen-voltage domains (LOV domains) are relatively small (~110 amino 
acid) blue light responsive proteins. There are a multitude of LOV-domain containing 
proteins found in the environment (Spencer T. Glantz et al., 2016), but only a few have been 
characterized for optogenetic usage. LOV domains are flavin-binding structural motifs that 
belong to the larger family of Period-ARNT-Singleminded (PAS) domain proteins. They 
bind Flavin mononucleotide (FMN) or flavin adenine dinucleotide (FAD) as a chromophore 
and show a peak absorbance at 450 nm (Zoltowski and Imaizumi, 2014). It acts to create 




and flavin (Moglich et al., 2010). The LOV domains that have been developed for 
optogenetic use are engineered from naturally occurring proteins, but often synthetic 
alterations have been made to change characteristics like kinetics and sensitivity. Below the 
differences between LOV variants AsLOV2, FKF1, Aureochrome-1, VVD and EL222 are 
described. 
AsLOV2 
This photoreceptor is currently the most widely utilized of LOV based photosensory 
proteins, likely due to its small size and fast kinetics. This domain is the second LOV domain 
from the phototropin 1 protein of Avena sativa (AsLOV2). It contains a PAS core that utilizes 
flavin mononucleotide (FMN) as a cofactor. Upon photoexcitation, a covalent bond is formed 
between the FMN isoalloxazine ring and a conserved cysteine residue of LOV2 (Christie et 
al., 2012; Salomon et al., 2000), this bond formation stimulates unwinding of a C-terminal 
Jα-helix that is docked to the protein in the dark state (Halavaty and Moffat, 2007; Harper et 
al., 2003). Structural changes within the Jα-helix have been utilized to cage peptide 
sequences in a light dependent manner (Wu et al., 2009). The peroxisomal trafficking tool 
detailed in Chapter II uses AsLOV2 properties to harness its caging abilities. 
 Multiple synthetic systems using AsLOV2 core as the photosensory protein have been 
developed and further optimized. The tunable light-controlled interacting proteins (TULIPs) 
system uses a combination of caging and dimerization through fusion of a PDZ-binding 
peptide to the C-terminus of the Jα-helix, which cages the peptide in the dark but upon 
illumination the Jα-helix unwinds allowing for an engineered PDZ domain to bind 
(Strickland et al., 2012). This study also explored a series of mutations that alter kinetics of 
reversion and the sensitivity of the tool. In a similar approach a bacterial SsrA peptide was 
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engineered into the Jα-helix to allow for light dependent interaction with its binding partner 
SspB (Lungu et al., 2012). The SsrA/SspB tool was further optimized to increase dynamic 
range and decrease background interactions. These optimizations have led to systems 
including iLID nano, iLID micro, and iLID/SspB-milli, all with tunable kinetic properties 
(Guntas et al., 2015; Zimmerman et al., 2016).  
 AsLOV2 was also used in the synthetic system, LOVTRAP, which allows for 
regulation of light-dissociation (Wang et al., 2016). LOVTRAP has two components: the 
AsLOV2 domain and a mutated domain of the Z domain of protein A, Zdark (Zdk). Zdk was 
found in a randomized mutation screen selecting for peptides that have dark association with 
AsLOV2. Wang et al. were able to demonstrate the ability to regulate signaling cascades by 
using the light initiated release tool (Wang et al., 2016). LOVTRAP, TULIPs, and the iLID 
variants are all examples of successful hybrids of naturally based AsLOV2 domains with 
engineered components. 
FKF1 
 Flavin Binding, Kelch Repeat, F-Box 1 (FKF1) is an Arabidopsis thaliana protein 
that contains a LOV domain, and is known to interact with Gigantea (GI) (Imaizumi et al., 
2003; Sawa et al., 2007). Similar to AsLOV2, FKF1 uses FMN as the chromophore. While 
the FKF1/GI interaction was the first blue light optogenetic tool published (Yazawa et al., 
2009) the size of the components are extremely bulky (FKF1 is 619 amino acids and GI is 
1173 amino acids). The minimal photoactivation domain is between amino acids 56-168 of 
FKF1 suggesting that FKF1 can be reduced in size without altering photosensitivity; 
however, the interaction with GI requires a larger minimal domain. Other alterations to FKF1 
include mutations to the endogenous nuclear localization signal (NLS) when utilizing the 
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protein in the cytosol. Compared with other LOV domain containing proteins, FKF1 has very 
slow reversion kinetics to dark state with a half time of over 100 hrs. This is a disadvantage 
for fine temporal or dose-dependent control, but a long-lasting dimerization can be 
advantageous if a more permanent interaction is desired. 
Aureochrome 
Aureochrome-1 is a LOV-domain containing protein found in Vaucheria frigida that 
differs from the previously described LOV-domain containing proteins because it 
homodimerizes upon illumination (Takahashi et al., 2007). Aureochrome-1 is composed of a 
N-terminal basic region/leucine zipper (bZIP) DNA-binding domain and a single C-terminal 
LOV domain and also binds a FMN cofactor (Takahashi et al., 2007). The bZIP dimerization 
has been utilized for optogenetic applications to bring proteins together (Grusch et al., 2014). 
It is known that light stimulation induces conformational change leading to 
homodimerization, but the exact mechanism is currently not fully understood. Kinetic studies 
of AuLOV show reversion rates in the range of minutes, but like with other LOV domains, 
mutations have tuned the kinetics (Mitra et al., 2012). 
VVD  
Vivid (VVD) is a LOV-domain-containing protein from the fungus Neurospora 
crassa (Schwerdtfeger and Linden, 2003) that also homodimerizes when illuminated with 
blue light (Zoltowski and Crane, 2008; Zoltowski et al., 2007). It differs from other LOV 
domains utilized in optogenetics due to its use of flavin adenine dinucleotide (FAD) rather 
than FMN as a chromophore (Zoltowski et al., 2007). Light dependent dimerization of VVD 
was first used to regulate transcription (Wang et al., 2012). A mutation of I52C was able to 
increase VVD’s homodimerization property enhancing the gene induction (Nihongaki et al., 
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2014). VVD’s kinetics are slow in comparison to other LOV domains with a dark reversion 
half-life of 2.8 hr (Zoltowski et al., 2007). 
 A synthetic version of VVD-VVD was engineered to confer heterodimerization to the 
system, termed Magnets (pMag/nMag), with mutations of VVD at I52R/M55R (pMag) and 
I52D/M55G (nMag) (Kawano et al., 2015). Heterodimerization occurs within seconds and 
dissociation takes hours, while homodimerization is significantly reduced. Optimized 
variants of Magnets have been designed including ‘High’ mutants (M135I and M165I) that 
show enhanced dimerization but reduced dissociation kinetics, and ‘Fast’ mutants (I74V and 
I85V) with a shortened photocycle but decreased dimerization. Combination of ‘High’ and 
‘Fast’ mutations results in increased heterodimerization and faster system kinetics (Kawano 
et al., 2015).  
EL222 
EL222 is a 208 amino acid domain designed from a LOV domain containing 
transcription factor from bacteria, Erythrobacter litoralis (Motta-Mena et al., 2014; Nash et 
al., 2011) The N-terminal LOV domain cages a helix-turn-helix (HTH) DNA binding domain 
that becomes exposed with light and permits dimerization. To use EL222 to modulate 
transcription, VP16 transcriptional activation domain was fused to the N-terminus of EL222 
(LOV-HTH) which under illumination binds the HTH promoter (Motta-Mena et al., 2014). 
With kinetics in the seconds and extremely low background, this LOV domain has potential 
for precise temporal tunability and propensity for high dynamic range. 
Cryptochromes 
Cryptochromes (CRYs) are found in bacteria and eukaryotes, but the optogenetic 
tools use plant cryptochromes from Arabidiopsis thaliana. CRYs are blue light sensitive 
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photoreceptors that are known to regulate hypocotyl elongation, photoperiodic flowering 
initiation, and other light dependent processes in plants. They are composed of a N-terminal 
photosensory domain (photolyase homology region, PHR) with structural homology to DNA 
photolyase, and a relatively unstructured C-terminal tail domain (CTD). CRYs use flavin 
adenine dinucleotide (FAD) as their cofactor, similar to some LOV domains. FAD is thought 
to undergo photoreduction upon light stimulation, leading to conformational changes within 
the CRY2 protein but the exact mechanism has not been proven (Conrad et al., 2014).  
The blue light dependent Arabidopsis CRY2 interaction with CIB1 (Liu et al., 2008) 
was first used as a light dependent dimerization tool to modulate protein localization, 
transcription, and reconstitute a split enzyme (Kennedy et al., 2010). The original CRY2 and 
CIB1 proteins are relatively large, at 612 amino acids and 335 amino acids, respectively. A 
498 residue tructation of CRY, CRY2PHR, expressed better than full length and in many 
cases reduces the background binding of CRY2 and CIB1 in the dark. A 170 residue 
truncation of CIB1, termed CIBN, retains interaction with CRY2 and can be substituted for 
CIB1. Recent studies show a 535 amino acid truncation of CRY2 has improved functionality 
over full length and may be the most optimized version (Taslimi et al., 2016). In the same 
study a drastically shorted CIB1, residues 1-81, retained light dependent interaction with 
CRY2 demonstrating a more minimal motif (Taslimi et al., 2016). Unless the constructs are 
to be used in the nucleus, the endogenous nuclear localization signals of CRY2 and CIB1 
must be removed to sustain cytosolic localization (Kennedy et al., 2010). The CRY2-CIB1 
interaction occurs within seconds and dissociation occurs within minutes, with a half-life of 
about five minutes. As with many photoreceptors, mutants modulating kinetics of CRY2 
have been identified for use (Taslimi et al., 2016). 
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CRY2 is also known to have low levels of self-association in the dark and 
oligomerizes upon light exposure. CRY2 oligomerization has been used successfully as an 
optogenetic tool in multiple studies to activate or inactivate biological processes with light 
(Bugaj et al., 2013, 2015; Chang et al., 2014; Kim et al., 2014; Lee et al., 2014; Ozkan-
Dagliyan et al., 2013; Taslimi et al., 2014; Wend et al., 2014). While this oligomerization has 
proven useful, it can also disrupt CRY2-CIB1 dimerization tools, as discussed in Chapter III. 
The Tucker laboratory explored further CRY2 oligomerization by engineering an E490G 
mutation in CRY2PHR, termed “CRY2olig”, which has enhanced oligomerization with blue 
light illumination and has been used to perturb cellular events (Taslimi et al., 2014).  
Phytochromes  
Phytochromes are red and far-red light responding plant photoreceptors. Two 
optogenetic systems utilizing Arabidopsis thaliana phytochrome B (phyB) have been 
developed: phyB/PIF3 and phyB/PIF6. The phyB/PIF3 dimerizers uses residues 1-621 of 
phyB, a N-terminal photosensory domain which interacts with PIF3, a transcription factor 
that specifically binds red light-stimulated phyB (Ni et al., 1999; Shimizu-Sato et al., 2002). 
The phyB/PIF6 dimerizers use residues 1-908 of phyB which binds residues 1-100, the N-
terminal domain, of PIF6 (Levskaya et al., 2009).  
PhyB has low affinity for PIF family proteins in the red light responsive (Pr) state, but 
upon red light illumination it adopts a far-red-light responsive (Pfr) state with high affinity to 
PIF proteins (Rockwell et al., 2006). An essential cofactor, bilin chromophore, 
phytochromobilin (PΦB), must be present to mediate light responsiveness. Phytochromobilin 
covalently links to phyB in dark and undergoes a cis-trans isomerization with photon 
absorption, resulting in conformational change of the protein to the Pfr state. In the Pfr state, 
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the molecule can absorb a second photon that reverts the protein back to the Pr state. The 
kinetics for the photoswitching between these two states are within seconds.  
There are multiple advantages to using phytochromes including the fast kinetics and 
ability to control association and dissociation with different wavelengths of light. While red 
light promotes the phyB-PIF interaction, far-red light is used for dissociation. Since longer 
wavelengths are less toxic and penetrate tissues deeper, red and far red illumination for in 
vivo applications is beneficial.  
Disadvantages of the phyB/PIF systems include the requirement for the PΦB 
cofactor, which must be added exogenously to non-plant cells. Often a related cofactor 
phycocyanobilin (PCB) extracted from spirulina is substituted for the plant cofactor PΦB, (Li 
and Lagarias, 1994; Shimizu-Sato et al., 2002). While PCB is absorbed slowly by cells, the 
exogenous addition makes the systems difficult for use in tissues and model organisms, 
though studies are making the chromophore purification and delivery more efficient 
(Buckley et al., 2016). Co-expressing biosynthetic enzymes that stimulate generation of the 
bilin cofactor is one way to circumvent this lack of cofactor, however, two different genes 
are required to synthesize PCB from heme (Gambetta and Lagarias, 2001; Levskaya et al., 
2005; Müller et al., 2013a). Another disadvantage is the phytochromes are also not tolerant 
of C-terminal fusions (Leung et al., 2008) and thus forces N-terminal fusions on the phyB for 
proteins of interest. These disadvantages have likely played a role in the limited widespread 
adoption of the phyB/PIF systems.  
Bacterial Phytochrome  
 Recently a novel BphP1/RpPpsR2 interaction was developed for optogenetics using 
a bacterial phytochrome, phBphP1, from Rhodopseudomonas palustris. This unique 
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phytochrome exists in a ground Pfr state but can be photoconverted to a Pr state with near-
infrared illumination (~740-780 nm) where it can interact with transcriptional repressor 
RpPpsR2 (Bellini and Papiz, 2012; Rottwinkel et al., 2010). These interacting proteins were 
used as the basis for a new red/far-red photodimerizer system (Kaberniuk et al., 2016).  
 There are innovative advantages to the BphP1-RpPpsR2 interaction such as use of a 
biliverdin chromophore that is endogenously found in mammalian cells. In addition, BphP1-
RpPpsR2 interaction is stimulated with 740 nm light and dissociation induced with 650 nm 
light. The near infrared (NIR) light at 740 nm penetrates even more deeply into tissues and 
organs than red light, which is a substantial advantage of this system. The kinetics are fast 
with dimerization occurring within seconds of light exposure. Light can also be used to 
induce dissociation; however, the only observed disadvantage is an overlap between Pr and 
Pfr light sensitivities leading to only ~80% of the BphP1 protein dissociated upon 
illumination. This can be overcome by allowing full dark reversion of the Pr state to the 
ground Pfr state, but the kinetics are dependent on BphP1-RpPpsR2 ratios, occurring with a 
half-time of 15 min for an 8:1 molar ratio (Kaberniuk et al., 2016).   
UVR8  
Ultraviolet resistance locus 8 (UVR8) is an UV-B sensitive photoreceptor from 
Arabidopsis thaliana that has been used in two optogenetic systems: UVR8-COP1 and 
UVR8-UVR8. The photoreceptor utilizes internal tryptophan residues W233 and W285 to 
form a chromophore and therefore has no prosthetic cofactor. In the dark UVR8 is dimeric 
and UV-B illumination releases it to a monomeric state where it can interact with its binding 
partner, COP1, to induce gene expression (Rizzini et al., 2011). UVR8 has been utilized in 
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optogenetic tools to stimulate dissociation of the UVR8-UVR8 dimer (Chen et al., 2013) and 
to mediate association of UVR8-COP1 heterodimer (Crefcoeur et al., 2013). 
Unique properties of UVR8 systems are the light stimulated dissociation and lack of 
cofactor necessary to form a chromophore. Also, UV-B light as a stimulus enables the 
cooperative imaging of most fluorescent proteins (FPs) due to the fact that FPs excitation 
spectrum do not generally overlap with the 280-315nm UV-B wavelength, which is an 
advantage for tracking cellular events. There are significant limitations to this system. The 
wavelength, while advantageous for imaging, can induce DNA damage and activate stress 
pathways. The kinetics of the system are fast, with dissociation to monomers occurring 
within seconds; however, reversibility requires a protein from plants (Heijde and Ulm, 2013) 
limiting the temporal tunability of the system.  
Dronpa 
 Dronpa is unique because it is a photoswitchable protein engineered from a 
tetrameric, 257 amino acid, Pectinidae coral protein (Ando et al., 2004). A mutant form, 
Dronpa145N, undergoes changes in subunit association (tetramer to monomer) upon 
illumination with 488-500 nm light (Mizuno et al., 2010), and this property has been utilized 
for optogenetic applications (Zhou et al., 2012). In concert with changes in subunit 
association, Dronpa145N also shows changes in fluorescence upon illumination, making it a 
unique molecule to use in optogenetics. Dronpa is converted by strong excitation at 490 nm 
to a non-fluorescent dark state, which can be switched back by illumination at ~400 nm. In 
addition to the traceable nature of Dronpa, it also does not need an external cofactor. Like 
GFP, Dronpa relies on the switch from cis- to trans-conformation of the chromophore 
formed by residues of the molecule, Cys-62–Tyr-63–Gly-64 (Andresen et al., 2007). The 
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switchable association/dissociation occurs within seconds allowing for fast kinetics of the 
Dronpa system.  
BLUF Domains 
 Sensors of Blue-Light Using FAD (BLUF) domains were first found in the N-
terminus of the AppA protein present in Rhodobacter sphaeroides (Gomelsky and Klug, 
2002). There are many other BLUF containing proteins including PixD and YcgF, often 
found in prokaryotes. They have binding properties in the dark and dissociate from their 
complex upon illumination (Masuda and Bauer, 2002; Masuda et al., 2008; Tschowri et al., 
2009). As the name implies, these are blue light photosensory domains that use FAD as 
cofactor. The kinetics of the BLUF domains varies from seconds to minutes for dark state 
reversions (Kraft et al., 2003; Zirak et al., 2006). These domains have not yet been developed 
for novel optogenetic tools but rather have been used to modulate their natural pathways; 
however, they are thought to be potential photoreceptors for synthesizing new optogenetic 
systems.  
Applications of Soluble Optogenetic Systems 
 As introduced throughout this Chapter, protein function directly correlates with 
protein localization. Optogenetics has utilized this principle to regulate protein function with 
many different tools (Table I-2). Proteins of interest can be controlled by fusing them to 
photoreceptor proteins which are designed to control their localization. Optogenetic tools 
have utilized this engineering technique to modulate target proteins in distinct ways 
including: recruitment to specific subcellular locations, reconstitution of split protein,  
























Figure I-2: Photodimerizer approaches to regulate protein function.  
Schematic showing approaches used to regulate protein activity using photodimerizers. The 
target protein regulated is colored in green, with photosensory proteins in blue, partner 
proteins in purple, and anchoring proteins in orange. A. Dimerization of two different 
proteins. Photodimerizers can be used to bring two different target proteins together with 
light. B. Reconstitution of a split protein. Activity is achieved by fusing the N-terminus and 
C-terminus of a split protein to the interacting photodimerizers, allowing functional 
reconstitution with light. C. Reconstitution of a split transcription factor. Variation of (B), 
where one of the photodimerizer partners is fused to a DNA binding domain, where it can 
bind to DNA at a promoter site. The partner photodimerizer is fused to a transcriptional 
activation domain. Light allows recruitment of the activation domain to this location, 
resulting in activation of transcription. D. Recruitment to anchored subcellular location. One 
of the photodimerizer components is fused to a protein or peptide allowing anchored 
subcellular localization (plasma membrane is shown as an example), while the other is fused 
to a target protein of interest. Light illumination allows recruitment of the target to the 
anchored location. E. Oligomerization. A target is fused to a photoreceptor (such as CRY2) 
that undergoes light dependent oligomerization, which can be used to induce or disrupt 
activity. F. Sequestration/release. Used with light-dissociated dimerizers, or light-
associated/dissociated dimerizers such as phyB/PIF. A target protein is anchored 
(sequestered) at an inactive subcellular location, then released with light illumination to 
allow function. G. Dissociation of protein clusters. Used with light-dissociated dimerizers, 
protein assembles into clusters that impede trafficking or activity, which are 
dissociated/dissolved with light. H. Single chain caging. Interacting partners are presented on 
the same protein chain, along with a target protein or domain. Function of the target protein 




Table I-2: Applications of soluble photoreceptor technologies 
System Utilization Reference 
Phytochrome based systems 
Plant phytochrome B 
phyB/PIF3 (1-621/FL) Reconstitution of a split Gal4 transcription factor to regulate 
gene expression in yeast 
(Shimizu-Sato et 
al., 2002) 
phyB/PIF3 (1-621/FL,  
1-621/1-100) 




phyB/PIF3 (1-651/1-100) Induced dimerization of GDP-bound form of Cdc42 with 
WASP to stimulate actin assembly  
(Leung et al., 
2008) 
PhyB/PIF6 (1-908/1-100) Activation of Rho GTPase pathways by recruiting the 
catalytic domain of Rho GEFs to the plasma membrane 
(Levskaya et al., 
2009) 
phyB/PIF3 (1-621/FL) Reconstitution of a split transcription factor to regulate gene 
expression in yeast  
(Hughes et al., 
2012a) 
PhyB/PIF6 (1-908/1-100) Recruitment of catalytic domain of SOS to the plasma 
membrane to activate Ras and the Ras/Raf/MEK/ERK 
pathway 
(Toettcher et al., 
2013) 
phyB/PIF6 (1-908/1-100) Recruitment of Gal80 to PM with 650 nm light, resulting in 
alleviation of Gal80 transcriptional repression in the 
nucleus; Recruitment of Clb2-PIF6 to intracellular sites 
(nucleus, spindle pole body) to disrupt function.  
(Yang et al., 
2013) 
phyB/PIF6 (1-650/1-100) Reconstitution of a split transcription factor to regulate gene 
expression in mammalian cells. 
(Müller et al., 
2013b) 
phyB/PIF6 (1-908, 1-650/1-100) Reconstitution of a split transcription factor to regulate gene 
expression in mammalian cells. 




Reconstitution of a split transcription factor to regulate gene 
expression in yeast  
(Pathak et al., 
2014) 
 phyB/PIF6 (1-908/1-100) Sequestration of Bem1 at inactive sites to prevent 
polarization and budding, probe consequences of release 
at different times 
(Jost and Weiner, 
2015) 
phyB/PIF6 Targeted AAV viral particles to the nucleus for enhanced 
gene delivery by recruiting a PIF6-fused viral capsid protein 
to a phyB-NLS 
(Gomez et al., 
2015) 
phyB/PIF3 (1-908/FL) Regulation of nuclear-cytoplasmic transport through 
phyB/PIF3 interaction in mammalian cells and zebrafish 
(Beyer et al., 
2015) 
phyB/PIF6 (1-908/1-100) Recruitment of Gαq, Gαs to plasma membrane, inducing 
activation of PLCβ 
(Yu et al., 2016) 
 phyB/PIF6 (1-908/1-100) Recruitment of apical polarity protein Pard3 to plasma 
membrane in zebrafish 
(Buckley et al., 
2016) 
Bacteriophytochrome 
BphP1-PpsR2 Recruitment of catalytic domain of intersectin to the plasma 
membrane; Reconstitution of a split transcription factor to 
induce gene expression in mammalian cells 
(Kaberniuk et al., 
2016) 




Recruitment of cargo to plasma membrane in mammalian 
cells; Reconstitution of a split Cre DNA recombinase; 
Reconstitution of a split transcription factor to induce gene 
expression in yeast  
(Kennedy et al., 
2010) 
CRY2PHR/CIBN Recruitment of an inositol 5-phosphatase domain to the 
plasma membrane to alter phosphoinositide metabolism; 
Recruitment of inter-SH2 domain of p85α, a regulatory 
subunit of PI3 kinase, to the plasma membrane 
(Idevall-Hagren et 
al., 2012) 
CRY2PHR/CIBN Reconstitution of a split transcription factor to regulate gene 
expression in yeast 
(Hughes et al., 
2012a) 
CRY2/CIB1 Reconstitution of a split transcription factor to modulate 
gene expression in zebrafish 
(Liu et al., 2012) 
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Table 1-2 continued 
System Utilization Reference 
CRY2/CIB1 (LITEs: light-inducible 
transcriptional effectors) 
Recruitment of transcriptional activator or epigenetic 




CRY2PHR/CIBN Recruitment of iSH2 domain of p85β, a regulatory subunit 




CRY2/CIBN Reconstitution of a split Cre DNA recombinase in 
Drosophila 
(Boulina et al., 
2013) 
CRY2PHR/CIBN Recruitment of an inositol 5-phosphatase domain to the 
plasma membrane to alter phosphoinositide metabolism 
(Giordano et al., 
2013) 
CRY2PHR/CIBN Recruitment of eIF4E to PUF domain that binds mRNA to 
regulate translation 
(Cao et al., 2014) 
CRY2/CIBN Recruitment of a protease to its target cleavage sequence, 
resulting in release of a membrane-tethered transcription 
factor 
(Wieland et al., 
2014) 
CRY2PHR/CIBN Recruitment of Raf1 to the plasma membrane to stimulate 
ERK signaling 
(Zhang et al., 
2014) 
TULIPs Reconstitution of a split transcription factor to regulate gene 
expression in yeast  
(Pathak et al., 
2014) 
CRY2PHR/CIBN Recruitment of cofilin to Lifeact to induce F-actin 
remodeling, filopodia, and directed cell motility 
(Hughes and 
Lawrence, 2014) 
CRY2PHR/CIBN Recruitment of catalytic domain of intersectin to plasma 
membrane 
(Valon et al., 
2015) 
CRY2/CIBN Split dCas9/CRISPR system regulating endogenous genes 
in mammalian cells 
(Polstein and 
Gersbach, 2015) 
CRY2PHR/CIB1 Reconstitution of split dCas9/CRISPR system regulating 
endogenous genes in mammalian cells 
(Nihongaki et al., 
2015a) 
CRY2/CIB1 Mitochondrial recruitment of Bax to stimulate Smac1 
release, activating caspase cleavage and apoptosis 
(Hughes et al., 
2015) 
CRY2/CIBN Mediation of actin polymerization by recruitment of Arpin 
away from leading edge 
(Maiuri et al., 
2015) 
CRY2/CIBN Reconstitution of split transcription factor in Drosophila  (Chan et al., 
2015) 
CRY2/CIBN Reconsitution of a split Cre DNA recombinase in mouse 
introduced via AAV 
(Schindler et al., 
2015) 
CRY2PHR/CIBN Recruitment of kinase domain of Akt to the plasma 
membrane to activate Akt signaling 
(Katsura et al., 
2015) 
CRY2PHR/CIBN Recruitment of organelles (mitochondria, peroxisome, 
lysosome) to cytoskeletal motors (kinesin, dynein) to 
regulate organelle positioning 
(Duan et al., 
2015) 
CRY2PHR/CIBN Recruitment of an inositol 5-phosphatase domain to the 
plasma membrane to alter phosphoinositide metabolism in 
Drosophila 
(Guglielmi et al., 
2015) 
CRY2PHR/CIBN Reconstitution of split Gal4 transcription factor; recruitment 
of Tiam catalytic domain to plasma membrane 
(Hallett et al., 
2016) 
CRY2PHR/CIBN Dimerization of Cav1.3S or Cav1.3L channels (Moreno et al., 
2016) 
CRY2/CIB1 Recruitment of DNA methyltranferase to subtelomeric 
regions to regulate methylation 
(Choudhury et al., 
2016) 
CRY2/CIB1; CRY2(535)/CIB1 Reconstitution of split Cre DNA recombinase using CRY2 
mutant L348F; Reconstitution of a split transcription factor 
to regulate gene expression in yeast  
(Taslimi et al., 
2016) 
CRY2/CIBN (EXPLORs) Recruitment of cargo protein into exosomes (Yim et al., 2016) 
CRY2PHR/CIBN Recruitment of Raf and Akt to the plasma membrane to 
activate signaling 
(Ong et al., 2016) 






Table 1-2 continued 
System Utilization Reference 
CRY2PHR/CIBN Recruitment of PLEKHG3 to Lifeact, Recruitment of iSH2 
domain of p85β to the plasma membrane 
(Nguyen et al., 
2016b) 
CRY2PHR/CIBN Recruitment of i-SH2 domain of p85α, a regulatory subunit 
of PI3 kinase, to the plasma membrane; Recruitment of PH 
domain of Akt to PM 
(Xu et al., 2016) 
CRY2 dimerization/ oligomerization 
CRY2/CRY2 Clustering of CRY2-LRP6 c-terminal domain to activate β-
catenin signaling; Clustering of CRY2-Rac1 or CRY2-RhoA 
to induce cytoskeletal changes 
(Bugaj et al., 
2013) 
CRY2/CRY2 Clustering CRY2-TopBP1 to activate ATR-mediated DNA 
damage checkpoint signaling in the absence of DNA 
damage 
(Ozkan-Dagliyan 
et al., 2013) 
CRY2/CRY2 and CRY2/CIBN Homodimerization of CRY2PHR-C-RAF or B-RAF; 
heterodimerization of C-Raf and B-Raf through CRY2PHR-
CIBN interaction 
(Wend et al., 
2014) 
CRY2PHR/CRY2PHR Dimerization of TrkB receptor to stimulate Trk signaling (Chang et al., 
2014) 
CRY2PHR/CRY2PHR Dimerization of FGFR to stimulate MAPK, PI3K, and 
phospholipase C signaling 
(Kim et al., 2014) 
CRY2PHR/CRY2PHR/CIB1 (LARIAT: 
light activated reversible inhibition by 
assembled trap) 
Use of a CaMKII-CIB1 along with target proteins fused to 
CRY2 to cluster and sequester activity (targeting: Vav2, 
Tiam1, Rac1, Cdc42, RhoG, PI3K) 
(Lee et al., 2014) 
CRY2olig (CRY2PHR E490G) Clustering of CRY2olig-NCK (SH3 domains) and VCA 
domain of N-WASP to induce changes in actin 
polymeration; Clustering of CRY2olig-clathrin light chain to 
disrupt endocytosis 
(Taslimi et al., 
2014) 
CRY2PHR/CRY2PHR (CLICR: 
clustering indirectly using CRY2) 
Clustering of PLC-γ SH2 domain using CRY2PHR resulting 
in targeting of SH2 domain to endogenous binding partners 
and activation of receptor tyrosine kinases; Similar 
approach with talin F3 domain targeting integrins 




Clustering of CIBN-Rab GTPases (Rab5, Rab11,Rab7, 
Rab3a, Rab2a, Rab6a) with CRY2PHR 
(Nguyen et al., 
2016a) 
CRY2PHR/CRY2PHR; CRY2/CIB1 Homodimerization of CRY2PHR-BRAF and CRY2PHR-
CRAF; heterodimerization of B-RAF and C-RAF via 
CRY2PHR-CIBN interaction 
(Chatelle et al., 
2016) 
CRY2PHR/CRY2PHR Dimerization of FGFR to induce FGFR signaling pathways (Kim et al., 2016) 
CRY2/CRY2 Dimerization of DCC receptor to stimulate axon extension 
through FAK and PLCϒ-1 signaling 
(Endo et al., 
2016) 
CRY2PHR/CRY2PHR/CIBN Utilized LARIAT (Lee et al. 2014) to cluster GFP binding 
antibody VHH-CRY2 and GFP-PLEKHG3  
(Nguyen et al., 
2016b) 
LOV Based Systems 
FKF1/GI 
FKF1/GI Reconstitution of a split transcription factor to regulate gene 
expression in mammalian cells; Plasma membrane 
recruitment of Rac1 
(Yazawa et al., 
2009) 
FKF1/GI (LITEZ) Recruitment of a transcriptional activator to programmed 




TULIPs  Membrane recruitment of Ste5 to stimulate mating MAP 
kinase pathways; Membrane recruitment of Cdc24 to 
modulate cell polarity  
(Strickland et al., 
2012) 
TULIPs Reconstitution of a split transcription factor to regulate gene 
expression in yeast  
(Pathak et al., 
2014) 
TULIPs Reconstitution of a split transcription factor to regulate gene 
expression in yeast  
(Müller et al., 
2014) 
TULIPs Reconstitution of split Gal4 transcription factor; Recruitment 
of Tiam DH/PH catalytic domain to PM 
(Hallett et al., 
2016) 
TULIPs Recruitment of peroxisomes or recycling endosomes to 
cytoskeletal motor proteins (kinesin, dynein or myosin) to 
regulate organelle positioning 




Table 1-2 continued 
System Utilization Reference 
TULIPs Recruitment of RhoA GEF LARG to plasma membrane (Wagner and 
Glotzer, 2016) 
VVD dimerization 
VVD-VVD (LightON) Dimerization of a transcription factor to regulate gene 
expression in mammalian cells 
(Wang et al., 
2012) 
VVD-VVD Dimerization of a transcription factor to regulate gene 
expression in mammalian cells 
(Müller et al., 
2013b) 
VVD-VVD Reconstitution of T7 RNA Polymerase (Han et al., 2016) 
VVD-VVD Caspase-9 dimerization (Nihongaki et al., 
2014) 
Magnets (nMag/pMag) 
Magnets (nMag/pMag) Recruitment of iSH2 domain of p85β, a regulatory subunit 
of PI3kinase, to the plasma membrane to stimulate PIP3 
production 
(Kawano et al., 
2015) 
Magnets Split dCas9/CRISPR gene regulation system (Nihongaki et al., 
2015b) 
Magnets Recruitment of Gαq to plasma membrane, inducing 
activation of PLCβ 
(Yu et al., 2016) 
Magnets Reconstitution of T7 RNA Polymerase (Han et al., 2016) 





Perturbation of actin co-sedimentation in vitro; 
Reconstitution of split Gal4 transcription factor in yeast 
(Lungu et al., 
2012) 
iLIDs (improved AsLOV2-SsrA/SspB) 
iLIDnano, iLIDmicro 
Recruitment of Tiam and Intersectin catalytic domains to 
the plasma membrane  
(Guntas et al., 
2015) 
iLID Recruitment of catalytic domain of Cdc42 GEF to plasma 
membrane 
(O’Neill et al., 
2016) 
iLID Reconstitution of split Gal4 transcription factor; Recruitment 
of Tiam DH/PH catalytic domain to PM 
(Hallett et al., 
2016) 
iLID/SspB_milli (A58V in SspB).   sLID 
(slow-cycling N414L AsLOV2 mutant) 
Recruitment of cargo to subcellular locations (Zimmerman et 
al., 2016) 
EL222 dimerization 





Aureochrome 1 Dimerization of receptor tyrosine kinases (FGFR1, EGFR, 
and RET) 
(Grusch et al., 
2014) 
LOVTRAP 
Zdk/AsLOV2 (LOVTRAP) Release of constitutively active Vav2, Rac1, or RhoA from 
anchored sites through dissociation of Zdk/AsLOV2 
interaction. 
(Wang et al., 
2016) 
Dronpa based systems 
Dronpa Plasma membrane recruitment; caging Cdc42 GEF 
intersectin activity, caging HCV NS3-4A protease 
(Zhou et al., 
2012) 
UVR8 based systems 
UVR8/COP1 Recruitment of cargo to chromatin; Reconstitution of a split 
transcription factor to drive a reporter gene 
(Crefcoeur et al., 
2013) 
UVR8/COP1 Reconstitution of a split transcription factor to regulate gene 
expression in mammalian cells. 
(Müller et al., 
2013b) 
UVR8/UVR8 Light mediated dissociation of UVR8 fused VSVG to 
release from ER 
(Chen et al., 
2013) 
Combined systems 
CRY1/phyB Reconstitution of a split transcription factor to drive a 
reporter gene  
(Hughes et al., 
2012b) 
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I-2). These modulations of proteins of interest are achieved through photoreceptor caging, 
association, dissociation, and oligomerization. 
 Recruitment to Specific Cellular Locations  
 Regulating protein localization is a powerful way to regulate its activity and thus has 
been the focus of many optogenetic tools. In order to regulate specific localization, a 
dimerizing approach is used where one half of the dimer is fixed with a docking tag specific 
to a subcellular location, and the protein of interest is fused to the other half of the 
dimerization pair. Dimerization occurs upon illumination recruiting the target proteins to the 
location of the anchored half of the interacting partners. 
 Recruitment of proteins to the plasma membrane is a broadly utilized approach 
demonstrating high efficiency at regulating a large variety of proteins. One of the first studies 
used the PhyB/PIF6 optogenetic system to recruit the DHPH catalytic domains of GDP-GTP 
exchange factors (GEFs) Tiam or intersectin to the plasma membrane, resulting in induction 
of Rac1 or Cdc42 activity, respectively (Levskaya et al., 2009). This system was also able to 
show spatial precision by localizing the DHPH domains to specific locations to regulate 
membrane morphology. Due to the use of a phytochrome system the tool was also shown to 
be reversible and could be activated/deactivation through multiple photocycles.  
Many other photoreceptor systems demonstrated efficiency at regulating RhoGTPase 
pathways through membrane recruitment, and others also showed robust modulation of 
kinase signaling pathways. Using TULIPs and CRY2/CIB1 dimerization tools, MAP kinase 
scaffold Ste5 was recruited to the plasma membrane in yeast resulting in activation of the 
MAP kinase dependent mating pathway (Pathak et al., 2014; Strickland et al., 2012). 
CRY2PHR/CIBN  has been used to recruit multiple proteins to the plasma membrane 
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including: Raf1 which stimulated the ERK pathway and neurite outgrowth in PC12 cells 
(Zhang et al., 2014) and Akt stimulating downstream signaling (Katsura et al., 2015).  
 Optogenetic tools have the advantage of temporal specificity for probing signaling 
pathways, and thus scientists began to use them to observe signaling dynamics in the cell. By 
recruiting the SOS catalytic domain to the plasma membrane using phyB/PIF6 dimerizers, 
Ras-ERK signaling pathways were activated (Toettcher et al., 2013). This study 
demonstrated the ability to regulate signaling of a pathway by activating one singular node, 
in this case with SOS. By using this approach specific nodes of pathways can be probed, 
bypassing other signaling events that may complicate downstream effectors. In addition to 
the ability to stimulate a pathway at intermediate nodes, this study showed the ability to 
stimulate signaling nodes for precise, user-specified amounts of time, allowing for 
temporally specific activation/deactivation effects to be understood.      
 Another cellular pathway that has been regulated successfully with optogenetics is  
lipid metabolism signaling. Membrane recruitment with CRY2PHR/CIBN interaction was 
used for recruiting kinases or phosphatases to the plasma membrane. One application was to 
recruit an inositol 5-phosphatase domain or a PI3-kinase domain (inter-SH2 (iSH2) region of 
the p85α regulatory subunit of PI3-kinase) to the plasma membrane, which resulted in rapid, 
local control of phosphoinositide metabolism (Idevall-Hagren et al., 2012). In another 
experiment the recruitment of the inositol 5-phosphatase domain of OCRL resulted in 
PI(4,5)P2 dephosphorylation, loss of membrane ruffling, and disappearance of clathrin coated 
endocytic pits, and opposite this the recruitment of PI3-kinase resulted in induction of 
PI(3,4,5)P3 synthesis and membrane ruffling (Idevall-Hagren et al., 2012).   
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Other subcellular locations have also been targeted with optogenetic approaches. 
Organelle cargo trafficking using cytoskeletal motor proteins was achieved with TULIP and 
CRY2PHR/CIBN interactions. Both tools recruit cytoskeletal motor proteins to cargos, 
including peroxisomes and mitochondria, resulting in light dependent organelle trafficking 
(van Bergeijk et al., 2015; Duan et al., 2015). Multiple systems have also been developed to 
regulate shuttling between the nucleus and cytoplasm. One method fused phyB(1-908) and 
an NES to a target protein, resulting in cytosolic localization of the target in dark but induced 
nuclear targeting by stimulating interaction with nuclear PIF3 (Beyer et al., 2015). By fusing 
CRY2PHR to cargo and anchoring CIBN to an exosome-associated tetraspanin protein, CD9, 
CRY2/CIBN dimerization directed cargo into exosomes (Yim et al., 2016).  
Reconstituting Split Proteins 
 This approach involves attaching split protein halves to a dimerizing pair in order to 
confer light dependent reconstitution. It is important that the split protein halves do not have 
sufficient affinity on their own. Splitting enzymes has been done with chemical dimerizers 
previous to the advent of soluble optogenetic approaches. Split transcription factors are 
commonly used in techniques probing protein-protein interactions, such as the yeast two-
hybrid assay (Fields and Song, 1989). 
Reconstituting Split Transcription Factors 
   The first soluble optogenetic tool that demonstrated the ability to reconstitute a split 
protein transcription factor used phyB and PIF3 to regulate a split Gal4 binding domain and 
activation domain (Shimizu-Sato et al., 2002). Gal4 DNA binding domain was fused to phyB 
and Gal4 activation domain was fused to PIF3. While the transcription factor is separated and 
inactive in the dark, red-light-induced dimerization of phyB and PIF3 reconstituted the 
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protein and activated transcription. This was reversible with far-red light which dissociated 
the fragments leading to inactivation. Light-dependent transcriptional regulation was shown 
to be dose-dependent with relation to the intensity of light applied. Many others have 
followed up on this technology with novel photoreceptors, but none have the optimal 
characteristics for global use in many model systems. 
Optogenetic photodimerizer systems have also been used to target endogenous gene 
expression using TALE and CRISPR technologies. Zinc finger binding proteins were used to 
target a transcriptional activator to specific DNA binding using a light dependentFKF1/GI 
interaction (Polstein and Gersbach, 2012). A similar approach was taken with CRY2/CIB1 
photoreceptors to recruit an activation domain to TALE DNA binding domains targeting an 
endogenous promoter (Konermann et al., 2013). Multiple CRISPR approaches have used a 
split dCas9/CRISPR to recruit a VP64 activation domain to an endogenous promoter site 
(Nihongaki et al., 2015a, 2015b; Polstein and Gersbach, 2015).  
Reconstituting Split Enzymes 
Tools regulating genetic activation did not attempt to reconstitute split enzymes, but 
rather they split a multi-domain protein. The phyB/PIF3 system was again one of the first 
examples. The system uses the photodimerizers to reconstitute a split protein splicing 
enzyme, the yeast vacuolar ATPase intein (Tyszkiewicz and Muir, 2008). This system 
showed the ability to reconstitute split enzymes with light rather than the traditional chemical 
dimerizer methods.  
Cre recombinase is a widely-used enzyme which allows recombination at loxP sites 
in the genome. The first publication of the CRY2/CIB interactions demonstrated the ability to 
reconstitute a split Cre recombinase (Kennedy et al., 2010). While this system had little to no 
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dark background, activation was not robust and took intense light exposures to achieve.  
Recently, the Tucker laboratory improved upon this split Cre tool using site directed 
mutagenesis and truncations to create the PA-Cre2.0 system with higher dynamic range, 
which can be activated by a single pulse of light (Taslimi et al., 2016). In similar timing 
another photoactivateable Cre system using nMag and pMag photodimerizers was developed 
which showed robust light reponse and in vivo application (Kawano et al., 2016).  
Inducing Protein Interactions 
Inducing protein interactions is another method of regulating protein activity. In one 
of the first optogenetic examples of this technique the phyB and PIF3 interaction was used to 
modulate actin assembly by recruitment of a weak-affinity, GDP-bound form of Cdc42 to its 
effector, Wiskott-Aldrich Syndrome Protein (WASP) (Leung et al., 2008). This study 
showed that cellular events can be regulated through forcing interactions of proteins with 
naturally weak affinity for one another. It has also been demonstrated that using 
photodimerizers attached to membrane bound receptors confers light dependent activation 
through induced interaction. This approach was used by fusing CRY2PHR and CIBN to 
intracellular domains of tyrosine kinase receptors in order to induce synthetic interaction 
with: TrkB receptor (Chang et al., 2014) and FGFR receptor (Kim et al., 2014). The LOV 
domains of aureochrome-1 have also been used to dimerize receptor tyrosine kinases 
(FGFR1, EGFR, and RET) (Grusch et al., 2014). CRY2PHR/CIBN interactions were used 
again to regulate downstream kinases, such as C-Raf and B-Raf through induced 
homodimerization and heterodimerization using approaches (Wend et al., 2014). 
 CRY2 oligomerization properties were harnessed to activate biological processes 
normally triggered by protein oligomerization. TopBP1, a protein that activates ATR kinase, 
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was clustered to induce the DNA damage response in the absence of DNA damage through 
CRY2 light induced oligomerization (Ozkan-Dagliyan et al., 2013). CRY2PHR clustering 
was again used to stimulate β-catenin or Rho GTPase pathways by light-induced clustering 
of CRY2PHR-LRP6c or CRY2PHR-Rac1/RhoA, respectively (Bugaj et al., 2013). In a 
follow up study, binding domains fused to CRY2PHR showed increased binding avidity 
upon light-induced clustering, providing a means to target and activate endogenous receptors 
with light (Bugaj et al., 2015). CRY2olig fused SH3 domains of Nck were used to stimulate 
actin polymerization with light (Taslimi et al., 2014).  
Caging/Sequestering and Releasing Proteins 
Caging 
Caging is the idea of blocking an interaction in the dark by steric hindrance and then 
releasing it. The most common way caging has been achieved is throught utilization of the 
LOV domains. Small peptides are sequestered into the Ja-helix in the dark, and upon light 
illumination they are exposed and active. This was first used to control membrane 
perterbations and movement with light by caging Rho GTPase, Rac1, in the Ja-helix (Wu et 
al., 2009). Others have used the same strategy to cage degron sequences to produce light 
stimulated degradation tags (Bonger et al., 2014), nuclear localization sequences to stimulate 
translocation with light (Niopek et al., 2014; Yumerefendi et al., 2015).  Another way caging 
was achieved was through the utilization of two Dronpa monomers which were appended to 
either side of an enzyme, to cage the catalytic site in dark. Light stimulation released the 
steric hindrance and exposed the catalytic site of the enzyme (Zhou et al., 2012). This 
approach was also used to stimulate Cdc42 with GEF proteins, as well as the hepatitis C 
virus NS3-4A protease (Zhou et al., 2012). 
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Homodimerization Sequesetering 
 Homodimerization sequestering involves interactions between the same 
photoreceptors sequestering proteins from their functional location. UVR8 homointeractions 
were the first to be used in order to sequester an endoplasmic reticulum(ER)-processed 
protein, VSVG, from trafficking. Using a UVR8-VSVG fusion, in dark, UVR8-UVR8 
interactions trapped the fused VSVG in the ER and upon illumination the UVR8 were 
dissolved allowing release of VSVG into the ER for trafficking (Chen et al., 2013). This 
work demonstrated the importance of protein release in probing cellular trafficking. 
The  LARIAT (light activated reversible inhibition by assembled trap) system takes 
advantage of CRY2’s propensity to cluster when associated with a multimeric protein and 
showed the ability to sequester activity of Vav2, Tiam1, Rac1, Cdc42, RhoG, and tubulin 
through clustering the proteins (Lee et al., 2014). CRY2olig’s clustering phenotype has also 
been used to cluster clathrin light chain resulting in light mediated disruption of endocytosis 
(Taslimi et al., 2014). 
Heterodimerization Sequestering 
 Heterodimerization sequestration is similar in theory to homodimerization, but it uses 
heterodimerizing photosensory proteins. Using the phyB/PIF6 interaction, a mitotic cyclin, 
Clb2, was sequestered to specific locations within the cell. This involved fusion of Clb2 to 
PIF6 and anchoring of phyB to subcellular locations such as the nucleus or spindle pole 
body. Red light resulted in sequestered activity and disruptions in Clb2-dependent pathways. 
Far-red light released Clb2 from sequestration at specific times, for specific durations, testing 
whether recovery of Clb2 function at those times and durations was sufficient for rescue of 
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altered pathways (Yang et al., 2013). Bem1 was regulated using a similar approach to 
modulate activity of Cdc42 in yeast (Jost and Weiner, 2015).  
 LOVTRAP used Zdk to sequester fused proteins of interest to an anchored AsLOV2 
location in the dark and then release them upon light illumination. This approach was used to 
regulate Rho GTPase signaling by sequestering constitutively active versions of Vav2, Rac1, 
or PI3K at the mitochondria in dark and releasing them with light (Wang et al., 2016). This 
system can be used with AsLOV2 mutants with half-lives from two seconds to over eight 
minutes, allowing tunability of sequestration/ release (Wang et al., 2016). These tools 
demonstrate the ability to regulate protein function through modulating the proteins’ location 
with light. 
Thesis Statement 
 The studies in this thesis aim to further the field of optogenetics by creating novel 
tools to regulate protein function in the cytosol and nucleus. Chapter II details an approach to 
regulate cytosolic protein function with an AsLOV2 domain to create an inducible 
peroxiomal targeting tag that can be appended to proteins to sequester activity into 
peroxisomes. In Chapter III, nuclear tools were developed to regulate transcription through 
light initiated induction or sequestration of activity with CRY2 technologies. While it was 
clear how the cytosolic peroxisomal system functioned, Chapter IV provided further 
examination of the nuclear transcription tools to try to determine the mechanism behind the 
reaction to light. These systems combined aimed to develop novel approaches to control 
cellular processes that are universally useful to many fields of science such as transcription 
and protein activity, where other systems showed high background activity and low dynamic 
range of control over protein activities in dark versus light. Also, we aimed to uncover 
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Peroxisomes and Peroxisomal Targeting 
Peroxisomes are small organelles found in almost all eukaryotic cells, however their 
morphology differs depending upon the type of tissue and species. These organelles are about 
0.1-1µm in diameter with a single lipid bilayer enclosing them from the rest of the cytosol 
(van den Bosch et al., 1992). Peroxisomes are highly enzymatic, with over 50 enzymes 
known to exist within them. Major roles of these enzymes are detoxification of chemicals, 
such hydrogen peroxide, and beta-oxidation of fatty acids. Due to the role in detoxification of 
potentially hazardous chemicals, the membrane remains tightly closed off to the rest of the 
cytosol even during division through a process of highly regulated fission. Various species 
have other specializations for their peroxisomes including human, whose peroxisomes are 
also involved in the synthesis of cholesterol, bile acids, and ether lipids.  
The number of peroxisomes per cell is highly variable depending upon not only the 
type of cell but also the level of metabolic requirements. Due to the role in detoxification and 
synthesis of bile acids in humans the liver’s hepatic cells are highly abundant in peroxisome, 
but other detoxifying cells such as those in the kidneys also are rich in peroxisomes. In 
comparison yeast cells may have one or two peroxisomes, but higher numbers (and size) can 
be induced in Saccharomyces cerevisiae by growing them with fatty acids as their sole  
2 A portion of this research is published with permission from the American Chemical 
Society Synthetic Biology: Spiltoir et al. 5(7) (2016): 554-560, © ACS Publications 
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source of carbon (Kunau et al., 1995; Veenhuis et al., 1987). Due to the peroxisome’s ability 
to adapt in number, morphology, and contents to environmental stimuli, the role of 
peroxisomal biogenesis was studied in various organisms. This led to many years of heated 
debate of how peroxisomes originated and replicated (Kunau, 2005). The debate ended when 
conclusive evidence that de novo peroxisomes originate from the endoplasmic reticulum was 
published (Hoepfner et al., 2005) and replicated through a process of fission (Hoepfner et al., 
2001; South and Gould, 1999). 
Since peroxisomes are enzymatic powerhouses of the cells they are essential for the 
health of the cells and organism. There are a group of 32 known genes called peroxins or 
PEX genes that function in the maintenance and inheritance of peroxisomes in eukaryotes. 
These genes are necessary for proper peroxisomal formation of the membrane, 
compartmentalization of proteins in the matrix, and proliferation of new peroxisomes. 
Mutations in these genes are debilitating for peroxisomal biogenesis and can lead to a 
number of debilitating or fatal diseases in humans. Examples of peroxisomal biogenesis 
disorders are Zellweger spectrum syndrome, which is the most common and includes 
Zellweger syndrome, infantile Refsum disease, and neonatal adrenoleukodystrophy. Other 
examples are rhizometlic chondrodysplasia punctate type 1 (RCDP-1) as well as multiple 
other less life threatening disorders such as hyperoxaluria type 1, pipecolic academia, 
acatalasia and a multitude more. Zellweger spectrum syndrome disorders are characterized 
by a multitude of symptoms involving a build up of large branch-chain fatty acids causing 
developmental brain disorder which lead to a multitude of other developmental 
malformations. Other disorders have a range of symptoms that can be relatively benign to life 
threatening, but most do not have a cure so treatments target symptom relief.  
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Figure II-1: Peroxisomal targeting with PTS1 or PTS2. Pex5 and Pex7 recognize PTS1 
and PTS2 respectively. Pex7 complexes with Pex18 and Pex21 to form a receptor cargo 
complex. These import receptors shuttle the PTS containing cytosolic protein to the 
peroxisomal membrane for import into the peroxisomal lumen. Pex5 is known to be either 
recycled back out to the cytosol or polyubiquitinated for proteosomal degradation. Figure 1 









While few organelles such as mitochondria have DNA within them, the peroxisome 
relies on nuclear genes to synthesize all of its components and therefore has specific targeting 
methods to transport peroxisomal proteins to the correct location. A short peptide sequence at 
the N- or C- terminal tail of the targeted peroxisomal protein is able to signal peroxisomal 
import receptors, shuttling chaperones, to bind the protein and traffic them to the 
peroxisomal membrane where they are imported into the peroxisomal lumen. Membrane 
bound peroxisomal proteins are recognized and imported by their own receptor and therefore 
will not be discussed. 
 The peroxisomal targeting sequence 1 or 2 (PTS1 or PTS2) designates that the signal 
is on the C- or N-terminal tail of the lumen targeted protein respectively. The PTS2 is 
recognized by peroxisomal import receptor PEX7 which complexes with PEX18 and PEX21 
to form the receptor cargo complex. The PTS1 containing proteins are recognized by 
peroxisomal import receptor PEX5, which is currently not thought to complex with other 
import proteins, but alone can shuttle targeted proteins to the peroxisome (Figure II-1). The 
PTS2 is 26 amino acids in length, but the PTS1 has a minimal motif of three amino acids 
serine-lysine-leucine (-SKL), which have been determined to be sufficient for peroxisomal 
targeting for non-perixosomal proteins (Gould et al., 1987, 1989). This short PTS1 motif is 
used for the majority of peroxisomal proteins and is ideal for the use in optogenetic systems 
such as the one discussed in this chapter because it can easily be appended onto proteins and 
masked. 
Optogenetic Peroxisomal Trafficking Tool Design 
The blue-light-responsive LOV2 domain of Avena sativa phototropin1 (AsLOV2) has 
been used to regulate activity and binding of diverse protein targets with light as discussed in 
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the introduction. In the dark, a C-terminal Jα-helix is bound tightly to the core of AsLOV2 
(Harper et al., 2003), and blue light triggers covalent bond formation between a conserved 
cysteine residue on the LOV domain and a flavin mononucleotide chromophore (Salomon et 
al., 2000; Swartz et al., 2001). This results in unwinding of the Jα-helix and dissociation from 
the LOV core, ultimately affecting phototropin kinase activity (Halavaty and Moffat, 2007; 
Harper et al., 2003, 2004).  
Many optogenetic tools have utilized these structural changes that occur between the 
main LOV domain and the Jα-helix (Bonger et al., 2014; Guntas et al., 2015; Lee et al., 2008; 
Lungu et al., 2012; Niopek et al., 2014; Pham et al., 2011; Rao et al., 2013; Renicke et al., 
2013; Schmidt et al., 2014; Strickland et al., 2010, 2012, 2008; Wu et al., 2009; Yumerefendi 
et al., 2015). Our aim was to develop a light inducible peroxisomal targeting tool, and to do 
this we cloned a PTS1 into the C-terminus of the Jα-helix of AsLOV2 (Figure II-1). A LOV-
PTS1 tag would be easy to fuse onto the C-terminus of proteins to regulate peroxisomal 
targeting, and the small size of the tag would make it ideal for appending onto other proteins. 
LOV Domain Mutations That Alter Kinetics 
In this study, we use multiple variations of the AsLOV2 in order to alter the kinetics 
of our tool to provide a longer half life and to stabilize dark state docking of the Jα-helix. A 
V416I variant of AsLOV2 was shown to have a longer half-life of ~3 min (Strickland et al., 
2012; Zoltowski et al., 2009) and the core also contained mutations T406A and T407A which 
were shown to increase Jα-helix docking (Strickland et al., 2012) and G528A and N538E 
which have been shown to be helix-stabilizing mutations (Strickland et al., 2010). With those 
mutations in the main core specialized mutations were also used to alter the characteristics 
including a deletion, ΔK533, which renders the LOV domain constitutively active with 
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Figure II-2: Model of Optogenetic Peroxisomal Trafficking Tool. (A) Schematic of caged 
LOV-PTS1 construct showing the C-terminal Jα-helix that dissociates from the LOV core 















the Jα-helix in an undocked state. A mutation to strengthen dark state docking of the Jα-helix 
is I532A which has been used in multiple studies to reduce background activity when using 
AsLOV2 as the photoreceptor (Strickland et al., 2010, 2012).  
Materials and Methods 
Strains and Plasmid Construction 
Relevant primer sequences used in cloning described (Table II-1). We used PCR to 
amplify the ‘TULIP’ LOVpep construct pDS248 (Strickland et al., 2012), containing an erbin 
binding peptide at the C-terminus of GFP-AsLOV2-Jα. This construct contains residues 404-
540 of AsLOV2 (numbering corresponds to the corresponding location in the wild-type 
Arabidopsis phototropin 1 sequence), as well as additional mutations T406A, T407A, and 
V416I in the AsLOV2 core. In addition, we added helix-stabilizing mutations G528A and 
N538E. A canonical PTS1 peroxisomal targeting sequence, ‘LQSKL’, was added at the C-
terminus, replacing the erbin PDZ domain. To generate the constitutively active ΔK533 
variant, we used pDS420 as template (Strickland et al., 2012). The GFP-LOV-PTS1 insert 
was cloned into pcDNA3.1 at BamHI and EcoRI sites, using primers 1068f/1070r (LOV-
PTS1.1), 1068f/1072 (LOV-PTS1.2), 1068f/1071r (LOV-PTS1.3), or 1068f/1069r (LOV-
PTS1(∆K533)). To create a tetracycline regulated construct, a nuclear export signal was 
cloned into pcDNA3.1-GFP-LOV-PTS1 at HindIII and BamHI to create pcDNA3.1-NES-
GFP-LOV-PTS1. NES-GFP-LOV-PTS1 was PCR-amplified and cloned into pTRE3G-luc 
between SalI and EcoN1 using primers 1713f/ 1714r. Site directed mutagenesis was used to 
change Ile532 to Ala using primers 1567f/ 1568r. The mCherry-AGTma construct was 




primers 1347f/1373r, and then inserting the coding sequence for alanine: glyoxylate 
aminotransferase at EcoRV and XhoI using 1548f/1541r. For yeast two-hybrid studies, the 
Gal4AD-Pex5 fusion protein was in pGADT7rec (Clontech). LOV-PTS1 was cloned by 
homologous recombination in pDBTrp (a version of pDBLeu (Invitrogen) with a TRP1 
selection marker) (Tucker et al., 2009) using primers 1084f/1085r. The mCherry-FRB 
construct was generously provided by Dr. Matthew Kennedy (University of Colorado School 
of Medicine). 2xFKBP was amplified from 2xFKBP-GFP-homer1c (provided by Dr. 
Kennedy) by PCR and cloned into the pcDNA3.1-GFP-LOV-PTS1.1 vector at KpnI and 
BamHI sites. 
Indirect Immunofluorescence 
HEK293T and COS-7 cells were fixed with 4% paraformaldehyde, permeabilized 
with 0.2% Triton X-100 in PBS with 5% normal goat serum, and incubated with an α-PMP70 
monoclonal antibody (Sigma clone 70-18, SAB4200181, 1:100 dilution) and Cy3-conjugated 
goat anti-mouse secondary antibody (Jackson Immunoresearch 115-165-146, 1:500 dilution).    
Microscopy and Image analysis 
Imaging was performed using two systems:  
1) An Olympus IX71 microscope equipped with a spinning disc scan head (Yokogawa 
Corporation) with a 60x/NA 1.4 objective. Excitation illumination was delivered from an 
AOTF controlled laser launch (Andor Technology) and images collected on a 1024 x 1024 
pixel EM-CCD camera (iXon; Andor Technology). The emission bandpass filters were 
525/30 (GFP), and 685/36 (mCherry). Metamorph software was used for collection of images 
on this system. For light-sensitive experiments, cells were protected from ambient light 
sources by focusing in the presence of filtered light (572/28 bandpass filter, Chroma). 
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 2) A Zeiss AxioObserver Z1 Inverted Spinning Disc microscope with a 63x/NA 1.4 
objective and HQ 480/40x and HQ565/30x (Chroma) bandpass filters. Excitation 
illumination was delivered by a 3i Ablate!™ Model 3iL13 and image collected using a 
Yokogawa CSU-X1CU camera. Slidebook 6 was used for collection of images on this 
system.  
 ImageJ 1.45s and Fiji were used for image analysis. Percent of protein in puncta was 
calculated by first determining the total fluorescence within the cell or cell region and 
subtracting background. Then, the total fluorescence within peroxisomal puncta (background 
subtracted as well was determined using ImageJ thresholding (Otsu’s method) to delineate 
protein within puncta (also background subtracted). The % fluorescence within peroxisomes 
was calculated by dividing the fluorescence within puncta by total fluorescence within each 
cell or analyzed region.  
Cell Culture and Live Cell Imaging 
HeLa, HEK293T, and COS-7 cells were maintained in Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 10% FBS and 1% penicillin-streptomycin at 37o C 
with 5% CO2. Cells were seeded onto a 35 mm glass bottom dish (live cell images) or 
coverslips on a 12 well plate (fixed images) and transfected using Lipofectamine 2000 
(Invitrogen) according to the manufacturer’s protocol. Dark samples were wrapped in 
aluminum foil immediately after transfection, and all manipulations carried out using a red 
safelight. Unless otherwise indicated, light-treated cells were illuminated using a custom 
programmable blue LED light source (461 nm) with a 1 s pulse per 1 min interval, 5.8 
mW/cm2. Media in glass bottom dishes was changed to HBS with 1 mM CaCl2 directly 
before imaging. Live cell imaging was performed at 34o C. 
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Yeast Studies 
Yeast two-hybrid studies were performed using strain AH109 (MATa, trp1-901, leu2-
3, 112, ura3-52, his3-200, gal4∆, gal80∆, LYS2::GAL1UAS-GAL1TATA-HIS3, GAL2UAS-
GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZ, MEL1). Yeast were transformed with 
indicated GalBD and GalAD fusion plasmids, then grown on SC -Trp/-Leu/-His/ +3mM 3-
AT for 3 days at 30˚C in light or dark. The AD-control used was a pGADT7rec-CIB1 
construct that is not expected to bind Pex5. 
Results 
Optogenetic Regulation of Peroxisomal Trafficking 
 To test the model of controlling peroxisomal trafficking through a LOV-PTS1 tag we 
developed a constitutively active form of the tag using AsLOV2(∆K533) fused to the C-
terminus of GFP. The ∆K533 mutant of AsLOV2 has a permanently unwound Jα-helix 
(Strickland et al., 2012) and when an acyl-CoA oxidase PTS1 (-LQSKL) is fused to the end 
of the C-terminal Jα-helix this short peptide sequence would be continually available for 
PEX5 interaction regardless of light illumination. Expression of the GFP-LOV2(∆K533)-
PTS1 showed a punctate pattern resembling peroxisomal localization (Figure II-3A). After 
realizing the feasibility of using the LOV-PTS1 tag we tested a series of Jα-helix truncations 
with AsLOV2 to screen for light dependent peroxisomal targeting (Figure II-3B). The 
AsLOV2 domain used for initial studies also had T406A and T407A mutations that increase 
Jα-helix docking and a V416I mutation 
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Figure II-3: Optogenetic Regulation of Peroxisomal Trafficking. (A) A GFP-
LOV(ΔK533)-PTS1 fusion protein carrying a mutation that eliminates Jα-helix docking 
(ΔK533) shows peroxisomal localization even without blue-light illumination. Scale bar, 
5µm. (B) Alignment of tested sequences with AsLOV2-Jα sequence. Numbering corresponds 
to amino acid residue in the plant AsLOV2 sequence. LOV-PTS1.1 (*) was used in further 
studies. Orange residues indicate regions where mutations were introduced. Yellow residues 
indicate the PTS1 signal. ‘+’ depicts < 5% of cells show peroxisomal localization; ‘-‘ depicts 
> 95% of cells show peroxisomal localization. (C) Localization of GFP-LOV-PTS1 in fixed 
COS-7 cells exposed to light or dark (representative cells shown). COS-7 cells were 
transfected with GFP-LOV-PTS1 and exposed to dark or blue light pulses for 24 hrs,18 hrs 
after transfection. Localization of the peroxisomal marker protein PMP70 is shown at left. 
Scale bar, 10µm (D) Quantification of peroxisomal fluorescence in HeLa cells. Cells were 
transfected with GFP-LOV-PTS1, incubated in dark for 18 hours, then imaged every 10 min 
for 3 hrs. During imaging, cells were exposed to additional LED light treatments. Dark 
treated quantification used the initial image capture at time 0, while light treated 
quantification used the last image in the series (at 3 hr). Data represents the average and 
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that prolongs the illuminated state (Strickland et al., 2012; Zayner et al., 2012; Zoltowski et 
al., 2009) in addition to mutations, G528A and N538E, that were shown to increase the 
dynamic range of previously developed LOV-based tools (Strickland et al., 2010). Insertion 
of the PTS1 in the Jα-helix truncations displayed varying levels of peroxisomal trafficking 
abilities ranging from a inability to traffic GFP to the peroxisome (PTS1.2) to trafficking to 
the peroxisome without light dependence (PTS1.3). The construct GFP-LOV-PTS1.1 with a 
full acyl-CoA oxidase PTS1 starting at amino acid 543 displayed clear light dependent 
trafficking to puncta, which colocalized precisely with a perixomal marker, PMP70 (Figure 
II-3C). This PTS1.1 tag will herein after be referred to as LOV-PTS1 for simplicity. 
Quantification of the peroxisomal import in HeLa cells showed low levels of background 
(dark-state) localization in peroxisomes (1.9+/-1.9% total fluorescence in peroxisomes), but 
within four hours of light stimulation the peroxisomal import was 31.7+/-6.5% of total 
fluorescence in peroxisomes (Figure II-3D).  
Tracking Peroxisomal Import Kinetics with Live-Cell Imaging 
 In order to visualize the kinetics of peroxisomal import with the LOV-PTS1 tag, a 
live-cell imaging approach was taken. HeLa cells were transiently transfected with a NES-
GFP-LOV-PTS1 construct containing a nuclear export signal to deplete the nuclear pool of 
protein. After 18 hours the cells were exposed to blue light pulses and time-lapse microscopy 
was used to visualize import. Within 10-20 minutes of illumination peroxisomal puncta were 
detectable (Figure II-4A), similar to studies of peroxisomal trafficking of permeabilized or 
injected cells (Stephen, 1992; Wendland and Subramani, 1993). Quantification of the import 
over four hours shows the beginning of a plateau in import, which may represent a saturation 




Figure II-4: Kinetics of photostimulated peroxisomal import in HeLa cells over four 
hours. (A) Time lapse images of representative HeLa cell expressing NES-GFP-LOV-PTS1 
exposed to blue light pulses for 4 hrs,18 hrs after transfection. Peroxisomes are highlighted 
using a mCherry-AGTma reporter that localizes to the peroxisome. DNA was transfected at a 
ratio of 3:1 (NES-GFP-LOV-PTS1 to mCherry-AGTma). Scale bar, 10µm. (B) 


















































informed us that a singular pulse of blue light was unable to direct a detectable amount of 
peroxisomal import but rather continuous pulsing was required.  It is unclear how long the 
PEX5 association with the PTS1 lasts after uncaging of the LOV-PTS1 occurs. 
Peroxisomal Translocation is Due to Light-Dependent Binding to PEX5 
 Using a yeast two-hybrid approach we probed whether the light-dependent import of 
GFP-LOV-PTS1 was indeed due to light-dependent binding to PEX5, the peroxisomal 
import receptor (Figure II-5). The yeast two-hybrid arrangement was LOV-PTS1 fused to a 
Gal4 DNA binding domain which was tested for interaction with a PEX5-Gal4 activation 
domain fusion protein (Figure II-5A). While LOV-PTS1 and PEX5 did not interact in the 
dark, they interacted upon blue light illumination as detected by yeast growth from a HIS3 
reporter gene  (Figure II-5B).  
Comparison of Peroxisomal Import with Mutants and Fluorescent Reporters on LOV-PTS1 
 In an effort to optimize the LOV-PTS1 tool we compared the peroxisomal import of 
the original GFP-LOV-PTS1 with multiple AsLOV2 mutants and different fluorescent 
reporters in HEK293T cells (Figure II-6A). After 24 hours of illumination the original GFP-
LOV-PTS1 showed 35.7 +/- 9% of total protein in the peroxisome with only 3.3 +/-3% 
localized in the dark. The constitutively active GFP-LOV(∆K533)-PTS1 was able to achieve 
53 +/-7% total protein in the peroxisome in the same timeframe, which was higher than a 
mCherry tagged version of a naturally peroxisomal protein, alanine: glyoxylate 
aminotransferase major allele (mCh-AGTma), at only 38 +/- 6% total protein in the 
peroxisome. We also tested light dependence of a mCherry fluorescent protein tagged with 
our LOV-PTS1 (mCh-LOV-PTS1), which underperformed the equivalent GFP version when 




Figure II-5: Peroxisomal translocation is due to light-dependent binding to Pex5. (A) 
Schematic showing yeast two-hybrid assay testing interaction of LOV-PTS1 with PEX5. (B) 
BD-LOV-PTS1 does not interact with AD-PEX5 in the dark, but shows interaction under 





























Figure II-6: Varying Levels of Peroxisomal Localization of LOV-PTS1 Tag Mutants 
and Fluorescent Reporters. (A) Quantification of levels of peroxisomal protein with 
indicated PTS1-fused peroxisomal targets. HEK293T cells were tranfected and fluorescence 
quantified after 24 hrs. Light samples received 24hr blue light pulses. Data represents the 
average and standard deviation of one imaging experiment, n = 8. (b-d) Analysis of higher 
caging AsLOV2 mutant I532A in GFP-LOV-PTS1. (B) COS-7 cells were transfected with 
GFP-LOV-PTS1 or GFP-LOV-PTS1(I532A) and incubated in dark or 24 hrs light. Scale bar, 
10μm (C) Quantification of peroxisomal localization in HeLa cells transfected with GFP-
LOV-PTS1(I532A). Cells were incubated in dark 18 hours, then imaged for GFP 
fluorescence every 5 min for 3 hrs. The first image was used to quantify dark background, 
and the last image for light quantification. Cells were exposed to light pulses from an 
external LED during imaging. Data represents the average and standard deviation of one 
imaging experiment, n = 7. This experiment was repeated two times with similar results. (D) 
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 In order to reduce the dark state background localization seen with our original 
construct known mutations were explored that increase docking of the Jα-helix to the LOV 
domain in the dark state. Literature showed an I532A mutation on AsLOV2 was able to  
stabilize the dark state and reduce spontaneous unwinding of the Jα-helix (Strickland et al., 
2010). Using the I532A mutation on our LOV-PTS1 tag was able to eliminate detectable 
dark state localization but also decreased the light initiated import after four hours to about 
half, 16.2 +/-4% total fluorescence in the peroxisome, of the non-mutant version (Figure II-
6B and C). Using live-cell imaging the lack of visible puncta at the initiation of the 
experiment was seen and within 30 minutes of light exposure the peroxisomal puncta were 
detectable (Figure II-6D). While the overall light induced import is decreased with the I532A 
mutation, the spontaneous localization of the dark state was eliminated. 
Cargo Protein Stays Relatively Stable at Peroxisomes After Trafficking 
 To test whether this tool could be used to sequester the protein more permanently in 
the peroxisomes we used the GFP-LOV(I532A)-PTS1 and initiated import for 18 hours 
followed by a dark chase for 24 hours with protein at steady state levels. The I532A mutation 
was able to keep the background levels to 0.5% total protein in the peroxisomes after a total 
of 48 hours post-transfection. The samples that were primed with peroxisomal import for 18 
hours showed no significant difference between levels of peroxisomal protein between cells 
quantified at the start of the dark chase or 24 hours after dark incubation (Figure II-7A). 
These data suggest that over a time period of 24 hours levels of protein in the peroxisomes 
are relatively stable.  
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Figure II-7: Peroxisomal Cargo Protein is Relatively Stable Over 24 Hours. (A) 
Quantification of peroxisomal localization in HEK293T cells transfected with GFP-LOV-
PTS1(I532A). Cells were either incubated in dark for the 48 hrs (‘Dark’), or in dark for 6 hrs, 
then in light for 18 hrs to induce peroxisomal import. Samples were quantified at this initial 
time (t=0), or after an additional 24hr dark incubation (t=24). Data represents the average and 
standard deviation, n = 8. N.S., p > .05. 
 
 
Figure II-8: Light-triggered depletion of a cytosolic reporter protein. HEK293T cells 
expressing NES-GFP-LOV-PTS1 were incubated initially in the dark for 18 hrs. At 18 hrs, 
cycloheximide was added to block translation and light treatment was initiated. GFP 
localization was quantified 0, 4, and 8 hrs after initiation of light treatment. (A) Images of 
representative cells. Scale bar, 10µm. (B) Quantification of percent peroxisomal protein at 0, 
4, or 8 hrs. Data represents average and standard deviation of one experiment; this 
experiment was repeated 2 times with similar results. Dark analysis was from 4 cells; 4 and 8 


































































Peroxisomal Sequestering of a Cytosolic Reporter Protein 
 To more accurately depict how much protein is being sequestered into the 
peroxisomes, new protein synthesis was blocked using cycloheximide. This  
allowed for quantification of peroxisomal import of a singular bulk amount of protein. Using 
cytosolic reporter NES-GFP-LOV-PTS1 there was only 3% peroxisomal localization in dark, 
but blue light illumination resulted in significant depletion of cytosolic protein into the 
peroxisome to 55 +/-6.8% of total cytosolic protein (Figure II-8A and B). This robust 
sequestering of the protein into peroxisomes was dose dependent with duration of light 
illumination. This suggested the LOV-PTS1 tag could be used as a light-regulated trafficking 
signal to sequester a protein of interest from the cytosol, a tactic that has been used with other 
optogenetic tools (Crefcoeur et al., 2013; Lee et al., 2014; Niopek et al., 2014; Yang et al., 
2013; Yumerefendi et al., 2015). 
The LOV-PTS1 Tag is Unable to Traffic Rapamycin-Induced Dimers into Peroxisomes 
 With the notion of using the LOV-PTS1 tag to regulate endogenous proteins that 
interact in the cell, we designed an experiment using proteins that dimerize upon the addition 
of rapamycin. Multiple studies suggest that proteins can be imported into the peroxisome as a 
‘piggybacking’ pair (Glover et al., 1994; Islinger et al., 2009; McNew and Goodman, 1994), 
so our approach tests if our tag can deplete interacting proteins from the cytosol. We used 
inducible dimerizers FRB and FKBP, which do not interact when coexpressed but dimerize 
in the presence of rapamycin (Spencer et al., 1993). FKBP12 was fused to the N-terminus of 
GFP-LOV-PTS1 and this was coexpressed with a mCherry-labeled FRB (mCh-FRB) (Figure 
II-9A). When expressed alone or coexpressed with mCh-FRB in the absence of rapamycin, 
peroxisomal trafficking of FKBP-GFP-LOV-PTS1 could be triggered upon light  
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Figure II-9: Rapamycin-induced dimerization blocks light-triggered peroxisomal 
import of GFP-LOV-PTS1. (A) Schematic of constructs used in studies. (B) When 
coexpressed in COS-7 cells with mCherry-FRB, FKBP-tagged GFP-LOV-PTS1 is inducibly 
targeted to the peroxisome in the presence of a DMSO control, but targeting is blocked with 
addition of rapamycin, which induces FRB-FKPB dimerization. Constructs were transfected 
at a ratio of 2:1 (FKBP-GFP-LOV-PTS1 to mCherry-FRB). Translocation of FKBP-GFP-
LOV-PTS1 expressed alone is not affected by DMSO or rapamycin. Scale bar, 10µm.
me? 
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illumination; however, when the dimerizing constructs are co-expressed in the presence of 
rapamycin, no peroxisomal import could be detected for either construct (Figure II-9B). 
Testing the effect of rapamycin demonstrated that it has no effect on peroxisomal import. 
 These data suggest that the LOV-PTS1 is not sufficient for trafficking a multimeric 
protein, in the form of dimerizing proteins, into the peroxisome. Recent studies have 
suggested that peroxisomal import of oligomeric proteins can be inefficient (Freitas et al., 
2015), which proposes that oligomeric proteins or protein complexes may have other factors 
that influence their import into peroxisomes that are currently not known. In addition, it 
cannot be excluded that dimerization with FRB-mCh may sterically interfere with the 
interaction of LOV-PTS1 and Pex5. 
LOV-PTS1 with Actin Nucleating Factor, VCA, is Unable to Traffic to Peroxisomes 
 In a design to regulate actin cytoskeleton with the LOV-PTS1 tool, the Verprolin, 
Central, Acidic (VCA), the C-terminal domain of the Wiskott-Aldrich Syndrome Protein, 
was fused to the NES-GFP-LOV-PTS1. This domain in isolation is a constitutively active 
actin nucleation regulator, as the N-terminus acts to suppress its activity in the wildtype 
protein. We hypothesized VCA-NES-GFP-LOV-PTS1 would be available to stimulate actin 
polymerization in the dark state, but illumination would sequester the protein into 
peroxisomes and block VCA activity (Figure II-10A). The results revealed VCA-NES-GFP-
LOV-PTS1 was unable to be trafficked into peroxisomes upon light illumination (Figure II-
10B) and overexpression of the VCA containing construct disrupted actin cytoskeleton 
(Figure II-10C and D). Peroxisomes are known to be associated with actin fibers, which are 
important for mobility of the organelle (Hoepfner et al., 2001; Schollenberger et al., 2010), it  
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      C   NES-GFP-LOV-PTS1 + mCh-Actin 
 
      D    VCA-NES-GFP-LOV-PTS1 + mCh-Actin 
 
Figure II-10: Fusion of VCA to LOV-PTS1 tagged protein disrupts actin cytoskelton 
and blocks peroxisomal import. (A) Schematic of constructs used for experiments (B) 
When coexpressed in COS-7 cells with mCherry-Actin, NES-GFP-LOV-PTS1 is targeted to 
the peroxisome with light, but targeting is blocked by fusion of VCA. (C and D) Magnified 
images of the mCherry-Actin filaments with (C) NES-GFP-LOV-PTS1 alone and (D) VCA 

























































cannot be discounted that the disruption of actin cytoskeleton may also interrupt proper 
trafficking to these organelles.  
Discussion 
These data together show the ability of a LOV-PTS1 tag to control peroxisomal 
localization of proteins of interest with light. The highest dynamic range was achieved with 
an acyl-CoA oxidase PTS1 (-LQSKL) fused within the Jα-helix of AsLOV2 starting at amino 
acid A543. This placement mimic sites used in the optogenetic TULIP dimerizers (Strickland 
et al., 2012) and is close to where others have caged short peptide sequences such as the 
degron sequence (-RRRG) (Bonger et al., 2014) and a ssrA peptide for dimerization (Lungu 
et al., 2012). Multiple groups have also successfully caged variations of nuclear localization 
signals at Ile539, Asp540, or to cage a bipartite NLS, Lys544 (Niopek et al., 2014; 
Yumerefendi et al., 2015), which have allowed them to control cellular trafficking between 
compartments in the cell similar to the way our tool was intended. Our results and others 
show the comprehensive way in which the AsLOV2 caging mechanism can be utilized by 
fusing short peptides into the Jα-helix within residues 539-544. Each tool has slightly 
different kinetics and dynamic range, which suggests even with the same photoreceptor each 
tool needs to be experimentally tested for novel uses. Also, as we saw with our truncations 
(Figure II-3B), placement of the peptide can produce drastically different results, so cloning 
optimization is necessary. 
The LOV-PTS1 tag demonstrated some inefficiency throughout these studies. The 
tool was not able to completely sequester the cytosolic reporter protein within eight hours, 
despite new protein synthesis being turned off. Potential saturation of the import machinery 
may be at play. Due to the fact that we are highly overexpressing these proteins, there is the 
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possibility that expressing proteins at lower levels equivalent to endogenous genes we may 
see better results. Our attempts to regulate interacting proteins and cytoskeletal regulators 
were unsuccessful, which suggests that the PTS1 is not universally sufficient for import into 
the peroxisome. There may be specific requirements to importing multimeric proteins into 
peroxisomes.  
With optimization, we think our tool could have use in studying various disease states 
and remaining biological questions related to peroxisomal trafficking. With the LOV-PTS1 
tag, users can inducibly target proteins to the peroxisome at specific times, or within defined 
locations, and to study kinetics of peroxisomal import and to track peroxisomal cargo. The 
various peroxisomal biogenesis diseases such as Zellweger Syndrome Spectrum, where 
mutations cause aberrant peroxisomal function, can be explored through trafficking specific 
mutations on PEX proteins to peroxisomes during biogenesis to tease apart their roles. 
Mislocalization of peroxisomal proteins, as with metabolic disease primary hyperoxaluria 
(Danpure et al., 1989), can be explored. Since the peroxisomal import machinery can reach 
saturation (Wendland and Subramani, 1993), we posit that the LOV-PTS1 module may also 
be utilized in competition experiments, broadly blocking peroxisomal protein import at 
specific times and locations. 
We also envision this tool being used broadly to deplete protein from the cytosol, 
however this process is slow and does not completely remove the protein from the cytosol 
within eight hours, but, these timescales, are comparable to other approaches to deplete 
protein activity with light through inducible degradation (Bonger et al., 2014; Renicke et al., 
2013). With the ubiquitous nature of peroxisomes and the conserved mechanism of import 
we believe this tool can be optimized to many systems and novel uses. 
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CHAPTER III 




History of Regulating Transcription 
As the first step to gene expression, transcription is a key regulatory factor in the cell 
and thus the means to precisely control it is a powerful tool. The first inducible system was a 
crude method of control using a heat shock promoter as the regulatory agent upstream of a 
gene. Activation was achieved by heat shocking the model organism, usually a transgenic 
animal (Blochlinger et al., 1991; González-Reyes and Morata, 1990; Ish-Horowicz and 
Pinchin, 1987; Ish-Horowicz et al., 1989; Schneuwly et al., 1987; Steingrimsson et al., 1991; 
Struhl, 1985). A more spatially specific, but less tunable method of gene regulation was to 
use a well characterized, specific promoter to regulate the gene, such as a tissue specific 
promoter which limited transcription to a subset of cells (Parkhurst and Ish-Horowicz, 1991; 
Parkhurst et al., 1990; Zuker et al., 1988). These methods often involve transgenic models 
and lack the fine-tuning that present transcriptional regulation systems have achieved. 
Bidirectional control over transcription was achieved when a chemically regulated 
system was developed using the control elements of a tetracycline-resistance operon with a 
tetracycline transactivator protein to control a downstream reporter gene with the presence or 
absence of tetracycline or doxycycline (Gossen and Bujard, 1992; Gossen et al., 1995). The  
Tet-On/Tet-Off regulatory systems demonstrated dose-dependent chemical control over  
3 A portion of this research is under review by Nucleic Acids Research: Pathak and Spiltoir et 
al. © Oxford University Press  
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transcription, which revolutionized the ability to regulate genes in vivo. Similar regulatory 
systems such as the GalUAS regulatory system using Gal4 transcription factor were 
developed showing similar tunability (Brand and Perrimon, 1993). While the dose dependent 
nature of these chemical systems was a substantial improvement over previous systems, they 
lacked spatial resolution and fast kinetics. In addition, chemicals can be difficult to 
completely remove from cells and the most aggressive methods of chemical removal 
involving replating of the cells. In a study it was found that doxycycline, the Tet-system 
regulator, binds nonspecifically to extracellular matrix and cell components leading to a slow 
release of the chemical throughout washes (Rennel and Gerwins, 2002).  
 Light regulation provided an alternative method to potentially overcome the 
limitations of chemical means of regulation. One of the first soluble optogenetic systems 
focused on using light to regulate transcription in yeast by reconstituting a split Gal4 
transcription factor using the phytochrome B and PIF3 light dependent interaction (Shimizu-
Sato et al., 2002). This study paved the way for optimizing usage of light to regulate 
transcription with a variety of optogenetic photoreceptors (Crefcoeur et al., 2013; 
Konermann et al., 2013; Liu et al., 2012; Motta-Mena et al., 2014; Müller et al., 2013b; 
Polstein and Gersbach, 2012; Wang et al., 2012; Yazawa et al., 2009). While these systems 
have shown great promise in regulating transcription, the level of background and dynamic 
range leave room for optimization in order to create a universal system that works in all cell 




Figure III-1: Optogenetic split transcription tool is unable to induce activity with light. 
(A) Model of the split transcription system. (B) Luciferase activity of mammalian split 
transcriptional system using GalBD-CRY2 and VP16AD-CIB1. HEK293T cells were 
transfected with the AD and BD constructs and a GalUAS-luciferase reporter, then incubated 
in dark or exposed to light pulses for 18 hrs before assaying for luciferase activity. Fold 
increase in luciferase activity is shown compared to reporter only controls. Data represents 












































































Regulating Transcription with CRY2 
The Tucker laboratory has worked extensively to develop novel uses for the 
Arabidopsis thaliana cryptochrome 2 (CRY2) photoreceptor including utilizing its light 
dependent interaction with CIB1 to reconstitute a split transcription factor in yeast, similar to 
the methods above (Hughes et al., 2012a; Kennedy et al., 2010; Pathak et al., 2014). With 
low background and a high dynamic range these systems showed great promise, but while 
transitioning the CRY2-CIB1 split transcription factor tool into mammalian cells our group 
found the ability to regulate transcription was severely diminished (Figure III-1); this 
phenomenon was seen in other studies as well (Chan et al., 2015; Konermann et al., 2013; 
Liu et al., 2012). Mammalian cell results demonstrated high background activity (Chan et al., 
2015; Konermann et al., 2013).. The DNA binding domain fused to CIB1, which is a 
transcriptional activator (Liu et al., 2008, 2012), allows for spontaneous activation of the 
reporter gene. Our system was designed with the Gal4 DNA binding domain fused to CRY2 
and the activation domain bound to CIB1 (Figure III-1A), which reduced background but 
abolished the light dependent activation. 
 The aim of this study was to determine why the tool that functioned so robustly in 
yeast was unable to stimulate transcription in mammalian cells. While exploring the possible 
mechanisms, we discovered that the fusion of CRY2 to multimeric transcription factor DNA 
binding domains stimulates a nuclear clearing phenotype. This nuclear clearing is associated 
with the loss of transcriptional function, which led to the optimization of a novel optogenetic 
tool to suppress transcription with light by fusing an intact multimeric transcription factor to 
CRY2. Using the information about the clearing of protein in the nucleus, a second 
generation of the split transcription factor tool was developed that removed the dimerization 
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domain from the DNA binding domain fused to CRY2. This improved system demonstrated 
induction of transcription with light with low background and high dynamic range. The 
systems developed in this aim not only improved upon current optogenetic regulation of 
transcription, but also the nuclear clearing information could lead to optimized higher 
dynamic range of previously developed optogenetic tools in the nucleus such as the light 
dependent CRISPR-dCas9 systems (Nihongaki et al., 2015a, 2015b; Polstein and Gersbach, 
2015).  
Materials and Methods 
Constructs 
Summarized construct features are provided for constructs described below (Table 
III-1). GalBD-CRY2 (B689) and VP16-CIB1 (B692) were PCR amplified from yeast two-
hybrid plasmids (Hughes et al., 2012a; Kennedy et al., 2010) and cloned into pCMV-Gal4 
(Addgene 24345) after removing Gal4 by Kpn I/Not I digestion (for GalBD-CRY2) or Kpn 
I/Age I digestion (for VP16-CIB1). CRY-GalVP16 (B695) was generated by digesting 
CRY2-CreN (Kennedy et al., 2010), containing CRY2(+NLS) downstream of a mCherry-
IRES sequence, with Not I and Xma I to remove CreN, and inserting a 573bp fragment of 
Gal4BD-VP16AD (also digested at Not I/Xma I sites) containing residues 413 to 454 of 
VP16. To generate CRY(∆NLS)-mCh-tTA (B714), tTA2 (from pBT224_(pCA-tTA2), 
Addgene 36430) was amplified by PCR and inserted into CRY(∆NLS)-mCh(Kennedy et al., 
2010) at Bsr GI/Not I sites. The galUAS-luciferase reporter was pGL2-GAL4UAS-Luc 
(Addgene 33020); the tetO-luciferase reporter was pTRE3G-luciferase (Clontech).  
CRY-GalΔDD-VP16 (B1012) is equivalent to CRY-GalVP16 but missing residues 
66-95 of the Gal4 binding domain (comprising the majority of the dimerization domain). To 
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generate this, a fragment containing Gal4BD residues 1-65 and an engineered ‘SR’ linker 
containing an Xba I site, and a second fragment containing Gal4BD residues 96-147 through 
the end of VP16 were amplified, then joined by overlap extension PCR. The GalBD(Δ66-
95)-VP16 PCR product was ligated into B695 (CRY-GalVP16) at Not I and Xma I sites. 
GalVP16 (B1018) and Gal∆DD-VP16 (B1019) were generated from B695 and B1012, 
respectively, by digesting with Not I and Sal I to remove the CRY2 fragment, followed by 
blunt end fill-in with T4 DNA Polymerase and ligation. To generate CRY-dsRed-GalΔDD-
VP16 (B1017), flanking Not I sites were added to dsRed by PCR, and this fragment was 
ligated between CRY2 and Gal(ΔDD) at the Not I site of GalBD(Δ66-95)-VP16. 
 CRY-Gal(1-65) (B1013) contains a fusion of CRY2 with Gal4(1-65), and was cloned 
by digesting CRY-Gal(ΔDD)-VP16 with Xba I and Sma I to remove Gal4(96-147) and 
VP16, blunt end fill-in with T4 DNA Polymerase, followed by ligation. CIB1-VP16-CIB1 
(B1015) was cloned by amplifying CIB1 using PCR to add flanking Kpn I sites, then ligating 
this fragment into B692 (VP16-CIB1) at a Kpn I site N-terminal to VP16. CIB1-VP16 
(B1014) was generated by amplifying CIB1-VP16 from CIB1-VP16-CIB1 using PCR, then 
ligating into pcDNA3.1+ at Eco RV and Xba I sites. CIB1-VP64 (B1016) was cloned by 
removing CreC in the plasmid CIB1-CreC(N1)(Taslimi et al., 2016) (Addgene 75367) at Bsp 
EI and Bsr GI sites and replacing with a SV40 NLS-VP64 fragment amplified from pcDNA-
dCas9-VP64 (Addgene 47107). 
To generate CRY-GalVP16l (B694), first mCherry was removed in the construct 
CRY(∆NLS)-mCh(Kennedy et al., 2010) (cut with Xma I/Not I) and replaced with the Gal4 
DNA binding domain (residues 1-147). Next, a fragment containing residues 1-147 of Gal4 
DNA binding domain, a glycine-serine (G-S) linker, then the VP16 activation domain 
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(residues 413-490) was inserted at Bsr GI-Not I sites to generate CRY-GalVP16l. To 
generate CRY-tTA (B702), CRY2(∆NLS)-mCh (Kennedy et al., 2010), containing CRY2 
with a mutated NLS sequence in the pmCherryN1 vector (Clontech), was digested at Xma I 
and Not I sites to remove mCherry, and replaced with tTA from pBT224_(pCA-tTA2) 
(Addgene 36430) digested with Xma I and Not I. CRY2olig(FL)-tTA (B703) was generated 
by inserting full length CRY2olig (E490G CRY2∆NLS) between the Xho I and Xma I sites 
of CRY-tTA. CRY2-dCas9-VP64 was cloned in the backbone pcDNA3.1 using Gibson 
Assembly. The dCas9 fragment was amplified from pcDNA3.1-dCas9-VP64 (Addgene 
47107) using the primers 5’-GAAACGCAAA GTTGGGCGCG CCCGCGGAAT 
GGATAAGAAATACTC-3’ and 5’- CGTCCAGCGC GTCGGCGCGC CCAACTTTGC 
GTTT-3’and cloned into pcDNA3.1-CRY2FL-VP64 (Addgene 60554) at the Pac I site. 
 pGL2-GalUAS-GFP-HA (B1007) contains GFP (GFPuv variant) followed by the 
nuclear export signal (NES) of Id1 (amplified from GFP-Id1NES by PCR) inserted at Hind 
III/Eco RI sites into pGL2-GalUAS-Luc (Addgene 33020). A HA epitope was ligated in 
frame after GFP at Avr II/Cla I sites to yield pGL2-GalUAS-GFP-HA. pGL2-GalUAS-GFP-
LOVdeg (B710) is in the same backbone, and contains GFP-NES followed by a LOV-degron 
sequence (PCR amplified from pBMN HAYFP-LOV24, Addgene 49570) inserted at the Bsr 
GI site at the C-terminus of GFP. The CMV-GFP-LOVdeg construct (B711) was generated 
by inserting the GFP-LOVdeg fragment from pGL2-GalUAS-LOVdeg into the pcDNA3.1 
backbone after the CMV promoter (Hind III site).  
Cell Culture and Light Treatment Conditions 
HEK293T cells were maintained in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% FBS at 37oC with 5% CO2. HEK293T cells were transfected using 
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calcium phosphate or Lipofectamine 2000 or 3000 (Invitrogen), according to the 
manufacturer’s protocol. Cells were transfected with 1 µg DNA for each construct (for 
experiments in 12-well plates) or scaled up accordingly for larger plates. DNA was 
transfected at a ratio of 1:1 (2 constructs, 2 µg total DNA per well), 1:1:1 (3 constructs, 3 µg 
total per well), or 1:1:1:1 (4 constructs, 4 µg total DNA). Nonspecific ‘stuffer’ DNA (for 
example, pmCherry-N1 empty vector) was included in transfections as needed to ensure all 
transfection wells contained equal amounts of DNA. Dark samples were wrapped in 
aluminum foil immediately after transfection. Light-treated cells were illuminated using a 
custom programmable blue LED light source (461 nm, 7.4-18 mW/cm2). Pulse length and 
interval used was 2s pulse every 3 min for all experiments (1.1% duty cycle), unless 
differently indicated. Light dosage experiments shown in Figure III-6F used a custom built 
LED light source designed for 24-well plates and low illumination levels (Gerhardt et al., 
2016) and used constant blue light rather than pulses. 
Luciferase Assays 
Measurement of luciferase activity (Fluc) was carried out using the Luciferase Assay 
System (Promega) according the manufacturer’s protocol. A Modulus microplate reader 
(Turner Biosystems) was used to quantify luminescence. Fluc activity was normalized using 
a cotransfected RSV-lacZ control in which ß-galactosidase activity was determined using an 
ONPG assay (Clontech Laboratories, protocol #PT3024-1) using o-Nitrophenyl-β-D-
Galactopyranoside (Thermo Scientific) as a substrate. Fluc/lac activity is represented as fold 





Total RNA was prepared using TRI reagent (Molecular Research Center) following 
the manufacturer’s protocol. RNA was verified by calculation of OD280/260 ratio using an 
Eppendorf spectrophotometer. To remove genomic DNA, total RNA was treated with RQ1 
RNAse free DNAse (Promega). High Capacity cDNA Archive Kit (Applied Biosystems) was 
used to synthesize cDNA from DNAse- treated total RNA (2 µg of total RNA) using random 
hexamers. Quantification of firefly luciferase mRNA and mCherry mRNA (internal control) 
was performed on Applied Biosystems 7300 real-time PCR system using Power SYBR 
Green Master Mix (Applied Biosystems). Samples were run in triplicate, and the average 
cycle threshold (CT) was calculated. The average luciferase CT value for each sample was 
normalized to the corresponding average mCherry CT value to obtain a ΔCT value. The fold 
change in luciferase mRNA expression relative to reporter only samples was calculated using 
the comparative CT (ΔΔCT) values. Primer sequences used for firefly luciferase were 5’-
GCTATTCTGA TTACACCCGA GG-3’ and 5’-TCCTCTGACA CATAATTCGC C-3’ and 
for mCherry were 5’-CACTACGACG CTGAGGTCAA-3’ and 5’-GTAGTCCTCG 
TTGTGGGAGG-3’.  
CRISPR/dCAS9-VP64 Studies 
HEK293T cells were transfected using Lipofectamine 3000 (Invitrogen) with 255 ng 
gRNA expression plasmid (63.75 ng of plasmid DNA encoding each of four gRNAs 
targeting IL1RN or the off-target control HBG1) and 245 ng of  pcDNA3.1-CRY-dCas9-
VP64. Primer sequences and standard curves were previously described (Perez-Pinera et al., 
2013). IL1RN gRNAs were CR1 (TGTACTCTCTGAGGTGCTC, at -29), CR2 
(ACGCAGATAAGAACCAGTT, at -180), CR3 (CATCAAGTCAGCCATCAGC, at -113), 
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CR4 (GAGTCACCCTCCTGGAAAC). HBG1 control gRNAs were CR1 ( 
GCTAGGGATGAAGAATAAA, -26), CR2 (TTGACCAATAGCCTTGACA, -101), 
(TGCAAATATCTGTCTGAAA, -163), (AAATTAGCAGTATCCTCTT, -209).  As a 
negative control cells were transfected with 500 ng of an empty pCMV plasmid. Cells were 
either illuminated with blue light using a custom-built 6x4 LED array (1 s pulses every 15 s, 
450 nm, 16 mW/cm2) starting four hours after transfection or incubated in the dark for the 
entire experiment. Three days after transfection total mRNA was purified using Qiagen 
RNeasy spin prep columns. cDNA was synthesized using the SuperScript® VILO cDNA 
Synthesis Kit (Life Technologies). Relative levels of cDNA were detected using Quanta 
PerfeCta® SYBR® Green FastMix® (Quanta Biosciences) and CFX96 Real-Time PCR 
Detection System (Bio-Rad). Raw data was normalized to GAPDH levels and cells 
transfected with an empty plasmid control using the ΔΔCT method.  
Immunoblotting 
For total cell preps, cells were washed in 1x PBS, collected, and lysed in 2x Laemmli 
sample buffer by boiling. Proteins were separated by electrophoresis on an SDS-PAGE gel 
and transferred to nitrocellulose membranes, followed by probing with primary antibodies: 
GFP (G1544, Sigma-Aldrich, dilution 1:3750), beta-actin (sc-47778, Santa Cruz 
Biotechnology, dilution 1:1000), mCherry (PA5-34974, Thermo Scientific, dilution 1:1000), 
α-tubulin (926-42213, LI-COR, dilution 1:1000), or Gal4DBD (sc-577, Santa Cruz 
Biotechnology, dilution 1:1000).  IRDye® secondary antibodies (dilution 1:15,000) and an 





Cells grown on coverslips were washed with PBS then fixed with 4% 
paraformaldehyde in PBS for 15 min. Coverslips were washed with PBS and 
permeabilized/blocked in 5% Normal Goat Serum (Jackson ImmunoResearch Laboratories) 
and 0.1% Triton® X-100 (Amresco) in PBS for one hour. Cells were incubated at room 
temperature for two hours with anti-Gal4BD primary antibody (Santa Cruz Biotechnology, 
sc-577) in permeablization buffer. Cells were washed in PBS and incubated with 
AlexaFluor® 488 Goat anti-rabbit IgG (Invitrogen) for one hour. Cells were washed in PBS 
and mounted on slides with FluoromountG® (SouthernBiotech) .  
Imaging 
HEK293T cells were cultured in DMEM with 10% FBS, then seeded onto 35-mm 
glass bottom dishes or on coverslips in 12-well plates prior to transfection. Calcium 
phosphate or Lipofectamine 2000 (Life Technologies) was used for transfection, according to 
the manufacturer’s protocol. For imaging of fixed cells, cells were washed in PBS, fixed in 
4% paraformaldehyde, and mounted on glass slides using Fluoromount-G (Southern 
Biotech). For live cell imaging, cells were grown in glass bottom dishes, then media was 
exchanged for HBS with 1 mM CaCl2 and samples were imaged at 33.5°C. Samples were 
protected from ambient light sources using a red safelight and by focusing in the presence of 
filtered light (572/28 bandpass filter, Chroma). Cell imaging was performed on either: 1) An 
Olympus IX71 microscope equipped with a spinning disc scan head (Yokogawa Corporation 
of America) with a 60x/NA 1.4 objective. Excitation illumination was delivered from an 
AOTF controlled laser launch (Andor Technology) and images collected on a 1024 x 1024 
pixel EM-CCD camera (iXon; Andor Technology) using Metamorph (Molecular Devices) 
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software. 2) A Ziess AxioObserver Z1 Inverted Spinning Disc Confocal Microscope with a 
63x/NA 1.4 objective. Excitation illumination was delivered by a 3i Ablate!™ Model 3iL13 
and image collected using a Yokogawa CSU-X1CU camera. Slidebook 6 was used for all 
collection of images on this system.  
 Spatial control studies were performed with HEK293T cells on 10cm plates and were 
imaged with an UltraThin LED Illuminator (GelCompany, TBL-01) using an iImage GelDoc 
imaging stage with PureShot imaging software on an iPhone 6S platform. 
Image Analysis 
 After initial image collection, ImageJ 1.45s was used for all image analysis. For 
nuclear:cytoplasmic quantification, confocal image Z-stacks were first compiled into a 
maximal projection. Total fluorescence in either the nucleus or cytosol was calculated by 
manually selecting either the nucleus or cytosolic region of interest and quantifying average 
fluorescence and area within these compartment. A separate region of the image was used to 
calculate background, which was subtracted from the average fluorescence. Average 
fluorescence was multiplied by area and calculated for nuclear vs cytosolic regions, then 
these were divided to obtain a ratio of nuclear: cytosolic protein.   
  For zebrafish image quantification, we calculated the total fluorescence for each 
embryo (Average Fluorescence x Area), after background subtraction. All embryos 
(including control uninjected embryos) showed significant autofluorescence, as indicated on 
graph. To control for variation in size between embryos in different groups, we normalized to 
a single, representative size, equal to the average. Nine embryo images were analyzed for 
light/dark samples, and seven for controls. Statistical significance for experiments comparing 
two populations was determined using a two-tailed unpaired Student's t-test.  
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Zebrafish Studies 
A UAS-GFP transgenic zebrafish line (Tg(5xUAS:EGFP)nkuasgfp1a) was 
used(Asakawa et al., 2008). This line was generated by the Kawakami laboratory (National 
Institute of Genetics, Japan) and was a kind gift from Maximiliano Suster (University of 
Bergen). The permits for the experiments were obtained from the Office of the Regional 
Government of Southern Finland in agreement with the ethical guidelines of the European 
convention. 
 Embryos were staged in hours post-fertilization (hpf). Developing embryos were 
injected at the one cell stage then incubated for 3 hr at 28°C in room light to recover from 
injections. After 3 hr (at 3 hpf) embryos were either placed under blue light (10s pulse every 
3min, 5mW/cm2) or put in the dark. The light source was a custom LED array (470 nm). 
Light treatment was maintained for the duration of the experiment. At indicated times, 
embryos were fixed in 4% paraformaldehyde in PBS, then washed with PBS and 
dechorionated. Embryos were subsequently incubated with 50% glycerol for 1h and 
transferred to 80% glycerol in PBS. Embryos were kept in 80% glycerol in PBS at 4°C, then 
placed on glass slides for imaging. Imaging was carried out using a Leica TCS SP2 AOBS 
Confocal microscope (Leica Microsystems, Mannheim, Germany). Stacks of images were 
taken at 1.1µm intervals (z-axis) using an Argon laser and compiled to maximum intensity 
projection images using Leica Confocal Software. For toxicity testing (Supplemental Table 
1), embryos were injected with 20pg CRY-GalVP16, treated with the same light/dark 
conditions as above, and assayed for viability at 27 hpf. Data is expressed as number of live 
embryos/number of embryos injected. Each group contained n = 20-43 embryos and each 
experiment was repeated three times.  
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Figure III-2: Nuclear loss is seen with GalBD-CRY2 but not with other CRY2 fusion 
proteins. (A) Representative HEK293T cells expressing GalBD-CRY2 kept in dark or 
exposed to blue light pulses for 18 hrs, immunostained using an anti-Gal4BD antibody. Scale 
bar, 10 µm (B) HEK293T Cells expressing CRY2-mCherry were kept in dark or exposed to 
18 hours blue light pulses Scale bar, 10 µm. Cells show a slight reduction of percent nuclear 
protein after blue light, as quantified in graph at right. Data represents average and error (s.d., 



















































































 Transcriptional activation has worked robustly in yeast models with various 
transcription factors (Hughes et al., 2012a; Kennedy et al., 2010; Pathak et al., 2014), but we  
were unable to repeat this in mammalian cells using Gal4 DNA binding domain-CRY2 
(GalBD-CRY2) and VP16 activation domain-CIB1 (VP16-CIB1) fusion proteins (Figure III-
1). To determine the cause of inefficiency in the mammalian system we tracked localization 
of the GalBD-CRY2 fusion protein. In the dark the protein showed robust nuclear 
localization, but after illumination with 18 hours of light the nucleus appeared to have 
cleared (Figure III-2A). The phenomenon is not universal to CRY2 fusion, as CRY2 fused to 
mCherry stay predominantly nuclear after eighteen hours of illumination (Figure III-2B).  
CRY2-fused Transcription Factors are Redistributed Correlating with Functional Loss 
In order to more directly track the correlation between localization and function of the 
CRY2-transcription factor fusion proteins, an intact transcription factor was fused to CRY2.  
Synthesized constructs included a CRY2 fused Gal4BD-VP16AD synthetic transcription 
factor (Sadowski et al., 1988) (CRY-GalVP16) and a ‘tTA’ (Tet-OFF) transcriptional 
activator (Gossen and Bujard, 1992) (CRY∆NLS-mCh-tTA). While both CRY2-intact 
transcription factor constructs showed robust activity in the dark, blue light exposure was 
able to significantly decrease the luciferase levels to 3.6% of dark level for CRY-GalVP16 
(Figure III-3A) and 6.8% of dark levels for CRY∆NLS-mCh-tTA (Figure III-3B). Steady-
state protein levels were not diminished with light for both constructs suggesting that protein 
loss was not the mechanism by which functional loss occurred (Figure III-3C). This led us to 
track the redistribution that occurs with the total protein after light exposure and both CRY- 
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Figure III-3: CRY2-fused transcription factors are cleared from the nucleus with light 
correlating with functional loss. (A-B) Luciferase activity of HEK293 cells expressing 
CRY-GalVP16 and a GalUAS-luciferase reporter (A) or CRY2∆NLS-mCh-tTA and a 
7xtetO-luciferase reporter (B) incubated 18 hrs in dark or with blue light pulses. Data 
represents average and error (s.d.) for 3 independent experiments. (C) Immunoblot of 
HEK293T cells expressing CRY-GalVP16 (top) or CRY2∆NLS-mCh-tTA (bottom) and 
exposed to dark or light pulses for 18 hr. Samples were also blotted with α-tubulin as a 
loading control. (D) Representative immunostaining (CRY-GalVP16, Gal4BD antibody) or 
fluorescence (CRY2(∆NLS)-mCh-tTA) images showing localization of CRY2-fused proteins 
exposed to dark or light for 18 hrs. The ratio of nuclear:cytosolic protein from multiple cells 
is quantified in graph at right. Data represents average and error (s.d., n=10). Scale bar, 10 
µm. (E) Kinetics of nuclear depletion. Cells expressing CRY2 fusion constructs were 
incubated in dark for 16 hrs, then exposed to blue light pulses for indicated times before 
fixation. The ratio of nuclear:cytosolic protein from fixed cells was then quantified. Data 
represents average and error (s.d., n=4). (F) Reversibility of nuclear depletion. HEK293T 
cells expressing CRY2(∆NLS)-mCh-tTA were treated with light for 18 hrs, then incubated in 
dark for indicated times before fixing and quantifying nuclear:cytoplasmic ratio as in (E). 
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GalVP16 and CRY∆NLS-mCh-tTA were redistributed in the nucleus, exhibiting a nuclear 
cleared phenotype similar to GalBD-CRY2 (Figure III-3D).  
  To probe the kinetics of the nuclear clearing phenotype we ran a timecourse tracking 
the fluorescent reporter-tagged CRY∆NLS-mCh-tTA protein or by immunostaining CRY- 
GalVP16 protein using an anti-Gal4BD antibody. With both constructs, nuclear clearing 
occurred over several hours (Figure III-3E), which gives insight into the mechanism of 
clearing. One consideration is that the protein is being diluted out through cell division; 
however, HEK293T cells double at a rate of approximately 20 hours, which does not fit the 
results of the timecourse. Triggered export of nuclear export signal (NES) containing 
proteins via the CRM1 pathways has been recorded on a much faster timescale in the realm 
of minutes (Niopek et al., 2016) suggesting it is not a rapid export pathway mechanism. The 
slower clearing over four hours suggests mechanisms such as degradation or protein 
sequestration.   
 This was followed up with explorations of the reversion kinetics to observe the 
nuclear protein rate of recovery. Nuclear clearing was induced with illumination after which 
cells were switched to dark and fluorescence was tracked using the CRY∆NLS-mCh-tTA 
construct. The recovery was heterogeneous and on a much slower timescale than the clearing 
with a portion of the cells fully recovered by eight hours (Figure III-3F). Cells left overnight 
showed a less heterogeneous fully recovered phenotype (data not shown). This slow recovery 




Figure III-4: A CRY2-fused dimerization domain is required for light-dependent 
nuclear depletion and functional loss of activity. (A) Live cell imaging showing formation 
of CRY2(∆NLS)-mCh-tTA clusters in the nucleus upon initial light exposure, which coalesce 
into larger puncta over the 90 min timecourse. Scale bar, 10 µm. (B) Schematic showing 
constructs used in (D) and (E). CRY-Gal∆DD-VP16 contains Gal4BD residues 1-147 but is 
missing residues 66-95, which are important for dimerization. (C) Functional analysis of 
dimerization domain deleted Gal4BD-VP16AD fusion constructs. Indicated constructs were 
transfected along with a GalUAS-luciferase reporter into HEK293T cells, then incubated in 
dark for 24 hrs before quantification of luciferase activity. While a construct (Gal∆DD) 
containing Gal4 residues 1-147 but with a deletion in the Gal4 DNA binding domain 
dimerization domain (residues 66-95) was not functional, activity could be restored with 
fusion to CRY2, which shows some degree of self-association in dark. Activity is expressed 
as fold over reporter only control. Data represents the average and error (s.d., n=3) for a 
single experiment, and experiments were repeated twice with similar results. (D) Luciferase 
activity of cells expressing indicated constructs exposed to 18 hours dark or blue light pulses. 
Data represents average and error (s.e.m.) from 4 independent experiments. Inset shows the 
ratio of activity in dark to activity in light. **, p-value <.05.  (E) Localization of protein 
fusions in HEK293T cells, assayed by immunohistochemistry using an anti-Gal4BD 
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Dimerization Domain is Required for Nuclear Depletion and Functional Loss 
It has been shown that multivalency of tagged proteins and high concentrations of 
CRY2-tagged proteins can lead to clustering (Bugaj et al., 2013; Lee et al., 2014; Mas et al., 
2000; Ozkan-Dagliyan et al., 2013; Taslimi et al., 2014; Yu et al., 2009). We used live cell 
imaging to track CRY∆NLS-mCh-tTA in response to light, which showed an immediate 
clustering phenotype in the nucleus (Figure III-4A). The clusters coalesce and appear to be 
dynamic over 1.5 hrs of imaging. Both of the transcription factors fused to CRY2 are known 
to dimerize, and Gal4 has a well-characterized dimerization domain between residues 50-94 
(Carey et al., 1989). To determine if this dimerization motif could play a role in the 
clustering and clearing of proteins in the nucleus we synthesized a construct with a deletion 
of amino acids 66-95 (Gal∆DD) in the DNA binding domain of GalVP16 (Figure III-4B). 
Gal∆DD-VP16 has only a minimal dimerization motif (Marmorstein et al., 1992) and cannot 
stimulate transcription on its own (Figure III-4C), demonstrating the dimerization domain’s 
importance in DNA binding. CRY2 fusion to Gal∆DD-VP16 is able to restore a larger 
portion of lost activity (Figure III-4C), likely due to the slight self-association of CRY2 that 
has been seen in dark (Taslimi et al., 2016) mimicking the dimerization domain.  
 When functionally compared with the robust dark activity of CRY-GalVP16, which is 
diminished with light, CRY-Gal∆DD-VP16 showed decreased dark activity with no 
reduction of activity upon light stimulation but rather a small increase (Figure III-4D). We 
hypothesize that the mild increase may be due to clustering of CRY-Gal∆DD-VP16 at the 
promoter region. This opposing functional result suggests the dimerization domain plays an 
important role in the loss of activity seen with the intact transcription factor. Correlating with  
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Figure III-5: Addition of a tetramerizing dsRed domain restores light dependent 
functional loss and nuclear clearing to CRY-Gal∆DD-VP16. (A) Schematic of construct 
used in (B) and (C). (B) Representative HEK293T cells expressing CRY-dsRed-Gal∆DD-
VP16, exposed to 18 hr dark or blue light pulses, and assayed for localization by 
immunohistochemistry using an anti-Gal4BD antibody. (C) Luciferase activity of cells 
expressing CRY-Gal∆DD-VP16 alone or with an added back multivalent domain (CRY-
dsRed-Gal∆DD-VP16) assayed after being exposed to 18 hours dark or blue light pulses. 
Data represents average and error (s.e.m.) for 3 independent experiments. Inset shows the 
ratio of activity in dark to activity in light. ***, p-value <.005. (D) Comparison of effect of 
adding back a tetramerizing dsRed domain versus a monomeric mCherry domain to CRY-
Gal∆DD-VP16. Luciferase assay was carried out as in (C). Data represents average and error 













































































































































































































the opposing functional results, CRY-Gal∆DD-VP16 shows no light dependent clearing in 
nuclear localization with light treatment (Figure III-4E).  
 Further examination was done to show that the dimerization motif was the necessary 
factor for the functional loss and phenotypic changes in the nucleus. An add-back experiment 
was performed by inserting a tetrameric dsRED domain into CRY-Gal∆DD-VP16 (Figure 
III-5A) and testing for functional and phenotypic changes. The add-back of a multimeric  
domain, CRY2-dsRED-Gal∆DD-VP16, was able to restore nuclear clearing  (Figure III-5B) 
and functional loss (Figure III-5C) upon light illumination. Due to the changes in size of the 
protein with the deletion of the dimerization motif we tested an add back of a monomeric 
mCherry domain, which is 29 kDa in comparison to the 28kDa dsRED domain, to prove that 
size was not the causative factor. CRY2-mCh-Gal∆DD-VP16 displayed no light-dependent 
loss of activity, similar to CRY2-Gal∆DD-VP16 (Figure III-5D). Together these data show 
the importance of the dimerization motif in the light dependent nuclear clearing and 
functional loss. 
An Optimized Light-Activated System For Transcriptional Control 
 With the newly realized importance of the dimerization domain in nuclear clearing, in 
conjunction with the clearing of GalBD-CRY2 (Figure III-2A), we redesigned the split 
transcription system (Figure III-1). The Gal4 DNA binding domain (residues 1-147) was 
replaced with a construct with a deletion of the critical portion of the dimerization motif, 
Gal4∆DD (Gal4 residues 1-65) (Figure III-6A). This optimized construct was retained in the 
nucleus after light illumination (Figure III-6A) as shown by immunostaining with anti-Gal4 
antibody. When coexpressed with VP16-CIB1, CRY-Gal(1-65) showed light dependent 
































































































































































































































Figure III-6: Optimization of split CRY2/CIB1 transcriptional system. (A) Schematic 
and immunostaining of new CRY2-BD construct (CRY-Gal(1-65)) assayed in split 
transcriptional system. HEK293T cells expressing CRY2-Gal(1-65) were kept in dark or 
exposed to blue light pulses for 18 hrs, then assayed for immunohistochemistry using an anti-
Gal4BD antibody. (B) Luciferase activity of HEK293T cells expressing indicated constructs 
and a GalUAS-luciferase reporter and exposed to dark or blue light pulses as in (A) for 18 
hours. Data represents average and error (s.d., n=3). Experiments were repeated two times 
with similar results. (C) Comparison of activation domain fusions. HEK293T cells were 
transiently transfected with CRY2-Gal(1-65) and indicated AD-fusion constructs, along with 
a GalUAS-luciferase reporter and tested for activity as in (B). Data represents average and 
error (s.d., n=3). Experiments were repeated three times with similar results. (D) Immunoblot 
of HEK293T cells expressing a GalUAS-GFP-HA reporter with CRY2-Gal(1-65) and CIB1-
VP64 incubated in dark or blue light for 18 hours. (E) Spatial regulation. HEK293T cells 
expressing CRY-Gal(1-65), VP64-CIB1, and a GalUAS-GFP reporter were exposed to 18 h 
patterned blue light, followed by imaging of GFP reporter expression. Scale bar, 1 cm. 
(F) Dose-dependent regulation. HEK293T cells expressing constructs as in (E) were 
illuminated with varying light intensities for 18 hrs, followed by immunoblotting using an 
anti-GFP antibody or anti-tubulin control. (G) Temporal regulation of split transcriptional 
system. HEK293T cells were transfected with CRY-Gal(1-65), VP64-CIB1, a GalUAS-
luciferase reporter, and a RSV-lacZ control. Cells were incubated for 6 hours in dark after 
transfection, followed by 12 hours in light to induce reporter expression. Samples were 
analyzed for luciferase and beta-galactosidase activity at this timepoint (t = 0 hr), maintained 
in light or dark for 6 h (t=6h timepoint), or maintained for 12 additional hours in either of 4 
conditions: 6h light/6h light, 6h light/6h dark, 6h dark/6h light, or 6h dark/6h dark. Light 
samples were exposed to pulsed blue light (2s every 3 min) during treatment. The ‘dark only’ 
control sample indiated in red was maintained in dark after transfection and not exposed to 
light for the duration of the experiment. Data represents results from two independent 
timecourse experiments. For each experiment, luciferase levels measured from each 
timepoint were normalized to the beta-galactosidase levels at that timepoint, and then 
expressed as a percent of the 12 h (6h light/ 6h light) timpoint. Data represents average and 










dynamic range the activation domain construct was also redesigned. The original VP16-CIB1 
construct showed 15.1 fold activation over dark levels, a CIB1-VP16-CIB1 construct 
containing an additional copy of CIB1 at the N-terminus, showed only a modest 2-fold 
increase in dynamic range (27.6 fold activation over dark levels). This double tag of CIB1 
had been shown to be beneficial in the recruitment of a CRY-activation domain construct in 
previous literature (Polstein and Gersbach, 2015). A N-terminal CIB1 fusion (CIB1-VP16) 
achieved 55.5 fold over dark levels but also had higher dark background. Replacing VP16 
with a stronger activation domain, VP64 (CIB1-VP64), provided the highest level of 
activation, 101.8 fold activation over dark levels, with only a small increase in dark 
background over VP16-CIB1 (Figure III-6C). In another method of tracking activation of 
reporter genes a GalUAS-GFP reporter was expressed with CRY-Gal(1-65) and CIB1-VP64 
resulting in no detectable background in dark and light duration dose-dependent induction of 
reporter expression (Figure III-6D).  
 In order to define the spatiotemporal limitations as well as tunability of the optimized 
split transcription tool we carried out additional experiments probing spatial and temporal 
specificity along with varied intensities of light. Using a patterned mask we blocked areas of 
illumination, allowing light to penetrate in a polka-dot pattern on a monolayer of HEK293T 
cells on a 10 cm plate expressing CRY-Gal(1-65) and CIB1-VP64 with a GalUAS-GFP 
reporter resulting in patterned GFP expression where cells had been illuminated (Figure III-
6E). Tunability of expression was probed using the same constructs expressed in cells 
exposed to increasing light intensities before they were harvested and immunoblotted, which 
displayed increasing amounts of reporter expression (Figure III-6F). Temporal regulation 
was tested in conjunction with reversibility by putting HEK293T cells through a series of 
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light/dark incubations and harvesting cells to track activity. Cells expressed CRY-Gal(1-65) 
and CIB1-VP64 with a GalUAS-luciferase reporter in light for 12 hours to initially induce 
reporter activity, then they were exposed to four different treatment regimes with two periods 
within each treatment: dark/dark, dark/light, light/dark, light/light. Each treatment lasted 12 
hours total and timepoints were harvested at 0 hours, 6 hours (post-period 1) and 12 hours 
(post-period 2) (Figure III-6G). Cells incubated in light the total 12 hours showed the highest 
levels of luciferase activity. In comparison cells incubated in 6 hours light then 6 hours dark 
were less transcriptionally active, and cells with a 6 hours dark then 6 hours light-regime 
showed even less activation. The least transcriptionally active were cells incubated in dark 
for 12 hours. These temporal activation patterns suggest that there is a small but detectable 
lag time to turning off the system and turning on the system; however, it also demonstrates 
the ability to tune activation of the system with varying durations of light. With the activation 
kinetics and tunability of this system, it is well suited to regulating genes of interest that are 
altered over a period of hours as the timescale of our system suggests.   
Light-Mediation Transcriptional Reduction  
 It was recognized that the functional loss seen with CRY2 fused to intact transcription 
factors could be harnessed as an optogenetic tool to inducibly decrease transcription with 
light. Optimization of constructs included placing the CRY-GalVP16 system on a stronger 
promoter and appending a longer version of VP16 (VP16l). The dark activity of CRY-
GalVP16l was about 2-fold better than intact Gal4 at activating a GalUAS-luciferase reporter 
and after 24 hours of illumination there was a 37-fold reduction in luciferase activity to 
2.7+/-0.6% of dark levels (Figure III-7A). This correlated with a 10-fold reduction in 
GalUAS-luciferase mRNA with light from dark levels (Figure III-7B). The light dependent  
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Figure III-7: Light-mediated reduction of transcription using optimized CRY-
GalVP16l. (A) Schematic and luciferase activity of optimized CRY-GalVP16l system. 
HEK293T cells were transiently transfected with a GalUAS-luciferase reporter and control 
DNA (reporter only), CRY-GalVP16l, or intact Gal4, grown for 24 hours in dark or pulsed 
blue light, then assayed for luciferase activity. Fold increase in luciferase activity is shown 
compared to reporter controls. Data represents average and error (s.d., n=3). (B) Quantitative 
RT-PCR showing luciferase mRNA levels in cells transfected as in (A) and harvested after 
22 hours. Shown is the average and range from two independent experiments (experiments 
were repeated two additional times with similar results). (C) Experimental strategy for (D) 
(D) Comparison of light inhibition of transcription with use of cycloheximide to halt protein 
synthesis. HEK293T cells were transiently transfected with a GalUAS-luciferase reporter and 
CRY-GalVP16 and incubated in dark for 16 hours, then exposed to 100 µg/ml 
cycloheximide, blue light, or dark for 8 additional hours. Initial (time 0) sample was 
harvested 16 hours after transfection. Graph represents average and error (s.d.) for three 
separate experiments. Samples were normalized relative to the activity at initial time 0 
harvest. (E) Spatial control. HEK293T cells expressing a GalUAS-EGFP reporter and CRY-
GalVP16l show patterned reduction of GFP expression in light. Cells exposed to 18 h 
patterned blue light, followed by imaging of GFP reporter expression. Scale bar, 1 cm. (F) 
Temporal regulation of CRY-GalVP16l. HEK293T cells were transfected with CRY-
GalVP16l, a GalUAS-luciferase reporter, and a RSV-lacZ control. Cells were illuminated for 
18 hours in dark to induce reporter expression. Samples were analyzed for luciferase and 
beta-galactosidase activity at this timepoint (t = 0 hr), maintained in light or dark for 6h (t=6h 
timepoint), or maintainedfor 12 additional hours in either of 4 conditions: 6h light/6h light, 
6h light/6h dark, 6h dark/6h light, or 6h dark/6h dark. Light samples were exposed to pulsed 
blue light (2s pulse every 3 min) during treatment. Data represents results from two 
independent timecourse experiments. For each experiment, luciferase levels measured from 
each timepoint were normalized to the beta-galactasidase levels at that timepoint, then 
expressed as a percent of the max activity (12 h (6h dark/ 6h dark) timpoint. Data represents 
average and error (s.d.). (G) HEK293T cells were transiently transfected with CRY-
GalVP16l and GalUAS-GFP, grown under blue light, and transferred to dark for indicated 
times before harvesting all samples at 24 hours and quantifying GFP reporter levels by 
immunoblotting using anti-GFP and anti-tubulin a antibodies. (H) Graph below shows 
quantification of immunoblot data from two independent experiments (average and error, 








decrease in expression was similar to using cycloheximide to block translation suggesting an 
efficient block with light (Figure III-7C). Spatial control with the optimized CRY-GalVP16l 
construct was tested by delivery of patterned light across a 10 cm plate, which displayed 
robust expression of GalUAS-GFP reporter in dark and undetectable levels where illuminated 
(Figure III-7D). Temporal control was tested with two approaches. First, a similar time series 
as used with the optimized split system was set up with cells expressing the optimized CRY-
GalVP16l with the GalUAS-luciferase reporter (Figure III-7E), and second, cells expressing 
CRY-GalVP16l and GalUAS-GFP reporter were exposed to varying durations of dark to tune 
activation (Figure III-7F). Both experiments resulted in dose dependent activation of 
transcription with varying levels of light exposure. These data suggest the optimized CRY2-
GalVP16l system is both spatially and temporally tunable for activation.  
 Optimization of the tetracycline transcactivator (tTA) transcriptional regulation 
system involved removal of any extraneous domains such as the mCherry fluorescent tag. 
Cells expressing the optimized CRY-tTA with a tetO-luciferase reporter (Figure III-8A) 
showed robust transcription in the dark, and blue light was able to reduce luciferase levels 
44-fold to 2.3% of dark levels (Figure III-8B). Light dependent block of transcription was 
compared to that of using the chemical doxycycline to control the system, and while light 
was unable to reach the same level of depletion (4-fold over background with CRY-tTA + 
light, compared with 2-fold over background with tTA + doxycycline) there was still a 
sizable reduction. This loss of luciferase activity correlated with an 8-fold reduction in 
luciferase mRNA levels with light (Figure III-8C). It was hypothesized that an enhanced 
clustering phenotype may increase the efficiency of the depletion system due to the 
correlation of protein aggregation and loss of function. To test this, CRY2(FL)olig, a mutated  
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Figure III-8: Optimization of CRY-tTA light-mediated reduction system. (A) Schematic 
of optimized CRY-tTA system. (B) Luciferase activity of HEK293T cells transiently 
transfected with a 7xtetO-luciferase reporter and either CRY-tTA, tTA, or control DNA 
(reporter only). Luciferase activity was measured after 24 hr incubation in dark or blue light 
pulses. Doxycycline samples included 0.5 µM doxycycline. Data represents average and 
error (s.d.) from three independent experiments. (C) Quantitative RT-PCR showing the levels 
of luciferase mRNA in HEK293T cells transfected as in (B) and harvested after 22 hr. Data 
represents average and standard deviation from 3 independent assays. (D) CRY2olig-tTA 
shows reduced luciferase reporter activity upon blue light illumination. CRY2olig-tTA was 
transfected along with a tetO-luciferase reporter into HEK293T cells, then incubated in dark 
for 18 hrs in dark or blue light before quantification of luciferase activity. Activity is 
expressed as percent of dark levels. Data represents the average and error (s.d.) for three 
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Figure III-9: Light regulation of endogenous IL1RN transcription using a CRISPR/ 
dCAS9-based approach. HEK293T cells were transfected with CRY-dCas9-VP64 and 
IL1RN or HBG1-targeted gRNAs and exposed to light (1s pulses every 15 s) or dark for 3 
days. Data represents average and range for two independent experiments (3 replicates each). 
Results from the Gersbach Laboratory. 
 
 
Figure III-10: In vivo testing of CRY-GalVP16l in GalUAS-GFP reporter zebrafish 
embryos. (A) Embryos were injected with 20 pg CRY-GalVP16l DNA at the one-cell stage 
and then incubated (after a 3 hr recovery period) in the dark or light (10s pulse every 3 min, 
470 nm, 5 mW/cm2). GFP images of representative embryos were acquired at 12 hpf and 27 
hpf . Controls show images of non-injected embryos at 12 and 27 hpf. (B) Quantification of 
zerafish embryo fluorescence. Embryos treated as described in (A) were imaged then 
quantified for total fluorescence (n=7-9 embryos each condition). Control embryos showed 
significant autofluorescence as indicated. ***, p-value < .005. n.s., not significant. Results 
from the Rossi Laboratory. 
 































































































3 Total % 
24h 
dark 19/22 27/31 31/40 77/93 83 
24h 
light 19/20 30/32 40/43 89/95 94 
non-inj  19/20 30/31 38/40 87/91 96 
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version of CRY2 (E490G) that shows enhanced clustering, was utilized (Taslimi et al., 
2014). When substituted on CRY2-tTA, CRY2(FL)olig-tTA showed similar functional loss, 
to 3.9% of dark levels, which is not significantly different when compared with CRY2-tTA 
(Figure III-8D).  
Utilizing the Light-Dependent Depletion Systems 
Relevant uses of optogenetic tools are key to their success, so we tested the ability for 
light to negatively regulate an endogenous gene promoter by fusing CRY2 to the  
VP16 transcriptional activator. In order to regulate an endogenous genomic loci we used 
dCas9 (a D10A, H840A catalytically inactive Cas9) and CRISPR guide RNA technologies 
(Cheng et al., 2013; Gilbert et al., 2013; Maeder et al., 2013; Perez-Pinera et al., 2013). 
Fusion of CRY2 to dCas9 and activation domain, VP64, generated CRY2-dCas9-VP64 
which was coexpressed with a gRNA targeting human IL1RN promoter in HEK293T cells. 
Theoretically, this construct would activate the IL1RN gene in the dark and upon light 
stimulation the construct is hypothesized to cluster resulting in associated functional loss. 
Similar to our Gal and tTA regulated systems the dark levels of IL1RN mRNA levels were 
robust, but with illumination the mRNA levels were reduced by approximately 4-fold (Figure 
III-9). This suggests that endogenous genes may be targeted using this approach, and also 
this suggests possible improvements to current optogenetic CRISPR regulated systems that 
may have reduced efficiency due to similar nuclear clearing phenomena that we see with our 
intact Gal and tTA system. 
Functional testing was also done in a vertebrate model of zebrafish, Danio rerio, to 
probe the dynamic range of light induced reduction of transcription in another experimental 
model. Embryos were microinjected at the one-cell stage with the CRY-GalVP16l plasmid 
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(20 pg DNA/embryo) then exposed to light or placed in the dark. The GFP expression in 
zebrafish embryos incubated in the light was significantly reduced in comparison with 
embryos that were incubated in the dark, and this difference was visible and quantifiable at 
both 12 hours and 27 hour post-fertilization (Figure III-10). Due to the uneven division of 
injected DNA, a mosaic pattern appears throughout the embryo of GFP expression. There 
was minimal toxicity at the injected dose of 20 pg DNA (Table III-2). It has been observed 
that the full length VP16 activation domain, as with that in CRY-GalVP16l, may have mild 
toxicity (Ogura et al., 2009). The light induced reduction of GFP expression in zebrafish and 
mRNA levels with the CRY2-dCas9-VP64 CRISPR study show the potential for a wide 
range of applications of this CRY2 transcription technology. 
Discussion 
 In this aim we wanted to understand why a split transcription tool that worked 
robustly in yeast was unable to translate to mammalian cells, and we determined that CRY2 
fusion to dimeric transcription factors led to light-induced nuclear clearing of the fusion 
protein rendering it unable to perform its function. Further characterization of the 
dimerization domain of the Gal4 transcription factor showed that removal of the dimerization 
motif retains the protein in the nucleus, but an add back of another multimeric domain can 
rescue the nuclear clearing. This dependence of nuclear clearing on the multimeric state of 
the CRY2 fused proteins led to the development of two novel approaches to regulating 
transcription including activation, with a split transcription factor, and reduction, with an 
intact transcription factor.  
Reconstitution of the split Gal4-VP16 with the CRY2-CIB1 interaction conferred 
light dependent transcriptional regulation, but only after the DNA binding domain 
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dimerization motif had been truncated, rendering it non-functional. Deletion of the 
dimerization domain eliminated the light dependent nuclear clearing of GalBD-CRY2. Due 
to the proper compartmentalization of the protein, light stimulated transcription was robust 
and was optimized with coexpression of a CIB1-VP64 activation domain. We demonstrated 
spatiotemporal control of the system in addition to tunability with duration of light as well as 
intensity of light, and thus with the low background of the system we believe this tool will be 
universally beneficial in many areas of genetic research. 
 Using the nuclear loss of the intact transcription factor, a second approach to regulate 
transcription with light was developed with a single-component transcription factor fused 
CRY2 to confer light dependence. This light dependent reduction of transcription not only 
works with multiple transcription factors fused to CRY2, including Gal4-VP16 and the tet-
transactivator, but it also showed promise in regulating endogenous gene loci by employing 
the CRISPR/dCas9 technology. In addition, the system shows clear light dependent reduction 
of reporter genes in a vertebrate model of zebrafish. This universal pattern suggests this tool 
can be used with a variety of multivalent nuclear proteins. The single component system has 
the advantage of being small, which as discussed in the introduction, means better efficiency 
in viral packing and more ease of use in vivo. While many groups have attempted systems to 
activate transcription with light, this single component system is a novel approach to 
reducing transcription with light. 
 The implications of the nuclear clearing phenotypes may extend to other systems, as 
suggested by our results with CRY-dCas9-VP64, as multiple groups have used CRY2 fusion 
proteins in the nucleus (Chan et al., 2015; Konermann et al., 2013; Nihongaki et al., 2015a; 
Polstein and Gersbach, 2015; Taslimi et al., 2016). Due to the fact that fusion of the DNA 
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binding domain to CIB1, a known transcriptional activator, causes high background, multiple 
groups have sought to fuse CRY2 to the DNA binding domain and seen low dynamic range 
of their tool (Chan et al., 2015; Konermann et al., 2013; Liu et al., 2012). This may be 
explained by our findings and could be due to nuclear clearing of their CRY2 fused protein. 
The knowledge of the effects of multimeric nuclear proteins fused to CRY2 is an example of 
how understanding how the tool works helps to optimize them and further improve other 
tools that may have similar mechanisms. 
It remained unclear whether the clearing phenotype indicates a loss of protein in the 
nucleus or a simply a redistribution of protein to other nuclear compartments. The live cell 
imaging clearly shows clusters initiate in the nucleus and fixed cell imaging shows nuclear 
clearing over several hours; however steady state protein levels are unchanged which 
suggests an overall redistribution of protein within the cell. The following chapter describes 
studies investigating the mechanism by which the protein is being cleared, to develop a better 






CRYPTOCHROME 2 IN THE MAMMALIAN NUCLEUS 
 
Introduction 
 In Chapter III a single component optogenetic transcription tool was described that 
demonstrated a light stimulated nuclear clearing phenotype that was associated with a 
reduction of transcription. It was also shown that this phenomenon was dependent upon a 
dimerization motif in the transcription factor, but the mechanism of clearing was never 
determined. It is important to understand how an optogenetic tool works in order to 
understand implications of the tool in the system it is being used. Thus, the aim of this 
portion of the thesis was to uncover possible mechanisms by which the clearing in the 
nucleus occurs. 
 It was hypothesized that two potential scenarios may be occurring, either individually 
or in conjunction with one another: the first, the nuclear protein was either being shuttled out 
of the nucleus or being degraded in the nucleus after clustering, and the second, the light 
illuminated CRY-transcription factor fusion proteins were clustered in the cytosol and 
beyond the size limit to traffic into the nucleus acting to enhance the nuclear cleared 
phenotype. Multiple approaches were taken to uncover possible mechanisms of action 
including probing for post-translational modifications (PTMs), assaying cellular pathways 
that were speculated to be involved, and tracking the protein via nuclear/cytosolic 
fractionation and live cell imaging with a photoconvertible protein. 
 We started to examine possible mechanisms by trying to characterize where in the 
nucleus the clustered protein localized. Using a straightforward microscopy approach, we 
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looked at potential co-localization with nuclear bodies (NBs). These small compartments in 
the nucleus, known as nuclear bodies, are known for separating nuclear processes. 
Promyelocytic Leukemia (PML) nuclear bodies are similar in size (0.3-1 micron) and 
number (10-30) to the clustered CRY2-mCh-tTA. They are known to have a diverse array of 
proteins that can be found within them at any certain time. PML is one of the few proteins 
that can always be detected in PML nuclear bodies. PML nuclear bodies have been 
implicated in many cellular disorders and have been thought to sequester, modify or degrade 
protein partners (Lallemand-Breitenbach and de Thé, 2010). They are also thought to 
regulate genome stability, DNA repair, control transcription and play a role in viral defense. 
Other nuclear bodies that have similar characteristic to our clusters are paraspeckles, which 
are thought to function in mRNA regulation and RNA editing, and nuclear stress bodies, 
which function in regulation of transcription and splicing under cell stress (Dundr and 
Misteli, 2010). There are many other nuclear bodies that the clusters could co-localize with, 
but the morphological differences in size and number suggest otherwise. PML nuclear body 
co-localization could suggest a potential mechanism for degradation of the transiently 
expressed protein in the nucleus.  
 CRY2 is known to be post-translationally modified in its native plant, Arabidopsis 
thaliana, with phosphorylation sites that determine regulation and function in the plant 
(Shalitin et al., 2002) and thus it could be postulated that PTMs may play a role in 
degradation. In a study looking at the sensitivity of plant purified CRY2 to blue light it was 
discovered that three serines (588, 599, and 605) in the CRY C-terminal Extension (CCE) 
region were phosphorylated upon illumination leading to functional changes (Wang et al., 
2015). While plant biology may be relevant to mammalian cells, that would require 
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homologous kinases and pathways for regulation. No studies to date have addressed 
regulation of CRY2 in mammalian cells through post-translational modifications. 
There are a series of nuclear transport receptors and signals that play a role in protein 
translocation in and out of the nucleus. One of the commonly referred to proteins is the 
chromosome region maintenance 1 (CRM1), also known as exportin 1, which recognizes a 
leucine rich Nuclear Export Signal (NES) and shuttles the protein containing this sequence 
out of the nucleus (Nguyen et al., 2012). A known inhibitor of this pathway, leptomycin B, 
blocks this transport pathway. CRM1 has many exportin family members that are responsible 
for trafficking cargo out of the nucleus through nuclear pore complexes, but most exportins 
have specific cargo that they carry (Kohler and Hurt, 2007). It has also been shown that some 
macromolecules, such as ribonucleoproteins, are excreted from the nucleus through budding 
of the nuclear envelope (Speese and Ashley et al., 2012). These types of protein translocation 
out of the nucleus are possible targets of the nuclear clearing phenotype.  
Materials and Methods 
Constructs 
 Experiments examining translocation from the nucleus used the CRY2(dNLS)-mCh-
tTA construct used in Chapter III due to its distinctive phenotype. For live cell imaging with 
photoswitchable proteins, mCherry was removed from this construct and replaced with an 
mEOS3.2 photoswitchable domain. The fractionation experiments were carried out with 
CRY2-GalVP16 (described in Chapter III) due to its distinct switch to a nuclear cleared 
phenotype and GalDBD epitope for probing by Western Blot. A NLS-containing 
CRY2(+NLS)-mCh-tTA was engineered with an HA tag to make CRY2(+NLS)-HA-mCh-
tTA, which was used for immunoprecipitation followed by mass spectrometry. 
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Site-Directed Mutagenesis 
 Samples were amplified using Phusion enzyme with primers containing the desired 
mutant sequence according to the manufacturer’s protocol. PNK enzyme was added to 
phosphorylate the ends, and a ligation was done with T4 Ligase according to the 
manufacturer’s protocol.   
Cell Culture and Live Cell Imaging 
HeLa, HEK293T, and COS-7 cells were maintained in Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 10% FBS and 1% penicillin-streptomycin at 37o C 
with 5% CO2. Cells were seeded onto a 35mm glass bottom dish (live cell images) or 
coverslips on a 12-well plate (fixed images) and transfected using Lipofectamine 2000 
(Invitrogen) according to the manufacturer’s protocol. Dark samples were wrapped in 
aluminum foil immediately after transfection, and all manipulations carried out using a red 
safelight. Unless otherwise indicated, light-treated cells were illuminated using a custom 
programmable blue LED light source (461 nm) with a 1 s pulse per 1 min interval, 5.8 
mW/cm2. Media in glass bottom dishes was changed to HBS with 1 mM CaCl2 directly 
before imaging. Live cell imaging was performed at 34o C. 
Immunofluorescence Staining 
Cells grown on coverslips were washed with PBS then fixed with 4% 
paraformaldehyde in PBS for 15 min. Coverslips were washed with PBS and 
permeabilized/blocked in 5% Normal Goat Serum (Jackson ImmunoResearch Laboratories) 
and 0.1% Triton® X-100 (Amresco) in PBS for one hour. Cells were incubated at room 
temperature for two hours with anti-PML primary antibody (Santa Cruz Biotechnology, H-
238) in permeabilization buffer. Cells were washed in PBS and incubated with AlexaFluor® 
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488 Goat anti-rabbit IgG (Invitrogen) for one hour. Cells were washed in PBS and mounted 
on slides with FluoromountG® (SouthernBiotech) .  
Microscopy and Image analysis 
Imaging was performed using two systems: 1) An Olympus IX71 microscope 
equipped with a spinning disc scan head (Yokogawa Corporation) with a 60x/NA 1.4 
objective. Excitation illumination was delivered from an AOTF controlled laser launch 
(Andor Technology) and images collected on a 1024 x 1024 pixel EM-CCD camera (iXon; 
Andor Technology). The emission bandpass filters were 525/30 (GFP), and 685/36 
(mCherry). Metamorph software was used for collection of images on this system. For light-
sensitive experiments, cells were protected from ambient light sources by focusing in the 
presence of filtered light (572/28 bandpass filter, Chroma).  2) A Zeiss AxioObserver Z1 
Inverted Spinning Disc microscope with a 63x/NA 1.4 objective and HQ 480/40x and 
HQ565/30x (Chroma) bandpass filters. Excitation illumination was delivered by a 3i 
Ablate!™ Model 3iL13 and image collected using a Yokogawa CSU-X1CU camera. 
Slidebook 6 was used for collection of images on this system. ImageJ 1.45s and Fiji were 
used for image analysis.  
Fractionation 
 After 18 hours of blue light or dark treatment cells were washed with cold PBS and 
then harvested into 1mL of cold PBS and placed in a 1.5mL microcentrifuge tube. An aliquot 
was removed to be used as the “Total” sample. The remainder was spun down at 10,000 rpm 
for 10 s to pellet the cells. The supernatant was removed and the cell pellet was resuspended 
in 9x volume of the cell pellet with homogenization medium (0.25M Sucrose, 5mM MgCl2, 
10mM Tris-HCl pH7.4). This cell suspension was homogenized using a Potter-Elvehjem 
	 102 
homogenizer on ice with 6 strokes and then passed through cheesecloth into a new 1.5mL 
microcentrifuge tube. The tube was then centrifuged at 600g for 10 min. at 4°C. The  top 
supernatant was collected as the “Cytosolic Fraction”. After the remaining supernatant was 
removed the pellet was resuspended in half the volume of the homogenization buffer from 
the preceeding step and centrifuged again at 600g for 10 min. at 4°C, after which the 
supernatant was discarded. The pellet was resuspended in 9 volumes of hypertonic sucrose 
buffer (2.2M Sucrose, 1mM MgCl2, 10mM Tris-HCl pH7.4) and centrifuged at 80,000xg for 
80 min. at 4°C. The sucrose was removed  and the remaining pellet considered the “Nuclear 
Fraction”. The fractions were mixed with an equal volume of 2x Laemmli Buffer and boiled 
for 10 minutes.  
Immunoprecipitation 
 After 3 hour light/dark treatment of a monolayer of HEK293Ts the cells were washed 
twice with PBS and then membranes were lysed in RIPA Buffer (25mM Tris•HCl, pH 7.6, 
150mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS)) 
with inhibitors: 1x Halt Protease, 1mM PMSF in EtOH, 0.2mM Sodium Orthovanadate, 
10mM Sodium Fluoride, and 5mM beta-glycerophosphate. Lysed cells were collected in a 
pre-chilled 1.5mL microcentrifuge tube and incubated on ice for 10 min. DNA was sheered 
with 5-7 passes through a 25-gauge needle. Samples were clarified with a 10 min full speed 
spin at 4°C. Supernatant was tranferred to a new pre-chilled 1.5mL microcentrifuge tube. 
100-500μg whole cell extract was combined with 1-5 µg antibody in final volume of 
500µL. This mixture was incubated at 4°C on a rotator for 1-4 hours. 24µl cold, cleaned 
Protein G Magnetic Beads were added to Antibody/Extract Mixture and incubated for 1hr on 
rotator at 4°C. Beads were pelleted using a magnetic rack, supernatant was removed and 
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discarded, and 500µl Wash Buffer (10mM Tris pH 7.4, 1mM EDTA, 1mM EGTA; pH 8.0, 
150mM NaCl, 1% Triton X-100) was added. This wash step was repeated 4-6 times. All 
Wash Buffer was removed and ~20µl of 2x Reducing Loading Buffer (2.5mL 1M Tris pH 
6.8, 5mL of 100% Glycerol, 2.5mL beta-mercaptoethanol, 1.2g SDS, 500µL H2O, 
bromophenol blue to final conc. of 0.02% (w/v)) was added. Sample was vortexed and kept 
on ice to bring to Mass Spectrometry Lab or frozen and used for Western Blot. 
Immunoblotting 
For total cell preps, cells were washed in 1x PBS, collected, and lysed in 2x Laemmli 
sample buffer with boiling. Proteins were separated by electrophoresis on an SDS-PAGE gel 
and transferred to nitrocellulose membranes, followed by probing with primary antibodies: 
Histone H3 (H0164, Sigma-Aldrich, dilution 1:5000), α-tubulin (926-42213, LI-COR, 
dilution 1:1000), or Gal4DBD (sc-577, Santa Cruz Biotechnology, dilution 1:1000).  
IRDye® secondary antibodies (dilution 1:15,000) and an Odyssey® FC Imager (LI-COR) 
were used to detect and visualize the target protein in the membrane.  
Mass Spectrometry  
The UC Denver Mass Spectrometry and Proteomic Core prepped and ran the 
immunoprecipitated samples with the following protocol. Bead-eluted CRY2-HA-tTA 
samples were loaded onto a 1.5-mm-thick NuPAGE Bis-Tris 4−12% gradient gel 
(Invitrogen). The BenchMark Protein Ladder (Invitrogen) was used as a protein molecular 
mass marker. The electrophoretic run was performed by using Mes SDS running buffer, in an 
X-Cell II mini gel system (Invitrogen) at 200 V, 120 mA, and 25 W per gel for 30 min. The 
gel was stained by using Simply Blue Safe Stain (Invitrogen) stain and destained with water 
according to the manufacturer’s protocol. After excision, gel pieces were destained in 200µL 
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of 25 mM ammonium bicarbonate in 50% vol/vol acetonitrile (ACN) for 15 min and washed 
twice with 200µL of 50% (vol/vol) ACN. Disulfide bonds in proteins were reduced by 
incubation in 10 mM DTT at 60 °C for 30 min, and cysteine residues were alkylated with 20 
mM iodoacetamide in the dark at room temperature for 45 min. Gel pieces were subsequently 
washed with 100µL of distilled water followed by the addition of 100µL of ACN and dried 
by SpeedVac (SavantThermoFisher). 100 ng of trypsin was then added to each sample and 
allowed to rehydrate the gel plugs at 4 °C for 45 min and incubated at 37 °C overnight. The 
tryptic mixtures were acidified with formic acid (FA) to a final concentration of 1%. Peptides 
were extracted two times from the gel plugs by using 1% FA in 50% ACN. The collected 
extractions were pooled with the initial digestion supernatant, and the volume was reduced 
by using SpeedVac. Samples were measured on an LTQ Orbitrap XL mass spectrometer 
(Thermo Fisher Scientific) coupled to an Eksigent nanoLC-2D system through a nano-
electrospray LC−MS interface. Eight microliters of sample was injected into a 10-µL loop by 
using the autosampler. To desalt the sample, material was flushed out of the loop and loaded 
onto a trapping column (ZORBAX 300SB-C18, dimensions 5×0.3mm×5µm) and washed 
with 5% (vol/vol) ACN and 0.1% FA ata flow rate of 10µL/min for 5 min. At this time, the 
trapping column was put online with the nano-pump at a flow rate of 350nL/min. The mobile 
phase included water with 0.1% FA (solvent A) and 99.9% ACN with 0.1% FA (solvent B). 
A 90-min gradientfrom 6% ACN to 40% (vol/vol) ACN was used to separate the peptides. 
Peptides were separated on a house-made 100µm inner diameter ×150 mm fused silica 
capillary packed with JupiterC18resin (Phenomex). Data acquisition was performed by 
usingthe instrument supplied Xcalibur (version 2.0.6) software. The mass spectrometer was 
operated in the positive ion mode; the peptide ion masses were measured in the Orbitrap 
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mass analyzer, whereas the peptide fragmentation was performed by using either higher 
energy collisional dissociation (HCD) or electron transfer dissociation (ETD) in the linear ion 
trap analyzer by using default settings. Ten most intense ions were selected for fragmentation 
in each scan cycle; fragmented masses were excluded from further sequencing for 90 s. 
MS/MS spectra were extracted from raw data files and converted into Mascot generic format 
(MGF) files by using a PAVA script (University of California, San Francisco). These mgf 
files were then independently searched against the Arabidopsis thaliana subset of the 
SwissProt database by using an in-house Mascot server (Version 2.2.06, Matrix Science). 
Mass tolerances were ± 15 ppm for MS peaks, and ± 0.6 Da for MS/MS fragment ions. For 
all HCD spectra, fragment ion tolerances were set to 0.05 Da. Trypsin specificity was used, 
allowing for one missed cleavage. Met oxidation, protein N-terminal acetylation, and peptide 
N-terminal pyroglutamic acid formation were allowed for variable modifications while 
carbamidomethyl of Cys was set as a fixed modification. 
Results 
Inconsistent PML Nuclear Body Colocalization 
Due to the enhanced clustering of CRY2-mCh-tTA in the nucleus with light, we 
examined whether these puncta could be localizing to nuclear bodies. The characteristic size 
and number of puncta formed when clusters are stimulated suggested PML nuclear bodies 
(NBs), which have similar morphology. Cells that showed robust clustering of CRY2-mCh-
tTA were stained with anti-PML antibody and visualized. Results showed that colocalization 
of protein aggregates with PML was inconsistent, with puncta that displayed colocalization 
and others that were localized to distinctly separate regions (Figure IV-1A and B). Since 
PML NBs are known to associate with the nuclear matrix, it is possible that colocalization 
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observed is due to similar localization on the matrix proteins. Because the cells needed to be 
fixed and stained in order to detect PML NBs, the cells were treated with light for 30 minutes 
to stimulate clustering prior to staining. In previous experiments exploring clustering, we 
have had difficulty visualizing the clusters with a fixed-cell imaging approach, and again 
after fixing the cells there were few cells maintained on the coverslip with robust clusters to 
observe potential colocalization. A live-cell approach with a fluorescently tagged nuclear 
body protein may result in more conclusive results. This follow up experiment would allow 
for visualization of enhanced nuclear clustering and the potential to see if the colocalized 
puncta are stable or dynamic in their observed proximity. 
Tracking Light Stimulated Nuclear Clearing  
 Being able to determine the relative quantities of protein in the cytosol versus nucleus 
would allow us to determine if CRY2-mCh-tTA or CRY2-GalVP16 was being degraded in 
the nucleus upon light stimulation or if was being exported into the cytosol. We attempted to 
quantify this phenotypic switch with a nuclear/cytosolic fractionation using multiple 
established protocols. Typical protocols use a series of buffers, spins, and occasional 
homogenization steps to lyse the outer membrane of the cell, collect the nuclei, then lyse the 
nuclei resulting in lysates from the cytosol and nuclear fractions. While multiple protocols 
using this approach successfully fractionated our control proteins (Histone H3, nuclear;  a-
Tubulin, cytosol), highly variable and unexpected results were seen with our protein of 
interest, likely due an insolubility of the protein aggregates seen upon illumination. This led 
us to track our protein throughout the fractionation steps using the mCh tag in CRY2-mCh-




Figure IV-1: Staining of PML with light induced clusters showed inconsistent co-
localization. HEK293T cells expressing CRY2-mCh-tTA were exposed to blue light pulses 
for 30 minutes before they were fixed and stained with PML. (A) A representative cell shows 
inconclusive results for colocalization. A blow up of the composite image shows the nucleus. 
The blue arrow indicated a point where colocalization may by occurring and the white arrows 
show distinctly different localization for PML and CRY2-mCh-tTA. Scale Bar, 10 µM. (B) 
Magnification of two representative nuclei shows further lack of colocalization between 
PML and CRY2-mCh-tTA aggregates. Scale Bar, 10 µM.  
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light the CRY2-transcription factor proteins cluster, and while this is enhanced in the nucleus 
it also occurs in the cytosol. While tracking the CRY2-mCh-tTA during a fractionation, we 
observed that large protein clusters that formed after illumination were spun down with our 
intact nuclei during our nuclear isolation step. These large fluorescent clusters were not part 
of the nuclei and did not appear to be adhered to them. Multiple washes were unable to 
remove these aggregates from our intact nuclear pellet. We used a new approach combining a 
traditional hypotonic salt solution fractionation protocol with a sucrose gradient in an attempt 
to remove these aggregates. While fewer aggregates were found in the nuclear pellet, there 
was no light-dependent loss of CRY2-GalVP16 in the nucleus (Figure IV-2).  The sucrose 
gradient method was able to improve upon the methods previously tested, but there were still 
aggregates in the nuclear pellet. Although we believe the aggregates may be complicating our 
results, it cannot be discounted that the protein may not actually leave the nucleus. Rather it 
may get redistributed to the periphery where it is difficult to detect with microscopy.   
In another approach to track nuclear clearing, a photoconvertible fluorescent protein domain 
was inserted into CRY2-mCh-tTA. mEOS3.2 is a green fluorescent protein that can be 
photoconverted to a red fluorescent protein using a 415nm wavelength pulse (Zhang et al., 
2012). We replaced mCherry with mEOS3.2 (CRY2-mEOS-tTA) to utilize the 
photoconverting properties to tease apart if protein is shuttled out of the nucleus, being 
degraded, or getting sequestered at the nuclear periphery. The un-photoconverted green 
fluorescent population shows similar distribution as CRY2-mCh-tTA but is unchanged 
throughout the entire one hour experiment (Figure IV-3A). Live-cell imaging was performed 
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Figure IV-2: No Light Dependent Protein Reduction Observed in the Nucleus. 
Nuclear/cytosolic fractionation was done on HEK293T cells expressing CRY2-GalVP16 
exposed to 18 hours blue light pulses or kept in the dark. An immunoblot was performed 
with the lysates with anti-Gal4 to probe CRY2-GalVP16 and controls: anti-histone H3 and 
anti-aTubulin. The fractionation controls, anti-histone H3 and anti-aTubulin, cleanly 






























































with blue light pulses to stimulate clearing, and while a nuclear pool was photoconverted, the 
fluorescence decreases over the hour-long experiment (Figure IV-3B). Imaging in the green 
channel suggests this loss of fluorescence is not due to the cell shifting out of focus. More 
frequent imaging hastens the loss of fluorescence suggesting a photobleaching effect during 
imaging rather than degradation.  
 The temporal control of photoconversion is extremely precise, but the spatial control 
needs optimization for subcellular photoconversion. Photoconversion of the nucleus targets a 
small amount of cytosolic protein above and below the targeted area of the nucleus, but cells 
with high concentrations of expressing protein have a global photoconversion. The 
complication remains: a large number of molecules must be photoconverted to have suitable 
resolution, but cells primed for efficient photoconversion are those with the highest 
concentrations, which globally photoconvert upon stimulation. Throughout troubleshooting 
experiments the best spatial control was achieved through a low intensity, high duration laser 
pulse of 415nm wavelength. While more optimization may lead to better results, the loss of  
fluorescence in the nucleus could mean it is being degraded but it could also suggest 
photobleaching of the red channel. 
Post-Translational Modification Effects on Nuclear Clearing 
CRY2 is endogenously found in the nucleus where it is known to undergo 
phosphorylation, ubiquitination, photobody formation, and degradation in plant cells (Zuo et 
al., 2012). While it is not yet understood how all of those interplay, it is thought that 
phosphorylation regulates periodic protein levels in plants. Phosphorylation of mouse CRY2 
at S557 has been shown to play a role in mouse circadian rhythm (Hirano et al., 2014) 
suggesting that there are mammalian kinases that act on CRY2. However, plant and
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Figure IV-3: Photoconvertible mEOS3.2 tracks nuclear pool during light stimulation. 
(A) Un-converted protein is unchanged throughout the 50 minute experiment. The star 
depicts where nucleus was photoconverted with a 415nm laser pulse. Panel 1 is t=0, panel 2 
is t=10min (time of photoconversion), and panel 3 is t=60min. (B) Panels are t= 0, 10, 20, 30 
, 40, and 50 min. time lapse images. Photoconversion occurs at 10 min. Photoconverted pool 
decreases in fluorescence over 50 minutes post-photoconversion. It is unclear whether this is 
due to protein degradation or fluorescent signal loss. Scale Bar, 10 µM.
A
B
10min 50min 0min 
10min 20min 0min 
40min 50min 30min 
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mammalian CRYs have little homology, and thus implications of overexpressing plant CRY2 
in mammalian cells remains unknown. 
In order to investigate modifications that may play a role in nuclear clearing, we 
synthesized a nuclear specific construct containing an HA-tag for immunoprecipitation (IP). 
We used a full length CRY2 with an intact NLS for our photoreceptor (CRY2+NLS-HA-
mCh-tTA). With lysates from HEK293T cells expressing our nuclear protein exposed to 18-
hours light stimulus or kept in dark, we performed an IP-immunoblot and probed for 
ubiquitination. Our input showed ubiquitination but we were unable to detect ubiquitin 
modifications in our IP lanes (data not shown). Since ubiquitin is an unreliable epitope to 
detect on Western Blots, this result was not assumed to be a definitive negative. 
In a more sensitive approach, we used mass spectrometry to detect post-translational 
modifications. HEK293T cells expressing CRY2+NLS-HA-mCh-tTA were exposed to blue 
light or kept in dark, then an IP was performed followed by analysis via mass spectrometry 
through the UC Denver Mass Spectrometry/Proteomics Core. Analysis of the data was done 
to detect differentially regulated modifications with light. PTMs detected in the screen 
include phosphorylation marks at S245 (2% of total fragments detected had modification), 
Y618 (15% of total fragments), T1037 (8% of total fragments) and T1039 (4% of total 
fragments), and ubiquitination marks at K219 (7% of total fragments), K375 (10% of total 
fragments), and K483 (100% of total fragments, only one fragment detected) (Figure IV-4A; 
Table IV-1). The Y618 mark falls on the HA tag and therefore was discarded as a potential 
residue of interest. Acetylation was also screened but no marks were detected. This assay was 
only done once with one sample per treatment. These PTM screen hits are potentially 
regulated marks and need further validation to prove their presence and significance. 
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Figure IV-4: Phosphorylation and ubiquitin marks detected with mass spectrometry. 
(A) Mass spectrometry resulted in hits for phosphorylation (peach) at S245, Y618, T1037 
and T1039, and ubiquitination (green) at K219, K375, and K483. (B) Mutational strategy for 



























Following up on this work, mutations were made to the residues to test the role of 
detected PTMs in nuclear clearing. We designed serine to glutamine, tyrosine to 
phenylalanine, and threonine to asparagine mutations for phospho-mutants and lysine to 
arginine for ubiquitin-mutants (Figure IV-4B). These mutations were built on the DNLS 
(CRY2-mCh-tTA) construct so that the effect on light stimulated clearing could be 
visualized. We expressed these mutants in HEK293T cells and exposed them to light or dark 
conditions for 18 hours and then fixed the cells. Imaging was performed and each mutant 
displayed nuclear clearing phenotypes when exposed to light (Figure IV-5). This does not 
rule out the possibility that multiple residues may need to be mutated in tandem to block the 
clearing phenotype, as they may function together. 
Pharmcological Inhibition Shows Translation is Important for Nuclear Clearing 
There are many mechanisms involved in the regulation of protein levels in the cell 
including rate of translation, proteosomal degradation, and autophagy. To determine which 
mechanisms may play a role in the  regulation of protein in the nucleus we applied an array 
of chemical inhibitors of pathways including cycloheximide to block translation, MG132 to 
block proteosomal degradation, and chloroquine to block autophagy.  In addition we used 
doxycycline to block the transactivator from binding the promoter to determine if the binding 
of the protein to DNA played a role. DMSO was used to dissolve the inhibitors and therefore 
was included as a control. Chemical inhibitors were applied to HEK293T cells expressing 
CRY2-mCh-tTA for 30 minutes before exposure to 8 hours of light stimulation or dark 
incubation. The cells were then fixed and imaged. Cycloheximide was the only inhibitor to 
change the phenotype of the nuclear clearing, resulting in the protein to be retained in the 
nucleus (Figure IV-6A).  While cycloheximide is commonly used in research as a protein 
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Table  IV-1: Percent of Fragments Detected that Showed Post-Translational 
Modifications 
Phophophorylation PTMs Ubiquitination PTMs 
Amino Acid 




Percent of Total 
Fragments 
Detected 
S245 2% K219 7% 
Y618 15% K375 10% 






Figure IV-5: Loss of individual phosphorylation or ubiquitination PTMs are not 
sufficient to block nuclear clearing. Cells expressing CRY2-mCh-tTA with described 
mutation show nuclear clearing after 18 hours (A) Respresentative HEK293 cells for (A) 









Figure IV-6: Cycloheximide blocks light triggered nuclear clearing. (A) HEK293T cells 
treated with protein synthesis blocker, cycloheximide (CHX), and exposed to light or dark 
for 8 hours shows a block of nuclear clearing. (B) This block was not seen with other 
inhibitors such as doxycycline (DOX), chloroquine, MG132 or DMSO control after an 






























synthesis inhibitor, there are off-target effects including DNA damage and activation of cell 
death and stress pathways  that may also be playing a role in blocking the clearing 
phenotype. Therefore, other methods of protein inhibition, such as high doses of antibiotics 
such as rifampicin, could be used to confirm its necessity. Cells treated with doxycycline, 
MG132, chloroquine, and DMSO showed relatively uniform levels of nuclear clearing 
(Figure IV-6B) suggesting a lack of a role for DNA binding, proteosomal degradation, and 
autophagy in the mechanism of nuclear clearing. As with cycloheximide discussed above, 
each pharmacological inhibitor used has considerations that must be taken into account when 
using them. MG132 blocks degradation of ubiquitinated proteins that are tagged for 
proteosomal degradation, but it can also stimulate cell death pathways and has off target 
inhibition of calpains and cathepsins. Chloroquine blocks autophagy as it binds the lysosome 
which opens the possibility that nuclear export can still occur. An early stage autophagy 
inhibitor such as bafilomycin A would be more appropriate as it blocks the autophagosome 
formation, but blocking autophagy can lead to alternate cell death pathway activation when 
the cells are stressed. Due to off target effects, these inhibitors must be precisely controlled 
for in order to extract the relevance of each mechanism they control.  
 Others inhibitors were tested to probe the roles of CRM1 export pathways and 
transcription in the clearing phenotype. A singular test of leptomycin B (CRM1 inhibitor) 
and actinomycin D (transcription inhibitor) showed no difference in nuclear clearing as a 
control after 8 hours of light exposure. In future experiments, tracking a protein known to 
export via the CRM1 exportin pathway while testing the leptomycin B is an important 
control to ensure the inhibitor is functioning as expected. Since many NLS containing 
proteins are exported via this pathway, a result seen with leptomycin B would not rule out 
	 118 
that one of these proteins may shuttle the protein out of the nucleus or play a role in the 
transport as well. Actinomycin D is a globally acting inhibitor of transcription, therefore, a 
result with this inhibitor would suggest that a transcriptional product is involved but does not 
rule out products with a short RNA and protein half-life that may play a role. In future 
experiments running a gel and measuring mRNA output in the cells would demonstrate the 
efficiency of the inhibitor. While repetition of this experiment would be necessary to 
conclude their lack of roles, these data suggest that these pathways are not essential for the 
nuclear clearing phenotype.   
Discussion 
 While we were unable to determine a specific mechanism for the clearing of nuclear 
CRY2-fusion proteins, we discovered that there may be differentially regulated PTMs that 
could be explored for changes in nuclear clearing and also that active translation is necessary 
for the clearing to occur. Understanding the mechanism is necessary for explaining how the 
single component transcription system functions, and that will give insights into how this tool 
can be used in the future. Because as described in the previous chapter CRY2/CIB1 split 
yeast transcription systems work very efficiently, this phenomenon may be specific to 
mammalian cells. Understanding more about the biology behind the mechanism could 
propose ways to make it a more universal system. 
 While the results of this aim raised more questions than they answered, there were 
some very intriguing outcomes of the experiments. Most notably, there may be a translational 
product that affects clearing, but active transcription is not necessary. This suggests there is 
already mRNA ready to be translated upon stimulation that is involved in the mechanism of 
clearing. Following this study with a proteomics approach to determine what proteins are 
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activately translated after blue light illumination may help identify which proteins are 
necessary for the clearing that are upregulated. This conclusion hinges on the cycloheximide 
result, and it is known that cycloheximide can have off-target effect such as DNA damage 
and upregulation of cellular stress pathways. One of the cycloheximide side effects may be 
playing a role in the block of nuclear clearing, and so another inhibitor of protein synthesis 
should be tested to confirm new protein translation is required for CRY2-nuclear protein 
clearing. 
 While we were unable to track the protein with the photoconvertible approach at this 
time using a mEOS3.2 domain, but there are other photoconvertible protein domains that 
may have better expression and spatial resolution. Dendra2 also switches from green to red 
and has been codon optimized for expression in mammalian cells. The spatial precision of 
photoconversion may be enhanced with another photoconvertible protein as well. This would 
give us an accurate way to track translocation across the nuclear membrane.  
 As discussed, the proteomic analysis of post-translational modifications gave us 
starting points for further functional analysis, however the reliability of a singular run with 
one sample per treatment group is not conclusive and more replicates should be done to 
enhance the statistical probablility that these modifications are authentic. There are ways to 
enrich for phorphorylation sites prior to running the mass spectrometry that gives a better 
probability of getting positive identifications. 
 There were many questions raised by these studies and the mechanism of nuclear 
clearing is still unknown.  However, we feel it is important to not only understand how 
optogenetic systems are functioning in the cells but also to appreciate the other effects of 
overexpressing a plant protein in a mammalian cell. It is possible that pathways involving 
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cellular stress are activated when aggregates of the proteins form in the nucleus, and this 
could have negative effects if these tools are being used to determine cellular mechanisms 
that these off target pathways may effect.  





PERSPECIVE, CONCLUSIONS, AND FUTURE DIRECTIONS 
 
Perspective 
 The last ten years exhibited exponential growth in the field of optogenetics, and there 
continue to be improvements made through novel applications of known photoreceptors, the 
characterization of new photoreceptors, and the enhancement of hardware used to regulate 
these systems. Optogenetics earned accolades as a discovery tool across many diverse fields 
such as the Method of the Year in 2010 (Nat. Methods Editorial, 2011) and it was highlighted 
as a breakthrough of the decade in the same year (Science Staff, 2010). Developing new 
soluble optogenetic tools and exploring their mechanisms is important to further the field, but 
also investigating the effects of expressing these engineered plant-based proteins in cell 
culture and in vivo models is important so scientists can better predict how an optogenetic 
tool may behave in their preferred system. The studies described in this Thesis contribute 
novel optogenetic approaches to regulate perosixomal trafficking and control transcriptional 
reduction and activation. Further they begin to probe the effects of illuminating 
cryptochrome 2 (CRY2) fusion proteins in the nucleus, as a start to understanding the 
mechanism of nuclear CRY2 tools. 
Summary of Major Findings 
 The tools developed in this thesis demonstrate novel approaches to regulate protein 
function through modulation of protein localization. The first aim focused on inducibly 
sequestering proteins into peroxisomes in order to isolate them from the cytosol. The second 
aim concentrated on another subcellular compartment, the nucleus, in order to regulate 
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transcription by controlling transcription factor localization. Lastly, the biology behind how 
the plant based photoreceptors respond to illumination in mammalian cells was explored. 
Chapter II- Optical Control of Peroxisomal Trafficking 
 The goal of the first aim was to develop a light dependent peroxisomal trafficking 
system to regulate cytosolic/peroxisomal protein activity and localization. By caging a 
peroxisomal targeting sequence (PTS1) into the Jα-helix of the AsLOV2 domain we were 
able to confer light control to peroxisomal trafficking. Using a yeast two-hybrid assay we 
demonstrated that the light initiated peroxisomal import was due to a light dependent 
interaction of the PTS1 with PEX5 peroxisomal import receptor. As a demonstration GFP 
was tagged with the LOV-PTS1 tag to show the efficiency of peroxisomal trafficking.  
 Optimizations were made to the tag by mutating the AsLOV2 to significantly reduce 
dark activity with a previously characterized I532A mutation; however, this also decreased 
trafficking efficiency by about 50%. Adding a nuclear export signal eliminated the nuclear 
pool, which localized the tagged protein to the cytosol where it could interact with PEX5 and 
be shuttled to the peroxisome. The last optimization made to the system gave more power 
over the amount of protein expressed by putting the GFP-LOV-PTS1 under control of a 
tetracycline-regulated inducible promoter. Being able to turn off transcription allowed for 
more precise quantification of how much protein is trafficked into peroxisomes, which was 
determined to be about 77% of cytosolic protein over 24 hours. This was an improvement 
over the original light inducible construct, which traffics 30-35% of GFP into the peroxisome 
over the same timescale; however new protein synthesis in the cytosol obstructs those 
numbers. Using a constitutively active LOV domain showed only 50% protein trafficked to 
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the peroxisome suggesting that new protein synthesis, as well as possible saturation of the 
trafficking machinery, may be at play. 
 Fusing the tag to other proteins showed that more optimization would be necessary to 
adapt the tag to specific systems. Surprisingly, fusing LOV-PTS1 onto mCherry was 
unsuccessful in initiating light induced peroxisomal trafficking. Using an inducible 
dimerization pair, we hypothesized that we could use our trafficking tag on one half of the 
dimer and a mCherry fluorescent tag on the other half to traffic the pair into the peroxisome. 
While the tag induced peroxisomal trafficking of the fused half, it was unable to traffic the 
dimerized pair into the peroxisome. Literature suggests this was not due to the size of the 
complex when dimerized, as the dimerization tags are relatively small, but it cannot be 
discounted. A last effort was made to fuse a modulator of actin cytoskeleton, the VCA 
domain of N-WASP, to the GFP-LOV-PTS1, but again trafficking was not observed when 
illuminated. While other factors such as VCA binding actin and blocking trafficking may be 
at play, it was also noted that overexpression of VCA-GFP-LOV-PTS1 disrupted the actin 
cytoskeleton and may alter the cellular cytoskeleton in a way that blocks the trafficking 
machinery from properly operating. 
Chapter III- Regulating Transcription with Light 
 The second aim probes the mechanism behind a light induced transcriptional 
regulation system. The first optogenetic system studied in this aim involves a light mediated 
reduction in transcription using a single component cryptochrome 2 (CRY2)-transcription 
factor fusion. Using knowledge gained by investigating this CRY2-transcription factor fusion 
tool, we were able to optimize a second optogenetic system involving a split transcription 
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factor system that is reconstituted with the stimulation of blue light giving precise control 
over turning transcription on. 
 Fusion of CRY2 to a transcription factor initiates clearing of the protein in the 
nucleus upon illumination, and this phenotype is associated with a significant reduction in 
transcription. This clearing occurs upon illumination when CRY2 is fused to tTA and Gal4 
transcription factors with nuclei 60% cleared over four hours. Time lapse imaging shows that 
the clearing starts with a distinct clustering phenotype when illuminated, and these clusters 
coalesce over time before disappearing. This phenomenon is similar to oligomerization seen 
with other CRY2-multimeric protein fusions (Lee et al., 2014). Reversion of the clearing in 
the nucleus is slow and heterogeneous at eight hours, but full reversion is seen at 18 hours. 
Western blot shows that total CRY2 transcription factor fusion protein levels are unchanged 
between dark and light stimulated cells, suggesting that the fusion proteins are not being 
depleted but rather redistributed.   
 Due to the similarities of clustering phenotypes with other CRY2-multimeric protein 
fusions, the dimeric properties of the transcription factors were explored. Gal4 has a well-
characterized dimerization domain that when deleted from the CRY2-Gal4 protein ablates 
the nuclear clearing phenotype after light stimulation and abrogates the functional reduction 
in transcription. The dimerization deletion (AA 66-95) shows the critical function of the 
multimeric properties of the transcription factor fused to CRY2, but to further test this we 
added back a tetrameric dsRED domain and monomeric mCherry domain. The dsRED 
domain was able to restore light dependent functional loss as well as the nuclear clearing 
phenotype, whereas the monomeric mCherry domain was unable to restore the original 
phenotype. The dimerization of the transcription factor is playing a critical role in the 
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clearing process and functional reduction of transcription when fused to CRY2, but what 
occurs to the protein in order to lead to the nuclear loss in phenotype and function is still 
unknown. 
 Originally Gal4-CRY2 and VP16-CIB1 were used to generate a split transcription 
system, which has a robust light dependent induction of transcription in yeast (Kennedy et 
al., 2010; Pathak et al., 2014) but has no significant light dependent effect on transcription in 
mammalian cells. Utilizing the knowledge gained from the previous studies we were able to 
revive the idea of a mammalian split transcription system with the hypothesis that the 
dimerization domain of Gal4 led to the depletion of the CRY-DBD protein from the nucleus. 
Deletion of the Gal4 dimerization domain in a split transcription factor system robustly 
increased the amount of transcription stimulated with blue light and reduced the background 
“dark” transcription occurring in HEK293T cells 
 While the original CRY-Gal(1-147) cleared from the nucleus in 18 hours of light 
illumination, the dimerization deletion CRY-Gal(1-65) was retained in the nucleus over the 
same time span. Both Gal4-CRY2 and CRY2-Gal4 showed no light dependent induction of 
transcription when expressed with VP16-CIB, but illumination of the co-expressed VP16-
CIB1 and CRY-Gal(1-65) resulted in robust transcription. The split transcription system was 
further optimized by altering the activation domain construct demonstrating that orientation 
matters and VP64 was superior to VP16 with a 101x fold activation level over dark when 
expressed with CRY-Gal(1-65) (VP16-CIB < CIB-VP16-CIB < CIB-VP16 < CIB-VP64). 
This optimized split transcription system was expressed in a GalUAS-GFP transgenic 
zebrafish vertebrate model, which showed light dependent GFP expression with no visible 
dark background.  
	 126 
Chapter IV- Cryptochrome 2 in the Mammalian Nucleus 
 The mechanism behind the peroxisomal trafficking LOV-PTS1 tag and split 
transcription factor tools were well understood, but how the nuclear clearing and associated 
functional loss in the single component transcription factor tool occurred was unknown. 
Trying to tease apart the mechanism and learn how cells were responding to the illumination 
of overexpressed clustered proteins in the nucleus gave us many insights into what does not 
occur, and in the end, never solidified exactly what mechanism was at play. 
 Various methods of tracking the protein as it cleared from the nucleus were all 
inconclusive. Nuclear/cytosolic fractionation was unable to cleanly separate the separate 
compartments due to insoluble aggregates complicating the method. An effort to track the 
clearing using a photoconvertible green-to-red protein tag also gave inconclusive results due 
to the photo-instability of the protein along with technical issues with the microscope over 
the extended live cell imaging capture. This has not resolved the difference between protein 
being redistributed within the nucleus versus leaving the nucleus. 
 As rapid degradation in the nucleus seemed most likely and it is known that CRY2 is 
regulated by phosphorylation in Arabidopsis, post-translational marks were assessed through 
western blot and mass spectrometry on an immunoprecipitated predominantly nuclear CRY2-
tTA (CRY2+NLS-HA-mCh-tTA). A pan-ubiquitin antibody was unable to detect 
ubiquitination on the immunoprecipitated protein; however, mass spectrometry results of the 
immunoprecipitated protein detected sites of ubiquitination and phosphorylation. Site-
directed mutagenesis of the modified amino acids on CRY2 was not sufficient to block the 
clearing phenotype. While none of these mutations individually are sufficient to block the 
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phenotype, this does not discount the possibility that these modified residues in tandem or in 
series may play a role and should be further addressed.  
 A series of inhibitors were used to probe specific pathways that were potential 
mechanisms of the light initiated nuclear clearing phenotype. Cycloheximide, an inhibitor of 
translation, blocked the nuclear clearing phenotype in the presence of light. This experiment 
was followed up with an inhibitor of transcription, actinomycin D, which did not block 
clearing. Results of these inhibitor experiments suggest something mechanistically necessary 
is translated upon illumination or protein clustering but the message for translation may 
already be present in the cells. Multiple other inhibitors were tested that had no effect on 
nuclear clearing including doxycycline, MG132, chloroquine, nocodazole and leptomycin B, 
which suggested that DNA binding, proteosomal degradation, autophagy, cell replication, 
and the CRM1 nuclear export pathway were not individually necessary for the clearing 
phenotype.  
Future Directions 
 Optogenetics is a field that is constantly in flux with new tools being introduced at a 
steady rate. To keep tools relevant, they need to be optimized and have broad utility. The 
AsLOV2 domain is a well characterized optogenetic photosensory protein and has many 
LOV family members that are continually being improved upon. The Tucker laboratory is 
working to advance CRY2 tools in multiple ways: testing truncations of CRY2 and its 
interacting partner CIB1, finding mutations that alter the kinetics of CRY2’s lit state and 
reduce dark state interactions, and finding novel utilizations. These innovations to CRY2 
would be able to enhance not only future tools but also previously developed tools. With the 
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development of our new optogenetic systems we demonstrated novel optogenetic approaches 
but also raised new questions.  
 While the mechanism of the inducible peroxisomal trafficking tool seems relatively 
simple, the failed attempts to traffic proteins, other than GFP, into the peroxisome offer 
complications to be explored and optimized. Experimentation on tool size limitations should 
be tested by using a series of small tags such as GFP in a 1x, 2x, 3x, etc. addition until a 
maximum size capability is reached. A tetrameric protein, catalase, which is 240kDa, is 
known to traffic in a folded state to the peroxisome for import (Léon et al., 2006), so while it 
is unlikely that size is the limiting factor, synthetic systems can differ from naturally 
occurring cellular processes.  
Utilization of this peroxisomal trafficking tool will be forefront in the future of this 
novel system. The permanence of the sequestration into peroxisomes is a caveat to using this 
tool, but this permanent removal may have a use for those not looking for a reversible 
system.  This particular tool may prove most useful for laboratories studying peroxisomal 
biogenesis disorders and peroxisomal trafficking. Being able to traffic peroxisomal proteins 
in a local and user defined manner could help uncover the role of various PEX genes in the 
biogenesis of new peroxisomes. 
 The optimized split transcription tool shows improvement over known systems with 
low background, high dynamic range, tunability and spatial precision. The future of this tool 
lies in utilization to regulate genes of interest with spatial and temporal precision without the 
side effects of chemically regulated systems. Since there are many options for genetic 
regulation with optogenetic systems, a full comparison to other systems is still needed.  
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 Perhaps the most important knowledge to come out of the transcription factor tools 
was the role of the dimerization motif in clearing nuclear CRY2 fusion proteins. This 
discovery allowed us to optimize our split transcription system and develop the single 
component system. We think this information will have broader implications on CRY2 
optogenetic tools used in the nucleus. With CRISPR technology revolutionizing research, it 
could be advantageous to revisit optimization of the previously developed CRISPR/dCAS9 
optogenetic systems which showed low levels of activation, which could be due to the 
clearing phenomenon. To support this, we saw that we were able to negatively control a 
CRISPR tool targeting gene loci in cell culture suggesting that these CRISPR constructs may 
be cleared from the nucleus (Figure III-9).  
 The single component system represents a novel approach to negatively regulating 
transcriptional activity with light, but it is unable to fully block transcription. Additional 
optimization may improve this system to allow enhanced light/dark differences and reduced 
background. The technology behind the single component system is truly the future of this 
tool, as the clearing of the protein from the nucleus in order to block nuclear activity may be 
applied to other nuclear effectors, for instance proteins that regulate chromatin structure. We 
believe this technology may be a general-use tool for many nuclear proteins. 
 The nuclear clearing phenomenon raised many questions that are still unanswered, 
and our attempts to probe the mechanism deeper led us to additional questions. With the 
potential implications for this nuclear clearing to be a globally used optogenetic technology, 
it is important that the mechanism be well understood. We have yet to answer how this 
clearing is facilitated and what potential signaling events play a role. It is still unclear where 
the nuclear protein redistributes upon illumination.  
	 130 
 Staining experiments to determine if the clusters formed in the nucleus co-localized 
with any known nuclear bodies showed that they were not conclusively PML bodies, but 
there are multiple other nuclear bodies that could be examined. In addition, PML could be 
knocked-down to inhibit PML nuclear body formation and clusters could be induced to 
confirm if PML nuclear bodies are necessary for aggregates. To look for colocalization of 
other nuclear bodies we could stain for coilin to test if the clusters colocalize with cajal 
bodies, PSP2 to test for paraspeckles localizatin, or HSF1 to determine if they colocalize with 
nuclear stress granules. Knowing where these clusters localize could give insights into the 
mechanism of control. 
 To follow up on previously explored experiments, it would be important to test the 
importance of the post-translationally modified amino acids identified in the mass 
spectrometry screen in tandem and in series with one another. This could be done through the 
same mutagenesis approach, but inserting multiple mutations onto each construct to test 
different combinations. This would further answer our question addressing if the identified 
PTMs may play a role in the clearing.  
To follow up on the cycloheximide result, which showed that inhibition of protein 
synthesis may block nuclear clearing, it would be important to confirm with other protein 
synthesis inhibitors that this is a necessary mechanism and not a side-effect of 
cycloheximide. This experiment has not ruled out the possibility that a protein involved in 
clearing may have a very short half-life since we are imaging at 8 hours post illumination. 
Images at shorter time periods may show partial clearing if a protein with a short half-life is 
involved in the nuclear clearing mechanism.  
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  A proteomics approach should be taken to follow up on the result where 
cycloheximide was able to block the nuclear clearing but actinomycin D was not. This 
suggests that protein synthesis is necessary for the mechanism of clearing. Through a mass 
spectrometry screen of samples exposed to light or dark we can identify proteins that are 
upregulated by light exposure which may give us information on pathways that are activated. 
It is hypothesized that the aggregates formed may induce cell stress pathways, and this 
experiment could help answer that question. 
 A more targeted mass spectrometry approach would be to immunoprecipitate samples 
exposed to light versus dark and follow this with mass spectrometry to identify potential 
binding partners that may affect light/dark responses. These targets would need to be verified 
using immunoprecipitation followed by immunoblotting to rule out false positives. 
Knockdown experiments of binding partners could tease apart which partners play an active 
role in the nuclear clearing process. 
 In conclusion, optogenetics is a dynamic field where tools are constantly being 
developed, and as optogenetic systems become more widespread throughout molecular and 
cellular biology it will be important to understand the mechanisms of each tool being used. 
Furthermore, since optogenetics uses engineered proteins that are often not endogenous to 
the cell, it will be important to probe what potential consequences overexpression of these 
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APPENDIX A 





Cardiac hypertrophy is an independent predictor of adverse outcomes in patients with 
heart failure, and thus represents an attractive target for novel therapeutic intervention.  JQ1, 
a small molecule inhibitor of bromodomain and extraterminal (BET) acetyl-lysine reader 
proteins, was identified in a high throughput screen designed to discover novel small 
molecule regulators of cardiomyocyte hypertrophy.  JQ1 dose-dependently blocked agonist-
dependent hypertrophy of cultured neonatal rat ventricular myocytes (NRVMs) and reversed 
the prototypical gene program associated with pathological cardiac hypertrophy.  JQ1 also 
blocked left ventricular hypertrophy (LVH) and improved cardiac function in adult mice 
subjected to transverse aortic constriction (TAC).  The BET family consists of BRD2, BRD3, 
BRD4 and BRDT.   BRD4 protein expression was increased during cardiac hypertrophy, and 
hypertrophic stimuli promoted recruitment of BRD4 to the transcriptional start site (TSS) of 
the gene encoding atrial natriuretic factor (ANF).  Binding of BRD4 to the ANF TSS was 
associated with increased phosphorylation of local RNA polymerase II.  These findings 
define a novel function for BET proteins as signal-responsive regulators of cardiac 
hypertrophy, and suggest that small molecule inhibitors of these epigenetic reader proteins 
have potential as therapeutics for heart failure.  
3 A portion of this research is published with permission from the Journal of Molecular and 




Approximately 6 million Americans suffer from heart failure, placing an economic 
burden on the United States that is projected to rise to nearly $100 billion annually by 2030 
(Roger et al., 2011). The 5-year mortality rate following first admission for heart failure is 
42.3%, further highlighting an urgent need for novel therapeutic approached (Lloyd-Jones et 
al., 2009).  A hallmark of heart failure is cardiomyocyte hypertrophy.  Cardiac hypertrophy 
has historically been viewed as a compensatory mechanism that normalizes wall stress and 
enhances cardiac performance. However, long-term suppression of left ventricular 
hypertrophy (LVH) is associated with reduced morbidity and mortality in patients with 
cardiovascular disease (Devereux et al., 2004; Gardin JM and Lauer MS, 2004), and thus 
cardiac hypertrophy is now recognized as an attractive target for novel therapeutic 
intervention (Hill and Olson, 2008).  
 Acetylation of lysine residues in core histones within chromatin provides an 
important post-translational mechanism for regulating gene expression, and enzymes that 
govern lysine acetylation have emerged as critical regulators of cardiac hypertrophy.  Genetic 
and pharmacological manipulation of histone deacetylases (HDACs) and histone 
acetyltransferases (HATs) in rodent models of heart failure has revealed several key roles for 
these enzymes as positive and negative regulators of pathological cardiac growth (Bush and 
McKinsey, 2010).  However, it is not known whether acetyl-lysine ‘reader’ proteins, which 
recruit multi-protein complexes to chromatin via bromodomains, function in the control of 
cardiac hypertrophy.  Here, we demonstrate that selective small molecule inhibition of 
bromodomain and extraterminal (BET) family proteins blocks agonist-dependent 
hypertrophy of cultured cardiac myocytes, and is efficacious in a mouse model of pressure 
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overload-induced LVH.  These findings establish a novel role for acetyl-lysine binding 
proteins in the control of pathological cardiac remodeling, and suggest potential for BET 
protein inhibitors for the treatment of heart failure.     
Materials and Methods 
Experimental animals 
Animal experiments were done in accordance with the Institutional Animal Care and Use 
Committee at the University of Colorado Denver. Ten week-old male C57BL6 mice (Jackson 
Laboratories) were used for transverse aortic constriction (TAC). TAC and sham surgeries 
were performed as previously described, using a 27 gauge needle to guide suture 
constriction(Rockman et al., 1991).  JQ1 was delivered via intraperitoneal injection at a 
concentration of 50 mg/kg in a 1:4 DMSO: 10% (2-Hydroxypropyl)-β-cyclodextrin (Sigma 
Aldrich; 389145) vehicle starting one day post TAC surgery.  Treatment groups were weight-
matched prior to start of study. 
Hemodynamic analysis 
Echocardiographic analyses were performed the day the animals were euthanized using a 
Vevo770 System equipped with a 30 mHz frequency mechanical transducer (VisualSonics).  
Hearts were imaged in the two-dimensional parasternal short axis. M-mode images were 
recorded to measure LV wall dimensions and internal diameter at the level of the papillary 
muscles. For analyses, animals were anesthetized using 2% isoflurane and their body 
temperature was maintained at 37°C. For data from all in vivo studies, GraphPad Prism 
software was used to generate graphs and analyze data. One-way ANOVA with Newman-




After hemodynamic recordings, mice were sacrificed by exsanguination and hearts were 
excised and placed in ice-cold saline. RV was dissected from LV by cutting along the septum 
and the outer wall of the LV. A 50 mg biopsy from the LV was flash-frozen in liquid 
nitrogen for subsequent biochemical and gene expression analyses. Tibia was cleaned of 
cartilage and length was measured.   
Cell culture 
Neonatal rat ventricular myocytes (NRVMs) and neonatal rat ventricular fibroblasts 
(NRVFs) were isolated from the hearts of 1-3 day-old Sprague Dawley rats (Charles River), 
as previously described (Long et al., 1991; Palmer et al., 1995). Cell counting and viability 
was assayed using a Vi-Cell Cell Viability Analyzer (Beckman Coulter). Cells were 
incubated overnight on 10-cm plates or 96-well clear-bottom plates (Greiner) coated with 
0.2% gelatin (Sigma; G9391) in DMEM with 10% calf serum, 2mM L-glutamine, and 
penicillin-streptomycin. The following morning, cells were washed with serum-free medium 
and maintained in DMEM supplemented with L-glutamine, penicillin-streptomycin and 
Neutridoma-SP (0.1%; Roche Applied Science), which contains albumin, insulin, transferrin, 
and other defined organic and inorganic compounds. Adult rat ventricular myocytes 
(ARVMs) and adult rat ventricular fibroblasts (ARVFs) were obtained from female SD rats, 
as described previously(Satoh et al., 2000).  ARVMs were plated at a density of 100 to 150 
cells/mm2 on laminin-coated 10-cm plates and maintained in serum-free DMEM 
supplemented with albumin (2 mg/ml), 2,3-butanedione monoxime (1 mg/ml), L-carnitine (2 
mM), creatine (5 mM), penicillin-streptomycin (100 µg/ml), triiodothyronine (1 pM), and  
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taurine (5 mM). In all studies, cells were treated in maintenance media for 48 hrs in the 
absence or presence of agonists. 
Gene expression analysis 
Total RNA was isolated from cells and tissue using TRIzol (Life Technologies; 15596) and 
tissues were homogenized using a Bullet Blender (Next Advance). For analysis of BET 
family member mRNA expression in primary neonatal and adult cardiac myocytes and 
fibroblasts, RNA was prepared from freshly isolated cells prior to culture.  A Verso™ cDNA 
Synthesis Kit (Thermo Scientific) was used to convert 500ng of RNA to cDNA. Quantitative 
PCR was performed using a DyNAmo Flash SYBR Green qPCR Kit (ThermoScientific; F-
415) on a StepOne qPCR Instrument (Applied Biosystems).  Sequences of primers used for 
qPCR are shown in Table A1. Relative expression levels were determined with 2-ΔΔCT 
method after primers were validated through a standard curve of serial dilutions from pooled 
cDNA. One-way ANOVA with Tukey’s post-hoc test (P<0.05) was used to determine 
statistical differences between groups. 
Protein analysis 
Protein lysates were prepared in PBS (pH7.4) containing 0.5% Triton X-100, 300mM 
NaCl and Halt™ Protease Phosphatase Inhibitor cocktail (ThermoScientific; 1861280). 
Tissues were homogenized using a Bullet Blender (Next Advance) and cells were sonicated 
prior to clarification by centrifugation.  Protein concentrations were determined using a BCA 
Protein Assay Kit (ThermoScientific). Proteins were resolved by SDS-PAGE, transferred to 
nitrocellulose membranes and probed with primary antibodies specific for calnexin (Santa 
Cruz Biotechnology; sc-11397), BRD2  (Cell Signaling Technology; #5848), BRD3 (Santa 
Cruz Biotechnology; sc-81202) or BRD4 (Bethyl Laboratories; A301-985A).  Proteins were 
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detected using SuperSignal West Pico Chemiluminescent Substrate (ThermoScientific; 
34080) and a FluorChem HD2 Imager (Alpha Innotech).  
Histological analysis 
Myocyte cross sectional area was quantified using latitudinal mid-sections of the LV treated 
with neuraminidase type V (Sigma) and stained with fluorescein labeled peanut agglutinin 
(10mg/ml; Vector Laboratories).  Images were captured with an AxioVert 200 inverted 
microscope using an AxioCam MRc digital camera, and analyzed with AxioVision Release 
4.8.1 imaging software (Zeiss, Germany). Approximately 100-125 myocytes were analyzed 
and averaged for each animal.  Analysis focused on the epicardium and endocardium, where 
the best cross sections of myocytes were present.  Data was analyzed using GraphPad Prism 
software, with a one-way ANOVA with Newman-Keuls post-hoc test (P<0.05) to determine 
statistical differences between groups. 
For fibrosis analysis, sectioned tissue was rehydrated and collagen was stained using 
picrosirus red dye (Chromaview, Richard-Allen Scientific). All histological analyses were 
carried out in a blinded manner using an Axiovert 200 inverted microscope with a digital 
camera equipped with AxioVision imaging software (Zeiss, Germany). Quantification of 
picrosirius red staining was completed by determining the average stained pixels2 per total 
pixels2 in images of the LV. 
Indirect immunofluorescence 
NRVMs were grown on gelatin-coated glass coverslips and fixed with 3.7% 
paraformaldehyde in PBS.  Cells were permeabilized with NP-40 (0.1%), blocked with 1 % 
BSA Fraction V (Fisher) and stained with antibodies against α-actinin (Sigma) and ANF 
(Phoenix Pharmaceuticals). Coverslips were incubated with fluorescein-conjugated anti-
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mouse and Cy3-conjugated anti-rabbit antibodies (Jackson ImmunoResearch Laboratory) and 
mounted on slides using SlowFade® Gold antifade reagent containing DAPI (Invitrogen). 
Images were captured using a Nikon Eclipse Ti inverted microscope with an Andor 
Technology digital camera and NIS Element software.  
Operetta high content imaging 
Fixed and stained cells on 96-well, clear-bottomed plates (Greiner) were imaged on 
an automated fluorescence microscopy system (Operetta, Perkin Elmer) using a 20X 
objective. Thirty fields were imaged in each well of the 96-well plates. Three channels were 
collected for each field, corresponding to fluorescein (a-actinin), Cy3 (ANF), and DAPI 
(nuclei). Images were analyzed using a custom algorithm in the Harmony high-content 
analysis software package (Perkin Elmer). Briefly, objects were initially defined using the 
nuclear channel, then cytoplasm was segmented using the fluorescein channel. Mean 
fluorescein intensity was calculated for each cell. Cells were selected using threshold values 
for mean fluorescein fluorescence in order to filter out residual fibroblasts or outlying bright 
objects. Perinuclear masks were defined for each valid cell, and total Cy3 fluorescence was 
calculated for each mask. Finally, cell area was calculated for each valid cell based on the 
fluorescein channel. 
Chromatin immunoprecipitation 
NRVMs were processed using the Magnify ChIP kit (Invitrogen).  After 16 hours of 
treatment with PE, cells were trypsinized, washed with PBS and crosslinked with 1% 
formaldehyde in PBS for 10 minutes.  After crosslinking, cells were washed with PBS and 
lysed at a concentration of 1x106 cells per 50µl of buffer. Chromatin was sheared using a 
Bioruptor UCD 200 (high setting, 16 cycles, 30 seconds on and 30 seconds off).  Sheared and 
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cleared chromatin (4x105 cell equivalents) was used for each immunoprecipitation.  
Antibodies recognizing BRD4 (Bethyl, A301-985A) or phospho-Ser-2 of RNA polymerase II 
(Covance, H5) were used for immunoprecipitation.  Normal IgG (Invitrogen) was used as a 
negative control.  The presence of ANF TSS sequence in purified and eluted DNA was 
quantified using DyNAmo Flash SYBR Green qPCR Kit (ThermoScientific) on a StepOne 
qPCR Instrument (Applied Biosystems).  Primer sequences are shown in Table A1.  Results 
were normalized to sheared and purified input DNA. 
Results  
To facilitate discovery of novel therapeutics for heart failure, we developed a high 
throughput assay of cardiomyocyte hypertrophy.  The assay is based on the use of primary 
neonatal rat ventricular myocytes (NRVMs) and a high content imaging platform that enables 
simultaneous quantification of cell size and expression of atrial natriuretic factor (ANF) 
protein as a biomarker of pathological cardiac hypertrophy (Figure A-1A).  Screening of 
small molecule libraries yielded several ‘hit’ compounds, which will be described in detail 
elsewhere.  JQ1, a compound that blocks binding of bromodomain and extraterminal (BET) 
proteins to acetyl-lysine (Filippakopoulos et al., 2010), was identified as a potent inhibitor of 
NRVM hypertrophy.  JQ1 dose-dependently suppressed cardiac hypertrophy mediated by 
phenylephrine (PE), which stimulates the α1-adrenergic receptor, and phorbol-12-myristate-
13-acetate (PMA), which stimulates hypertrophy intracellularly by activating protein kinase 
C (PKC) (Figure A-1B and C). JQ1 was well tolerated by NRVMs; representative images of 
cells exposed to PE and PMA in the absence or presence of JQ1 are shown (Figure A-1D).    
Pathological cardiac hypertrophy is associated with a prototypical gene program that 
includes induction of ANF and brain natriuretic peptide mRNA expression, downregulation  
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Figure A-1: A small molecule BET protein inhibitor blocks cardiac hypertrophy.  (A) A 
high throughput assay of cardiomyocyte hypertrophy based on culture of primary neonatal rat 
ventricular myocytes (NRVMs) on 96-well plates and high content imaging to quantify cell 
size and expression of atrial natriuretic factor (ANF) protein as a biomarker of pathological 
cardiac hypertrophy.  (B, C) A hit compound, JQ1, dose-dependently blocked hypertrophy in 
response to treatment with phenylephrine (PE; 10 µM) or phorbol myristate acetate (PMA; 
50 nM).  (D) Images of ANF and a-actinin staining in NRVMs treated with agonists in the 








of sarcoendoplasmic reticulum calcium ATPase (SERCA2a), and β- and α-myosin heavy 
chain isoform switching.  JQ1 completely blocked induction of this gene program in PE-
treated NRVMs (Figure A-2A-E). 
There are 47 bromodomain-containing proteins, and JQ1 has been shown to 
selectively inhibit binding of BET family bromodomains to acetyl-lysine (Filippakopoulos et 
al., 2010).  Quantitative PCR and immunoblotting was performed to determine whether BET 
family members (BRD2, BRD3, BRD4 and BRDT) are expressed in the heart.  Messenger 
RNA transcripts for BRD2, BRD3 and BRD4 were detected in isolated neonatal and adult rat 
cardiac myocytes and fibroblasts; BRDT mRNA was downregulated in adult cells (Figure A- 
3A).  BRD2, BRD3 and BRD4 protein was present in homogenates from cultured NRVMs, 
and BRD4 protein expression was upregulated following PE treatment (Figure A-3B). 
Given the increased expression of BRD4 in response to a hypertrophic signal, this 
BET family member was chosen for further investigation.  BRD4 has previously been shown 
to recruit the positive transcriptional elongation factor b (P-TEFb) complex to transcriptional 
start sites (TSSs) (Moon et al., 2005).  P-TEFb is a complex containing cyclin-dependent 
kinase 9 (CDK9) and cyclin T, which is able to phosphorylate the carboxy-terminal domain 
(CTD) of RNA polymerase II (RNA pol II) and thereby stimulate transcription elongation.  
P-TEFb and its negative regulators, 7SK RNA and Hexim/CLP-1, have all been shown to 
regulate cardiac hypertrophy (Espinoza-Derout et al., 2007, 2009; Sano and Schneider, 2004; 
Sano et al., 2002).  Using the ANF promoter as a prototype, we tested the hypothesis that 
BRD4 is recruited to target genes and regulates RNA pol II phosphorylation in response to 
hypertrophic stimuli.  Cultured NRVMs were stimulated with PE for 16 hours and harvested 




Figure A-2: JQ1 blocks induction of fetal gene program in phenylephrine treated 
neonatal rat ventricular myocytes. NRVMs were stimulated for 48 hrs with PE in the 
absence or presence of JQ1 and quantitative PCR was performed to assess expression of (A) 
ANF, (B) brain natriuretic peptide (BNP), (C) sarcoendoplasmic reticulum Ca2+ ATPase 2a 
(SERCA2a), (D) β-myosin heavy chain (β-MyHC) and (E) α-myosin heavy chain (α-MyHC).  
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Figure A-3:  BET family member mRNA expression in purified cardiac myocytes and 
fibroblasts.  (A) Quantitative PCR was performed to assess expression of BET family 
members in purified neonatal rat ventricular myocytes (NRVMs), neonatal rat ventricular 
fibroblasts (NRVFs), adult rat ventricular myocytes (ARVMs) and adult rat ventricular 
fibroblasts (ARVFs).  BRDT transcripts were not detected (ND) in adult myocytes or 
fibroblasts.  (B) Immunoblot analysis of BET proteins in NRVMs treated with PE for 48 hrs. 





or phosphorylated RNA pol II (Figure A-4A).  PE treatment led to increased abundance of 
BRD4 at the ANF TSS (Figure A-4B), and this correlated with enhanced phosphorylation of 
the CTD of RNA pol II (Figure A-4C).  Together, these data support the notion that BET 
proteins integrate upstream signals with the transcriptional program for cardiac growth. 
To address the role of BET proteins in cardiac remodeling in vivo, mice were 
subjected to transverse aortic constriction (TAC) and administered JQ1 or vehicle control 
every other day for four weeks.  Consistent with results obtained with cultured cardiac 
myocytes (Figure A-3B), pressure overload stimulated BRD4 protein expression in the LV 
(Figure A-5A). TAC promoted LV systolic dysfunction, which was rescued by JQ1, as 
determined by echocardiographic analysis (Figure A-5B and C).  Echocardiography also 
revealed that JQ1 normalized LV and septal wall thickness in mice subjected to TAC, 
suggesting that the compound reduced cardiac hypertrophy (Figure A-5D and E).  Consistent 
with this, JQ1 normalized LV weight-to-tibia length ratio, myocyte cross-sectional area and 
expression of ANF in the LV (Figure A-5F – I).  JQ1 also blunted pathological LV interstitial 
fibrosis in animals subjected to TAC (Figure A-5J-K). 
Discussion 
The findings of this study define a novel function for BET acetyl-lysine binding 
proteins in the control of cardiac hypertrophy.  We propose a model in which BET proteins 
serve as nodal regulators of the transcriptional program for cardiac hypertrophy.  According 
to this model, pro-hypertrophic stimuli stimulate gene transcription by promoting recruitment 
of BET proteins (e.g., BRD4) to regulatory regions of downstream target genes.  Since BRD4 






A  B         C 
   
Figure A-4:  Chromatin immunoprecipitation of NRVM lysates show BRD4 and 
Phospho-RNA Polymerase II enrichment at ANF transcription start site with PE 
stimulation. (A) Chromatin immunoprecipitation (ChIP) strategy.  (B, C) BRD4 and 
phospho-RNA Pol II association with the ANF transcription start site.  IP with normal IgG 
was used as a negative control.  N = 3 plates of cells per condition (4 pooled plates per N); 












Figure A-5: JQ1 suppresses left ventricular hypertrophy in response to pressure 





Figure A-5: JQ1 suppresses left ventricular hypertrophy in response to pressure 
overload.  (A) Immunoblot analysis of BET proteins in LVs of mice subjected to TAC for 
four weeks using a 25 gauge or 27 gauge needle to establish suture diameter.  Calnexin is a 
loading control. Mice were subjected to TAC or sham surgery and were dosed IP with JQ1 
(50 mg/kg) every other day for four weeks.  (B – E) M-mode echocardiographic images were 
used to quantify ejection fraction, LV posterior wall thickness, and interventricular septum 
thickness.  (F) LV weight-to-tibia length ratios were determined at necropsy.  (G) LV 
sections were stained with fluorescein-conjugated peanut agglutinin to assess myocyte cross-
sectional area. Scale bar = 10µm. (H) Quantification of myocyte cross-sectional area (µm2); 
>100 myocytes were quantified per the indicated number of LVs.  (I) Quantitative PCR 
analysis of ANF mRNA expression.  N = 3 plates of cells per condition; *P<0.05 vs. sham or 
unstimulated controls. (J-K) JQ1 attenuates LV fibrosis.  (J) LV sections were stained with 
picrosirius red dye to reveal deposition of interstitial collagen (red).  Images were captured at 
40X magnification; scale bar = 10 µm  (K) Collagen fraction was quantified.  Four weeks of 




results in CDK9-mediated phosphorylation of RNA pol II and enhanced transcriptional 
elongation (Figure A-6).   
Of the four BET proteins, only BRD2, BRD3 and BRD4 are expressed in adult 
cardiac myocytes.  Increased expression of BRD4 (Figures A-3B and 5A) and recruitment of 
BRD4 to the ANF promoter (Figure A-4B) in response to a hypertrophic signal suggests a 
prominent role for this BET family member in the control of cardiac remodeling.  However, 
the lack of induction of BRD2 and BRD3 expression during cardiac hypertrophy does not 
exclude the possibility that these proteins also control heart muscle growth.  For example, 
BRD2/3 activity, interacting partners or subcellular localization could be affected by 
hypertrophic stimuli.   
Regulation of ANF expression by BRD4 is an example of how BET proteins can 
affect gene expression during cardiac hypertrophy.  However, it should be noted that ANF 
itself does not promote hypertrophy.  We propose that BET proteins are required for 
induction of critical pro-hypertrophic genes.  BET protein-focused ChIP-sequencing should 
lead to the discovery of these target genes and will provide further mechanistic insight into 
the involvement of BET acetyl-lysine binding proteins in the regulation of cardiac growth.    
BET inhibitors are in clinical development for the treatment of cancer and atherosclerosis 
and have shown promise in pre-clinical models of inflammation and HIV latency (Prinjha et 
al., 2012).  Our data suggest novel potential for small molecule BET inhibitors for the 




Figure A-6: Model for the regulation of cardiac hypertrophy. 
